KOL | Erika RM von MutiusComprehensive Pneumology Center Munich (CPC-M), German Center for Lung Research (DZL), Munich, Germany; Dr. v. Haunersches Kinderspital, University Hospital, LMU Munich, ... |
Kol Lebenslauf für Erika RM von Mutius
| Year | |
|---|---|
| 2022 | Comprehensive Pneumology Center Munich (CPC-M), German Center for Lung Research (DZL), Munich, Germany; Dr. v. Haunersches Kinderspital, University Hospital, LMU Munich, Munich, Germany; Institute of Asthma and Allergy Prevention (IAP), Helmholtz Zentrum München, Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH). Institute for Asthma and Allergy Prevention, Helmholtz Centre Munich, 85764 Neuherberg, Germany |
| 2021 | Dr von Hauner Children's Hospital, Ludwig Maximilian University, Munich, Germany |
| 2020 | German Center for Lung Research, CPC-M From the Institute of Asthma and Allergy Prevention, Helmholtz Centre Munich, Munich, and the Asthma and Airway Disease Research Center, University of Arizona, Tucson. |
| 2019 | Dr. von Hauner Children's Hospital, Ludwig-Maximilians-Universität Munich, Munich, Germany. Institute for Asthma and Allergy Prevention, Helmholtz Center Munich, German Research Center for Environmental Health, Neuherberg, Germany Dr von Hauner Children's Hospital, Ludwig Maximilian University German Center for Lung Research (DZL) |
| 2018 | Member of the German Centre for Lung Research, Munich, Germany Direktorin, Institut für Asthma und Allergieprävention Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) Ingolstädter Landstraße 1, 85764 Neuherberg |
| 2017 | Children Hospital and Children Polyclinic in the Dr. von Haunersches Children Hospital, Ludwig-Maximilians-University, Lindwurmstr. 4, 80337 Munich, Germany Comprehensive Pneumology Center Munich (CPC-M), Member of the German Center for Lung Research (DZL) |
Erika RM von Mutius: Einflussstatistik
Bericht ausführen
| Concept | World rank |
|---|---|
| usage preventive measures | #1 |
| exposure muramic | #1 |
| current contact asthma | #1 |
| paper online questionnaires | #1 |
| hypersensitivity infections | #1 |
| atopic sensitization | #1 |
| newonset allergic rhinitis | #1 |
| farm milk | #1 |
| farming allergies | #1 |
| 035 iu sige | #1 |
| farm asthma | #1 |
| logistic models npsr1 | #1 |
| farming nasal samples | #1 |
| pets farm animals | #1 |
| phase isaac programme | #1 |
| male saline solution | #1 |
| diversity consumed types | #1 |
| fever atopic sensitization | #1 |
| protective childhood | #1 |
| allergoprotective capacity | #1 |
| cattle childrens bedrooms | #1 |
| offspring atopic mothers | #1 |
| preventive measures counselling | #1 |
| allergic allergic dermatitis | #1 |
| prenatal farm | #1 |
| lumbricoides farmers children | #1 |
| work overload followup | #1 |
| diversity microbial exposure | #1 |
| exposure farm | #1 |
| edta tubes countries | #1 |
| 1120 german schoolchildren | #1 |
| transmaternal asthma protection | #1 |
| asthma turkish children | #1 |
| functionality network differences | #1 |
| contact farm | #1 |
| current asthma soot | #1 |
| studies microbial exposures | #1 |
| stimulation 45yearold children | #1 |
| prediction quality snps | #1 |
| linens child dust | #1 |
| followup solar iii | #1 |
| estonia environmental differences | #1 |
| protective effects exposure | #1 |
| foxp3 cd4cd25hi | #1 |
| methods 2nd followup | #1 |
| egg aor | #1 |
| patients treg cells | #1 |
| hypopharynx moraxella | #1 |
| lower prevalence asthma | #1 |
| age bacterial endotoxin | #1 |
| allergic rhinitis jia | #1 |
| hrqol protective | #1 |
| visible mold homes | #1 |
| moisture damage kitchen | #1 |
| clinical examinations challenges | #1 |
| living area risk | #1 |
| health influential factors | #1 |
| children leipzig | #1 |
| cbmcs ormdl3 | #1 |
| wheeze environmental determinants | #1 |
| grass pollen 95 | #1 |
| germany prevalence differences | #1 |
| participants solar | #1 |
| wheezing fever | #1 |
| atopy rural subjects | #1 |
| west germany overweight | #1 |
| ml1 cohort studies | #1 |
| bifidobacterium breastfed infants | #1 |
| fever blood samples | #1 |
| maternal farming activities | #1 |
| atopic disease bias | #1 |
| farm animals childhood | #1 |
| exposure protective | #1 |
| higher hscrp values | #1 |
| aetiology atopic disease | #1 |
| epidemiologic phenotype | #1 |
| development preschool wheezing | #1 |
| agreement association | #1 |
| domestic cats child | #1 |
| maternal atopy tregs | #1 |
| solar iii | #1 |
| development childhood asthma | #1 |
| airborne moulds actinomycetes | #1 |
| pet contact infancy | #1 |
| farm exposure asthmatics | #1 |
| wheeze farming exposure | #1 |
| multicenter cohort prevalence | #1 |
| association farm contact | #1 |
| physiciandiagnosed asthma groups | #1 |
| jobs potential confounders | #1 |
| increased food diversity | #1 |
| cord blood offspring | #1 |
| phenotypes atopic sensitization | #1 |
| antiasthma drugs children | #1 |
| kitchen living area | #1 |
| gabriel advanced study | #1 |
| ppg lpa ppg | #1 |
| immunity innate infant | #1 |
| health services exposure | #1 |
| children amish farms | #1 |
| asthma symptoms community | #1 |
| asthma bacterial diversity | #1 |
| jia domestic arthritis | #1 |
| maternal farm exposure | #1 |
| age dust microbiota | #1 |
| muramic acid concentration | #1 |
| 911 yrs | #1 |
| atopic smokers baseline | #1 |
| asthma protective | #1 |
| agents reduced risk | #1 |
| network construction comparison | #1 |
| study parsifal | #1 |
| childrens bedrooms cowsheds | #1 |
| infancy jia | #1 |
| wheeze asthma questions | #1 |
| 18 months protective | #1 |
| spts agreement | #1 |
| 26 farms bavaria | #1 |
| unprocessed cows milk | #1 |
| il13cd4 cells ilcs | #1 |
| association ilt4 | #1 |
| igg1 galactosylation predictor | #1 |
| asthma rora | #1 |
| cough soot | #1 |
| indoor microbiota development | #1 |
| hyperreactive children | #1 |
| prenatal animal contact | #1 |
| polysaccharides cde | #1 |
| dairy products protective | #1 |
| stepwise protocol bhr | #1 |
| wheeze active smoking | #1 |
| age increased diversity | #1 |
| gene expression ilt4 | #1 |
| aetiology early years | #1 |
| late introduction solids | #1 |
| childhood asthma age | #1 |
| association farm milk | #1 |
| asthma risk pasture | #1 |
| microbes epigenetic mechanisms | #1 |
| allergies year | #1 |
| children unification | #1 |
| association haplotype studies | #1 |
| exposure farm children | #1 |
| pierced ears asthma | #1 |
| protective 6 years | #1 |
| questionnaires childhood | #1 |
| shop milk | #1 |
| spink5 kazal type | #1 |
| incident wheezing | #1 |
| stepwise protocol phase | #1 |
| mite sensitization aor | #1 |
| “hygiene hypothesis | #1 |
| atopic sensitization early | #1 |
| 7 yrs determinants | #1 |
| preschool children predictor | #1 |
| farm exposure exposure | #1 |
| soot benzene | #1 |
| 420lys | #1 |
| 95 late introduction | #1 |
| allergies viral infections | #1 |
| leur relation | #1 |
| dgge health outcomes | #1 |
| model hyperreactivity | #1 |
| wheezing children wheezing | #1 |
| sige spt | #1 |
| countries pasture study | #1 |
| role th2 immunity | #1 |
| benzene current wheeze | #1 |
| cowshed dust cde | #1 |
| childhood bronchial hyperreactivity | #1 |
| child environmental pollutants | #1 |
| risk hutterite children | #1 |
| 95 nonatopic asthma | #1 |
| asthma asthma bacteria | #1 |
| hlx1 polymorphisms | #1 |
| 1 year occurrence | #1 |
| rs11079788 | #1 |
| farm living symptoms | #1 |
| amish hutterite | #1 |
| factor school behavior | #1 |
| children diabimmune study | #1 |
| stable dust extract | #1 |
| dust parameters development | #1 |
| animal contact infancy | #1 |
| association spink5 420lys | #1 |
| lpastimulation carriers | #1 |
| protection hygiene hypothesis | #1 |
| environmental allergens variety | #1 |
| interquartile range asthma | #1 |
| anthroposophic lifestyle features | #1 |
| overweight munich | #1 |
| asthma bronchial response | #1 |
| cowsheds childrens bedrooms | #1 |
| 3785 adolescents | #1 |
| pcr sscp method | #1 |
| atopy interactions | #1 |
| psychosocial characteristics asthma | #1 |
| immunity newborn mothers | #1 |
| agriculture asthma | #1 |
| gsdma expression secretion | #1 |
| males pierced ears | #1 |
| girls mechanism | #1 |
| factors th1 | #1 |
| mrna expression tregs | #1 |
| wheezing 3rd year | #1 |
| perinatal influences | #1 |
| coexpression igg1 | #1 |
| ige seasonal allergens | #1 |
| childhood asthma allergies | #1 |
| farming environments | #1 |
| cowsheds peak | #1 |
| children severe atopy | #1 |
| spts specific ige | #1 |
| microbiome data package | #1 |
| aor farm exposures | #1 |
| relation late introduction | #1 |
| wheeze sensitisation | #1 |
| lower atopic sensitization | #1 |
| asthma food sensitization | #1 |
| farm cowsheds | #1 |
| allergies early phenotypes | #1 |
| moderate‐to‐adequate | #1 |
| asthma aor | #1 |
| demethylation foxp3 demethylation | #1 |
| gpra gene | #1 |
| allergies topic surveys | #1 |
| neonatal mice ahr | #1 |
| transient wheeze asthma | #1 |
| model bronchial hyperreactivity | #1 |
| feeding overweight | #1 |
| 95 endotoxin exposure | #1 |
| cd4cd25hi tcells | #1 |
| school university life | #1 |
| prognosis early wheeze | #1 |
| questionnaire responses asthma | #1 |
| loft farm milk | #1 |
| asthma wisc | #1 |
| asthma risk lca | #1 |
| participation rates phase | #1 |
| allergyprotective potential | #1 |
| atopic diseases association | #1 |
| tbx21 | #1 |
| genetic interaction npsr1 | #1 |
| study prehireonset | #1 |
| th2 th1 gsdma | #1 |
| prehireonset odds ratio | #1 |
| seasonal allergens | #1 |
| 1120 children | #1 |
| gene expression ilt3 | #1 |
| traditional farms | #1 |
| kazal type spink5 | #1 |
| asthmatic children result | #1 |
| endotoxin exposure association | #1 |
| 18 95 incidence | #1 |
| 9 10yold children | #1 |
| children atopic sensitization | #1 |
| leipzig munich | #1 |
| asthma concomitant asthma | #1 |
| associations pet contact | #1 |
| farm lifestyles | #1 |
| netcomi functionality | #1 |
| skin tests spt | #1 |
| maturation gut microbiome | #1 |
| 12 months crowding | #1 |
| common inhalants | #1 |
| rora susceptibility gene | #1 |
| persistence adolescence | #1 |
| farm animals cats | #1 |
| solar 2nd followup | #1 |
| farmrelated exposures | #1 |
| followup solar | #1 |
| bmi allergic dermatitis | #1 |
| breastfeeding length | #1 |
| initial cohort pattern | #1 |
| farm exposure asthma | #1 |
| farm environments asthma | #1 |
| preschool wheezing aor | #1 |
| west germany allergic | #1 |
| 1314 newborn infants | #1 |
| phase international | #1 |
| aa immunity receptors | #1 |
| fever farm | #1 |
| foxp3 demethylation tregs | #1 |
| development atopic sensitisation | #1 |
| farming environment protective | #1 |
| infants karelia | #1 |
| lca pasture | #1 |
| selection bias responders | #1 |
| crobiome data | #1 |
| protection childhood asthma | #1 |
| employment new onset | #1 |
| wheezing w12 | #1 |
| damage systemic inflammation | #1 |
| isolated cd4cd25hi tregs | #1 |
| association atopic sensitization | #1 |
| allergic rhinitis predictor | #1 |
| rs11071559 | #1 |
| yogurt diversity | #1 |
| crude measure exposure | #1 |
| study rural environment | #1 |
| copd sod3 | #1 |
| study questionnaire responses | #1 |
| tbx21 hlx1 | #1 |
| farm milk asthma | #1 |
| farming environments asthma | #1 |
| children predominant hyperreactivity | #1 |
| class pasture | #1 |
| exposure farming environment | #1 |
| asthma farm children | #1 |
| accuracy regression approach | #1 |
| stepwise procedure risk | #1 |
| ema protective farm | #1 |
| il4ra association | #1 |
| amish environment | #1 |
| dampness childhood | #1 |
| mattress dust association | #1 |
| cutoff 3 mm | #1 |
| throat microbiota | #1 |
| regular farm animal | #1 |
| maternal atopy secretion | #1 |
| farming protective farm | #1 |
| source arabinogalactan | #1 |
| childhood gondii seropositivity | #1 |
| unremitting wheeze | #1 |
| computing microbial associations | #1 |
| snps wheeze | #1 |
| asthmatics hc | #1 |
| animal farms substances | #1 |
| cowsheds cattle | #1 |
| stepwise procedure gene | #1 |
| lpastimulation cord blood | #1 |
| infant design | #1 |
| single microbial markers | #1 |
| changing gender ratio | #1 |
| 17q21 locus method | #1 |
| wheeze farm living | #1 |
| infant genetic polymorphism | #1 |
| 812 children | #1 |
| farming environment development | #1 |
| gpra polymorphisms asthma | #1 |
| cd4cd25hi isolated cells | #1 |
| tcells foxp3 | #1 |
| environments asthma | #1 |
| early development wheeze | #1 |
| rural children w12 | #1 |
| adolescents jobs | #1 |
| protective farming | #1 |
| asthma interactions | #1 |
| amish hutterite children | #1 |
| symptoms school age | #1 |
| diagnosed fever 95 | #1 |
| infant inflammation crp | #1 |
| atopic dermatitis jobs | #1 |
| rora asthma susceptibility | #1 |
| asthma genetic effects | #1 |
| farm protects | #1 |
| hlx1 snps cbmcs | #1 |
| allergies cohort studies | #1 |
| 95 atopic sensitization | #1 |
| regulatory triggering receptor | #1 |
| farm living | #1 |
| richness asthma | #1 |
| increased expression ormdl3 | #1 |
| gsdma expression | #1 |
| 30 amish | #1 |
| subtypes atopic dermatitis | #1 |
| fever atopic dermatitis | #1 |
| heattreated milk samples | #1 |
| rhinoconjunctivitis participation | #1 |
| tubes rnastabilizing solution | #1 |
| male parents receptors | #1 |
| data netcomi | #1 |
| dermatitis depending | #1 |
| predictive models incidence | #1 |
| selfreported nickel allergy | #1 |
| mrna expression year | #1 |
| ormdl3 gsdma expression | #1 |
| south bavarian population | #1 |
| diversity protective effects | #1 |
| rnastabilizing solution | #1 |
| children indoor mould | #1 |
| allergy‐protective effects | #1 |
| analyses isaac phase | #1 |
| endotoxin levels samples | #1 |
| ahr acinetobacter lwoffii | #1 |
| kitchen visible mold | #1 |
| coupled receptor polymorphisms | #1 |
| potential confounders jobs | #1 |
| animal sheds barns | #1 |
| development allergic illnesses | #1 |
| cleanliness dust parameters | #1 |
| asthma 105 years | #1 |
| dzl | #1 |
| gasdermin gsdma | #1 |
| associations maternal sensitization | #1 |
| new microscope | #1 |
| environmental factors sensitization | #1 |
| mold immune responsiveness | #1 |
| farm rural children | #1 |
| analyses provocation time | #1 |
| hc aa | #1 |
| life maternal atopy | #1 |
| repeated infections life | #1 |
| npsr1 messenger receptors | #1 |
| higher specificity asthma | #1 |
| grass arabinogalactan | #1 |
| rs7164773 | #1 |
| anthropometric data overweight | #1 |
| groups rural areas | #1 |
| harmful workplace exposure | #1 |
| protective farm asthma | #1 |
| farm dwellings homes | #1 |
| igg nglycosylation populations | #1 |
| farm indoor | #1 |
| reduced risk allergy | #1 |
| positive sensitization | #1 |
| atopic dermatitis onset | #1 |
| determinants airway responsiveness | #1 |
| 28 dust samples | #1 |
| classical definitions lca | #1 |
| tregs age | #1 |
| cε germline transcript | #1 |
| helminths protective | #1 |
| farm nonfarm children | #1 |
| dgge asthma | #1 |
| incident wheezing women | #1 |
| “atopic march | #1 |
| prevent allergic diseases | #1 |
| farm environments farms | #1 |
| grass arabinogalactan mice | #1 |
| asthma symptoms adolescence | #1 |
| interaction rora | #1 |
| mold problems kitchen | #1 |
| children rural allergy | #1 |
| netcomi network | #1 |
| introduction yogurt | #1 |
| asthma dresden | #1 |
| kitchen moisture damage | #1 |
| feeding cattle cowsheds | #1 |
| current wheeze benzene | #1 |
| nickel allergy asthma | #1 |
| bronchial hyperreactivity adolescence | #1 |
| atopic embryonic | #1 |
| asthma diversity | #1 |
| farm lung function | #1 |
| life protective | #1 |
| children alliance asthma | #1 |
| fever milk consumption | #1 |
| predictor igg1 galactosylation | #1 |
| environmental exposures protection | #1 |
| children 7 yrs | #1 |
| endotoxin levels stables | #1 |
| polymorphisms tbx21 | #1 |
| anti‐asthmatic drugs | #1 |
| farmers anthroposophic families | #1 |
| airborne fungi actinomycetes | #1 |
| 13 microbial influences | #1 |
| microorganisms animal sheds | #1 |
| transient wheeze age | #1 |
| lps recognition development | #1 |
| w12 ddhay fever | #1 |
| atopic sensitization birth | #1 |
| patients neutrophil inflammation | #1 |
| hyperreactivity expiratory volume | #1 |
| hlx1 polymorphisms influence | #1 |
| tregs cd4cd25hi | #1 |
| mold problems children | #1 |
| 5 years predictor | #1 |
| unpasteurized cows milk | #1 |
| protective effects diversity | #1 |
| farm milk exposure | #1 |
| polymorphisms lps recognition | #1 |
| 115 iu | #1 |
| asthma austria allergic | #1 |
| bronchial hyperreactivity age | #1 |
| asthmatic farm children | #1 |
| atopy microbial influences | #1 |
| infant contact animals | #1 |
| asthma consumption | #1 |
| cleanliness matter | #1 |
| aor interquartile range | #1 |
| asthma allergies | #1 |
| gene expression ormdl3 | #1 |
| pollen dairy farms | #1 |
| clec4e aa | #1 |
| anthroposophic families validity | #1 |
| wheezing atopic sensitization | #1 |
| increased prevalence cough | #1 |
| treatment childhood asthma | #1 |
| sod3 sod3 snps | #1 |
| asthma atopic disease | #1 |
| children early phenotypes | #1 |
| cumulative incidence finland | #1 |
| 15ans | #1 |
| atopic dermatitis increase | #1 |
| personal cleanliness | #1 |
| network construction netcomi | #1 |
| otitis fever | #1 |
| farm milk consumption | #1 |
| allergen exposure associations | #1 |
| allergic germany | #1 |
| lpastimulation | #1 |
| lca feeding patterns | #1 |
| wheeze classes | #1 |
| mold subclinical inflammation | #1 |
| 57 911yearold children | #1 |
| dermatitis symptoms | #1 |
| regular farm | #1 |
| hygiene hypothesis endotoxin | #1 |
| tnc npsr1 | #1 |
| food items year | #1 |
| carriers hlx1 | #1 |
| lukas2 birth cohorts | #1 |
| solids relation | #1 |
| farm children bavaria | #1 |
| solar cohort | #1 |
| crohns disease atopy | #1 |
| countries isaac phase | #1 |
| adolescent aging asthma | #1 |
| bacterial exposures | #1 |
| ilcs administration | #1 |
| bamse npsr1 | #1 |
| mice atopic sensitization | #1 |
| infections hygiene hypothesis | #1 |
| immune responses birth | #1 |
| personal cleanliness risk | #1 |
| work overload work | #1 |
| bacterial signals atopy | #1 |
| atopy farm | #1 |
| east germany allergic | #1 |
| 624 children | #1 |
| atopic dermatitis farm | #1 |
| children preschool conjunctivitis | #1 |
| occurrence generations | #1 |
| ormdl3 gasdermin | #1 |
| protective mechanisms asthma | #1 |
| late introduction egg | #1 |
| sensitised children wheeze | #1 |
| farms wheeze | #1 |
| farm studies | #1 |
| antipyretics increased risk | #1 |
| associations indoor mould | #1 |
| germany allergic | #1 |
| lower atopy asthma | #1 |
| food sensitization egg | #1 |
| exposures pieces | #1 |
| peak airborne moulds | #1 |
| transcription factors hlx1 | #1 |
| protective effects asthma | #1 |
| atopic sensitization development | #1 |
| children farm children | #1 |
| complementary food year | #1 |
| pollen concentration feeding | #1 |
| school children germany | #1 |
| microbial exposure endotoxin | #1 |
| 17q21 polymorphisms ormdl3 | #1 |
| environmental exposure age | #1 |
| symptoms gender ratio | #1 |
| germany dresden | #1 |
| followup solar cohort | #1 |
| girls late onset | #1 |
| endotoxin allergy | #1 |
| allergies | #1 |
| tempo method | #1 |
| asthma toll | #1 |
| food allergy yogurt | #1 |
| 6 types cheese | #1 |
| asthma rhinoconjunctivitis eczema | #1 |
| microbial exposure asthma | #1 |
| tobit regression ranks | #1 |
| animal sheds 28 | #1 |
| associations airwayrelated symptoms | #1 |
| excessive sige production | #1 |
| wheeze farmers children | #1 |
| 035 iu specificity | #1 |
| tnc risk gene | #1 |
| expression 17q21 | #1 |
| allergy symptoms childhood | #1 |
| unprocessed cow | #1 |
| swinesheds | #1 |
| environmental exposures asthma | #1 |
| farm fever | #1 |
| newborn leukocytes surveys | #1 |
| coding region il4ra | #1 |
| 95 allergen | #1 |
| netcomi | #1 |
| regression approach order | #1 |
| overweight marked differences | #1 |
| wheezing invertedu shape | #1 |
| pasture study spt | #1 |
| association occupational disinfectants | #1 |
| otus farming | #1 |
| innate immunity receptors | #1 |
| ilcs neonatal mice | #1 |
| barns samples | #1 |
| supplementation milk cla | #1 |
| pierced ears association | #1 |
| allergy cohort methods | #1 |
| asthmatics asthma phenotypes | #1 |
| respiratory symptoms childhood | #1 |
| phytohemagglutinin ormdl3 | #1 |
| farming exposure childhood | #1 |
| 168fold | #1 |
| infancy case status | #1 |
| maternal farm | #1 |
| ige levels exposure | #1 |
| predictor immune activation | #1 |
| protection yogurt | #1 |
| treg marker genes | #1 |
| allergies generations | #1 |
| igg1 galactosylation levels | #1 |
| increased atp2a3 fpr2 | #1 |
| unbalanced meat consumption | #1 |
| 95 asthmatic children | #1 |
| indicators total quantity | #1 |
| wheezing male respiratory | #1 |
| methods solar cohort | #1 |
| normal censored | #1 |
| epidemiologic phenotypes | #1 |
| farm animals asthma | #1 |
| immune activation populations | #1 |
| allergies existing cohort | #1 |
| alpine farms | #1 |
| parents allergies | #1 |
| feeding patterns risk | #1 |
| 17q21 risk | #1 |
| overweight dresden | #1 |
| ilt4 cb | #1 |
| microbial exposure patterns | #1 |
| associations dna fingerprinting | #1 |
| respiratory sounds immunity | #1 |
| heating children | #1 |
| protective cheese consumption | #1 |
| allergic rhinitis menarche | #1 |
| work overload school | #1 |
| immune receptors birth | #1 |
| gabriel advanced surveys | #1 |
| 1 ppg stimulation | #1 |
| 5 years aor | #1 |
| farm fungi humans | #1 |
| positive sensitization egg | #1 |
| subsample predominant obstruction | #1 |
| children farmers | #1 |
| secretion life | #1 |
| predominant hyperreactivity subsample | #1 |
| pasture lukas2 | #1 |
| milkassociated cla | #1 |
| 12 months doctor | #1 |
| psychosocial characteristics children | #1 |
| incident wheezing association | #1 |
| food diversity year | #1 |
| genetic association tnc | #1 |
| score total quantity | #1 |
| sige cutoff | #1 |
| spink5 420lys | #1 |
| childhood protective | #1 |
| fpr2 clec4e | #1 |
| package functionality | #1 |
| specific exposures cows | #1 |
| allergic diseases cutoff | #1 |
| allergies endotoxin | #1 |
| ilcs inception | #1 |
| adolescence bronchial hyperreactivity | #1 |
| occurrence allergy | #1 |
| life fungi humans | #1 |
| city air pollution | #1 |
| phenotypes lca | #1 |
| children automobiles child | #1 |
| life chronic asthma | #1 |
| provocation time bhr | #1 |
| menarche hormonal | #1 |
| ilt4 cord blood | #1 |
| gsdma phytohemagglutinin | #1 |
| children amish children | #1 |
| preschool dermatitis questionnaires | #1 |
| farmers children | #1 |
| menarche allergic | #1 |
| allergies atopic dermatitis | #1 |
| th2related genes | #1 |
| tregs life | #1 |
| inhaled steroids dresden | #1 |
| asthma symptoms adulthood | #1 |
| allergy protective | #1 |
| allergoprotective | #1 |
| aa nonallergic asthma | #1 |
| 95 hormonal contraceptives | #1 |
| nct02496468 | #1 |
| identified polymorphisms asthma | #1 |
| comparison microbiome data | #1 |
| richness farming | #1 |
| exposure gstm1 deficiency | #1 |
| east germany leipzig | #1 |
| lumbricoides crude measure | #1 |
| lpa ppg stimulation | #1 |
| munich dresden | #1 |
| boys fever | #1 |
| aa clec4e | #1 |
| menarche hormonal contraceptives | #1 |
| strongest predictor atopy | #1 |
| influential factors health | #1 |
| actinomycetes peak | #1 |
| epidemiological evidence consumption | #1 |
| pets associations | #1 |
| adolescent agriculture | #1 |
| samples farm dwellings | #1 |
| regulatory responses protection | #1 |
| farm exposure igg4 | #1 |
| protective factors strategies | #1 |
| chapter 16 epidemiology | #1 |
| tbx21 hlx1 snps | #1 |
| traditional upbringing | #1 |
| development asthma | #1 |
| late onset menarche | #1 |
| bronchial response wheeze | #1 |
| epigenetic regulation mechanism | #1 |
| evidence allergy prevention | #1 |
| solids development | #1 |
| prenatal animal | #1 |
| farm specific exposures | #1 |
| lca male phenotype | #1 |
| network differences groups | #1 |
| crowding dry cough | #1 |
| asthmaprotective farm | #1 |
| atopic eczema 95 | #1 |
| str bhr | #1 |
| microbial exposure sum | #1 |
| 1133 children | #1 |
| muramic acid wheezing | #1 |
| tenascin neuropeptide receptor | #1 |
| identification immune phenotypes | #1 |
| development allergies | #1 |
| alpine farm environments | #1 |
| consumption allergic | #1 |
| pasture cohort | #1 |
| aa hcs | #1 |
| children road traffic | #1 |
| 95 asthma | #1 |
| interaction npsr1 polymorphisms | #1 |
| incidence indoor allergens | #1 |
| hyperreaktivität | #1 |
| farm wheeze phenotypes | #1 |
| no2 traffic counts | #1 |
| asthma west germany | #1 |
| asthma tregs | #1 |
| validity food questionnaire | #1 |
| predominant obstruction | #1 |
| order covariates | #1 |
| tregs maternal atopy | #1 |
| exposure mattress dust | #1 |
| sige association | #1 |
| early life insight | #1 |
| sum indicators | #1 |
| cohorte pasture | #1 |
| work ilc2s | #1 |
| features anthroposophic lifestyle | #1 |
| 585883 | #1 |
| derp1lpa | #1 |
| parsifal‐study | #1 |
| 6 years subtypes | #1 |
| managing wheezing | #1 |
| maternal farming | #1 |
| protective exposures | #1 |
| consumption farm milk | #1 |
| allergic rhinitis childhood | #1 |
| allergic illnesses | #1 |
| allergyrisk factors | #1 |
| living farm | #1 |
| oropharyngeal microbiota children | #1 |
| protection asthma | #1 |
| covariates potential confounding | #1 |
| preschool children rhinitis | #1 |
| dairying environment pollen | #1 |
| allergic diseases hrqol | #1 |
| failure☆ | #1 |
| 5–13‐year school children | #1 |
| 17q21 polymorphisms | #1 |
| serum ige levels | #1 |
| pattern atopic sensitization | #1 |
| review hygiene hypothesis | #1 |
| atopy allergen specificity | #1 |
| gel variations gels | #1 |
| asthma puberty | #1 |
| fever spt cutoff | #1 |
| messenger surveys | #1 |
| bronchial obstruction hyperreactivity | #1 |
| eczema regions | #1 |
| 20 fall volume | #1 |
| prevalence environmental factors | #1 |
| acrossolar study | #1 |
| npsr1 rora | #1 |
| latent classes populations | #1 |
| birth tbx21 | #1 |
| incident wheezing asthma | #1 |
| 95 agmr | #1 |
| sensitisation early | #1 |
| bhr fall | #1 |
| generations birth cohort | #1 |
| association incident rhinoconjunctivitis | #1 |
| prevalence atopic sensitisation | #1 |
| german peers | #1 |
| homes farm dwellings | #1 |
| allergic rhinitis puberty | #1 |
| farm homes homes | #1 |
| juvenile crohn disease | #1 |
| asthma richness | #1 |
| blood ormdl3 | #1 |
| allergic sensitization latex | #1 |
| 048 95 95 | #1 |
| recurrence atopic dermatitis | #1 |
| year environmental exposures | #1 |
| maschildren | #1 |
| asthma risk class | #1 |
| early age risk | #1 |
| allergic asthmatics asthmatics | #1 |
| rhinoconjunctivitis sex | #1 |
| gabriel study | #1 |
| advanced surveys | #1 |
| protective asthma | #1 |
| marked differences prevalence | #1 |
| immune responsiveness life | #1 |
| spt atopic dermatitis | #1 |
| netcomi network construction | #1 |
| 5–13‐year | #1 |
| t1432c | #1 |
| doctor allergic rhinitis | #1 |
| histamine challenges age | #1 |
| ascaris lumbricoides exposure | #1 |
| adolescent agriculture dust | #1 |
| farming asthma | #1 |
| childhood allergy children | #1 |
| 2nd followup challenges | #1 |
| lukas2 lca | #1 |
| wheezerelated latent classes | #1 |
| allergy prevention studies | #1 |
| paediatric origins | #1 |
| cowsheds farm animals | #1 |
| male poland quality | #1 |
| npsr1 interaction | #1 |
| insight asthma | #1 |
| menarche allergic rhinitis | #1 |
| persistence earlylife exposures | #1 |
| farm dwellings children | #1 |
| barns farm dwellings | #1 |
| neonatal immune mechanisms | #1 |
| igein | #1 |
| asthmatics innate leukocytes | #1 |
| bhr str | #1 |
| data fetal growth | #1 |
| asthma microbiome analysis | #1 |
| increased risk rhinoconjunctivitis | #1 |
| asthma bacteria | #1 |
| domestic child child | #1 |
| yogurt year | #1 |
| risk gene asthma | #1 |
| cd4creil13 | #1 |
| allergic diseases questionnaires | #1 |
| igg4 ige expression | #1 |
| farms farm homes | #1 |
| parental questionnaires | #1 |
| solar study | #1 |
| moisture mold exposure | #1 |
| associations transient sensitization | #1 |
| atopic sensitization aor | #1 |
| domestic asthma child | #1 |
| groups netcomi | #1 |
| allergies personal cleanliness | #1 |
| life inversely | #1 |
| lukas2 umc | #1 |
| cla allergoprotective capacity | #1 |
| common infections infants | #1 |
| ddhay fever 95 | #1 |
| unhygienic contact | #1 |
| antibiotics allergies | #1 |
| health urbanrural differences | #1 |
| pets crowding | #1 |
| occupational disinfectants asthma | #1 |
| living environment children | #1 |
| vehicle traffic asthma | #1 |
| isaac phase data | #1 |
| provocation time | #1 |
| diseases farm | #1 |
| bronchial hyperreactivity childhood | #1 |
| risk mite sensitization | #1 |
| transient wheezing age | #1 |
| ranks performance | #1 |
| bronchial hyperreactivity wheezing | #1 |
| otus bacterial diversity | #1 |
| south bavarian | #1 |
| concomitant bhr 95 | #1 |
| asthma indoor exposure | #1 |
| ddhay fever children | #1 |
| alliance asthma | #1 |
| 457 iu | #1 |
| environments pasture | #1 |
| external microbial | #1 |
| interaction npsr1 protein | #1 |
| parasitic infections predictor | #1 |
| rs2738751 | #1 |
| farm children microorganisms | #1 |
| farm childhood asthma | #1 |
| farm dairy products | #1 |
| humans hypopharynx moraxella | #1 |
| rural allergy endotoxin | #1 |
| turkish children asthma | #1 |
| early phenotypes age | #1 |
| gpra polymorphisms | #1 |
| allergies addition | #1 |
| children isaac asthma | #1 |
| microorganisms farms | #1 |
| 95 grass pollen | #1 |
| 9 bronchodilators | #1 |
| helminth parasites exposure | #1 |
| asthma turkish | #1 |
| lps foxp3 demethylation | #1 |
| west germany munich | #1 |
| farm farm children | #1 |
| dresden east germany | #1 |
| ddhay fever | #1 |
| allergies cohort | #1 |
| atopic embryonic allergic | #1 |
| germany breast feeding | #1 |
| 105 years richness | #1 |
| arabinogalactan cde | #1 |
| farm animal exposure | #1 |
| increased diversity food | #1 |
| phenotype health variables | #1 |
| phase stratified sample | #1 |
| asthma german | #1 |
| protective atopic sensitization | #1 |
| farmingrelated exposures | #1 |
| school age early | #1 |
| insight environmental factors | #1 |
| th2related genes cytokines | #1 |
| munich leipzig | #1 |
| atopic sensitisation fever | #1 |
| repeated episodes fever | #1 |
| analysis step package | #1 |
| allergy exposures | #1 |
| followup farm living | #1 |
| fpr2 aa | #1 |
| non‐farm children | #1 |
| topic puberty rhinitis | #1 |
| observing children | #1 |
| newborn interleukin17 leukocytes | #1 |
| milk asthma | #1 |
| prediction farm children | #1 |
| tolllike receptor farmers | #1 |
| pasture cohort lca | #1 |
| children acrossolar cohort | #1 |
| allergic rhinitis type | #1 |
| obstruktive atemwegserkrankungen | #1 |
| tregs foxp3 demethylation | #1 |
| protective allergic diseases | #1 |
| dampness bronchial hyperreactivity | #1 |
| bacterial groups prevalence | #1 |
| fever atopic | #1 |
| farming environment role | #1 |
| asthma german children | #1 |
| seasonal rural | #1 |
| hrqol farm children | #1 |
| authors grass arabinogalactans | #1 |
| bhr asthma child | #1 |
| childhood asthma fever | #1 |
| rora neuropeptide receptor | #1 |
| cla content plasma | #1 |
| environmental differences finland | #1 |
| antipyretics reduced risk | #1 |
| increased risks rhinoconjunctivitis | #1 |
| aa ifih1 expression | #1 |
| farming children | #1 |
| persistence allergic rhinitis | #1 |
| allergen exposure age | #1 |
| farmers nonfarmers children | #1 |
| mite exposure risk | #1 |
| children beta 2agonists | #1 |
| actinomycetes alpine farms | #1 |
| influential factors phenotype | #1 |
| risk tcell phenotypes | #1 |
| atopic dermatitis adolescence | #1 |
| protective diversity | #1 |
| age asthma child | #1 |
| farm allergic rhinitis | #1 |
| actinomycetes cowsheds | #1 |
| worldwide asthma epidemic | #1 |
| expiratory volume lca | #1 |
| girls allergic rhinitis | #1 |
| abundances 6 otus | #1 |
| protection allergic diseases | #1 |
| recurrent unremitting wheeze | #1 |
| allergic diseases protective | #1 |
| pasture study tubes | #1 |
| cde source | #1 |
| yogurt cows milk | #1 |
| peptidoglycan ppg birth | #1 |
| puberty infant | #1 |
| single taxa groups | #1 |
| persistence bronchial hyperreactivity | #1 |
| unifying computational tool | #1 |
| allergies childhood phase | #1 |
| tnc asthma | #1 |
| endotoxin level production | #1 |
| farm reduced prevalence | #1 |
| bactoscan | #1 |
| dresden munich | #1 |
| 45yearold children protection | #1 |
| censored immunological | #1 |
| childhood design | #1 |
| tregs asthmatics | #1 |
| allergies protective pet | #1 |
| acrossolar | #1 |
| allergen exposure life | #1 |
| h4 acetylation offspring | #1 |
| associations hscrp values | #1 |
| quantitative confirmation associations | #1 |
| hrqol rural farm | #1 |
| childhood dampness | #1 |
| consumption asthma | #1 |
| bacterial exposures associations | #1 |
| igg4 coexpression | #1 |
| asthma arabinogalactan | #1 |
| asthma questionnaire responses | #1 |
| egg positive sensitization | #1 |
| sige sensitizations symptoms | #1 |
| current asthma age | #1 |
| prehireonset | #1 |
| farm milk meat | #1 |
| 95 atopic eczema | #1 |
| unprocessed farm milk | #1 |
| agreement spts | #1 |
| crp early age | #1 |
| treatment 9 bronchodilators | #1 |
| wholeto | #1 |
| aa increased atp2a3 | #1 |
| lca clinical phenotypes | #1 |
| 3 mm spt | #1 |
| environmental microbial | #1 |
| yoghurt asthma risk | #1 |
| indoor bacterial microbiota | #1 |
| rora snps | #1 |
| 95 puberty | #1 |
| jobs asthma risk | #1 |
| immune stimulation life | #1 |
| rhinitis predictor | #1 |
| followup work discontent | #1 |
| npsr1 tnc | #1 |
| life antibiotic exposure | #1 |
| europe protection | #1 |
| annual concentrations benzene | #1 |
| new onset wheeze | #1 |
| asthma concomitant bhr | #1 |
| association farm | #1 |
| no2 allergic sensitisation | #1 |
| wheeze bronchial | #1 |
| allergies respiratory infections | #1 |
| farm children hrqol | #1 |
| protective farm environment | #1 |
| phenotypes atopic | #1 |
| infant adolescent aging | #1 |
| auc spt | #1 |
| tregs cord blood | #2 |
| atopic dermatitis wheeze | #2 |
| asthma symptoms fever | #2 |
| time breastfed children | #2 |
| followup ndvi | #2 |
| farm animals symptoms | #2 |
| demethylation foxp3 | #2 |
| cd14 maternal exposures | #2 |
| polymorphisms card4 | #2 |
| germany asthma | #2 |
| halle west germany | #2 |
| childhood lca | #2 |
| premature respiratory | #2 |
| asthma adolescence | #2 |
| higher foxp3 | #2 |
| phase prevalence rates | #2 |
| fieldworkers absolute levels | #2 |
| hc ca2 | #2 |
| parent asthma | #2 |
| maternal contact protective | #2 |
| nocturnal asthma life | #2 |
| leipzig halle | #2 |
| agriculture allergens | #2 |
| farm children | #2 |
| fev1 fdr fdr | #2 |
| increased risk employment | #2 |
| farming families | #2 |
| 19th century allergic | #2 |
| arg130gln polymorphism linkage | #2 |
| immune responses function | #2 |
| test inhalent | #2 |
| early life prevalence | #2 |
| environmental microorganisms | #2 |
| microbial agents association | #2 |
| viable listeria spp | #2 |
| antiidiotypic aspergillosis | #2 |
| farming exposure | #2 |
| rna russia | #2 |
| pattern missing values | #2 |
| bhr west germany | #2 |
| antibiotic asthma risk | #2 |
| nocturnal asthma severity | #2 |
| severe exacerbations feno | #2 |
| eczema symptom prevalence | #2 |
| doctors diagnosed asthma | #2 |
| exposures farm | #2 |
| alk samples levels | #2 |
| ga²len harmonization | #2 |
| th17 markers | #2 |
| farming anthroposophic | #2 |
| association atopic children | #2 |
| farms reference | #2 |
| cd14 1721 children | #2 |
| artemisia olive pollen | #2 |
| probability incidence | #2 |
| imposed social isolation | #2 |
| lessaffluent countries adolescents | #2 |
| dresden higher greenness | #2 |
| low sensitization rates | #2 |
| influences development | #2 |
| farming nonfarming families | #2 |
| cd14 genotypes asthma | #2 |
| 14 260 | #2 |
| values edna concentrations | #2 |
| allergies farming status | #2 |
| inflammatory diseases allergy | #2 |
| coaacetate | #2 |
| dander artemisia | #2 |
| eczema affluent | #2 |
| data maternal weight | #2 |
| hutterite farm children | #2 |
| positive spt sige | #2 |
| influence cord | #2 |
| antiige therapy response | #2 |
| atopic developing countries | #2 |
| difference endotoxin levels | #2 |
| protein rhinitis allergic | #2 |
| current paracetamol 95 | #2 |
| isaac prevalence rates | #2 |
| individual level bhr | #2 |
| adult farmers role | #2 |
| antit2 biological therapy | #2 |
| asthma crp | #2 |
| foxp3 demethylation | #2 |
| farmers child cross | #2 |
| farmlike indoor microbiota | #2 |
| south bavaria | #2 |
| allele specific ige | #2 |
| atopic eczema phenotypes | #2 |
| pha maternal farming | #2 |
| card4 21596 | #2 |
| environmental exposures mother | #2 |
| ifnγ levels snps | #2 |
| processed cow | #2 |
| lifelong farm exposure | #2 |
| bronchial challenge children | #2 |
| atopic smokers | #2 |
| healthcare precision medicine | #2 |
| serum levels c4ma3 | #2 |
| human microbiota asthma | #2 |
| microbial exposure risk | #2 |
| endotoxin allergen exposure | #2 |
| asthma observed | #2 |
| nonfarm children | #2 |
| measles vaccination infection | #2 |
| messenger receptors tenascin | #2 |
| asthmaassociated | #2 |
| bhr tirana | #2 |
| isaac atopic eczema | #2 |
| beta1 endotoxin | #2 |
| interactions asthma | #2 |
| prenatal farm exposure | #2 |
| amish farms | #2 |
| levels alk samples | #2 |
| higher greenness quartile | #2 |
| opposite direction children | #2 |
| environmental microorganisms children | #2 |
| standardized procedure centres | #2 |
| eczema farm exposures | #2 |
| munich participants | #2 |
| genetic variation card4 | #2 |
| animal sheds pregnancy | #2 |
| phase isaac | #2 |
| sensitization patterns inhalant | #2 |
| agmr 95 | #2 |
| dust endotoxin allele | #2 |
| wheeze 12 | #2 |
| ages strongest associations | #2 |
| strachan | #2 |
| immunoglobulin nod1 | #2 |
| ors affluent countries | #2 |
| bacteriological properties | #2 |
| children bronchial obstruction | #2 |
| protection allergy | #2 |
| fdr clinical response | #2 |
| allergen levels socks | #2 |
| statistical analysis performance | #2 |
| domestic child dust | #2 |
| frequency nocturnal asthma | #2 |
| parsifal study phenotypes | #2 |
| allergic tolllike receptor | #2 |
| life increased risk | #2 |
| dendritic cells dust | #2 |
| work discontent | #2 |
| polymorphisms il13 gene | #2 |
| 95 protective factors | #2 |
| traditional farm | #2 |
| farming families allergies | #2 |
| lipid ppg | #2 |
| current interpretation | #2 |
| igg4 ige levels | #2 |
| association allergic diseases | #2 |
| cd14 1721 association | #2 |
| bronchitis east germany | #2 |
| allele cd14 1721 | #2 |
| exposure farming | #2 |
| participants dresden | #2 |
| paracetamol fever | #2 |
| th2 cytokines ilc2s | #2 |
| excessive edna production | #2 |
| improvements fdr score | #2 |
| allergic rhinitis adolescence | #2 |
| socks dust | #2 |
| prediction asthma | #2 |
| atopic sensitization 14 | #2 |
| collected dust indoor | #2 |
| positive maternal record | #2 |
| sod3 transcript | #2 |
| symptom control pa | #2 |
| studies farms | #2 |
| children farm | #2 |
| indoor bacterial | #2 |
| farming mothers ppg | #2 |
| relapse newonset | #2 |
| current exposure cats | #2 |
| study participants levels | #2 |
| milk cd14 | #2 |
| card4 21596 children | #2 |
| patients childhood symptoms | #2 |
| affluent countries centers | #2 |
| early immune maturation | #2 |
| il4 gene | #2 |
| bronchial hyperresponsiveness children | #2 |
| order sensitized patients | #2 |
| allergies cd14 expression | #2 |
| alliance ages | #2 |
| new onset wheezing | #2 |
| 95 school level | #2 |
| affluent countries eczema | #2 |
| atopic sensitization upregulation | #2 |
| cases objective measurements | #2 |
| t2inflammation | #2 |
| quartile work discontent | #2 |
| environmental microbial exposure | #2 |
| pha th17 lineage | #2 |
| associations atopy | #2 |
| immunoglobulin life | #2 |
| affluent countries | #2 |
| cd4cd25hi foxp3 | #2 |
| lessaffluent countries | #2 |
| microbial influences | #2 |
| histamine challenges | #2 |
| cd14 1721 | #2 |
| 047 95 gg | #2 |
| farmers asthma symptoms | #2 |
| highdna | #2 |
| adaptor protein rhinitis | #2 |
| socks alk samples | #2 |
| specificity lca | #2 |
| atopic diseases subjects | #2 |
| sputum extracellular | #2 |
| atopic dermatitis childhood | #2 |
| th17 lineage markers | #2 |
| relation dust endotoxin | #2 |
| alk samples fieldworkers | #2 |
| development atopic diseases | #2 |
| tbx21 gene | #2 |
| rhinitis adolescents | #2 |
| il4 il13 pathway | #2 |
| bhr individual level | #2 |
| c4ma3 biomarker | #2 |
| associations lessaffluent countries | #2 |
| dust samples levels | #2 |
| wheeze bronchial hyperresponsiveness | #2 |
| affluent countries associations | #2 |
| interval156 | #2 |
| farming environment mother | #2 |
| associations hscrp levels | #2 |
| cd4 cells offspring | #2 |
| gmcsf ifnγ levels | #2 |
| 645 children | #2 |
| snps inflammatory diseases | #2 |
| tregs demethylation | #2 |
| protect development | #2 |
| living farms | #2 |
| lipid lpa | #2 |
| ppg pha | #2 |
| c4ma3 asthma | #2 |
| asthma protection | #2 |
| role maternal exposures | #2 |
| asthmaassociated aor | #2 |
| neu5gc role | #2 |
| rora asthma | #2 |
| multivariate analyses haying | #2 |
| children dresden | #2 |
| age asthma cohort | #2 |
| asthma parsifal | #2 |
| eczema farmers children | #2 |
| improvements fdr | #2 |
| life pvalues | #2 |
| fieldworkers dust collection | #2 |
| exposure environmental microorganisms | #2 |
| developing allergies | #2 |
| frequency nocturnal symptoms | #2 |
| fev1 fdr | #2 |
| subsample children | #2 |
| farmers children children | #2 |
| current symptoms asthmaassociated | #2 |
| pregnancy specific ige | #2 |
| nonfarm homes children | #2 |
| atopic eczema causation | #2 |
| grass pollen dander | #2 |
| asthma cohort | #2 |
| children nonfarm homes | #2 |
| children affluent countries | #2 |
| pa interrelations | #2 |
| fever west germany | #2 |
| card4 protein rhinitis | #2 |
| nonfarming mothers lipid | #2 |
| asthma meeting | #2 |
| 17q21 | #2 |
| childhood symptoms relapse | #2 |
| snps il4 gene | #2 |
| allergic diseases allergies | #2 |
| lower atopy | #2 |
| onset male recurrence | #2 |
| eczema allergic dermatitis | #2 |
| increase parent | #2 |
| exposure farmers children | #2 |
| peptidoglycan ppg | #2 |
| asthma child dermatitis | #2 |
| bronchial hyperresponsiveness exposure | #2 |
| exposure life | #2 |
| immunoglobulin analyses children | #2 |
| olive pollen dander | #2 |
| consumption unpasteurized milk | #2 |
| university baseline | #2 |
| asthma symptoms children | #2 |
| life current symptoms | #2 |
| fieldworkers house dust | #2 |
| pha farming mothers | #2 |
| alternaria animals animals | #2 |
| age allergic rhinitis | #2 |
| asthma phenotypes negative | #2 |
| exposure lifestyle factors | #2 |
| fev1 score associations | #2 |
| geneenvironment interactions asthma | #2 |
| causation environmental associations | #2 |
| doctors diagnosis aor | #2 |
| neu5gc exposure | #2 |
| school level 95 | #2 |
| children bronchial hyperresponsiveness | #2 |
| atopy early life | #2 |
| ages current paracetamol | #2 |
| 95 047 95 | #2 |
| nonfarming families | #2 |
| amish hutterite homes | #2 |
| eczema lessaffluent countries | #2 |
| il13 gene linkage | #2 |
| asthma control pa | #2 |
| increase worldwide | #2 |
| severity spirometric measures | #2 |
| expression innate | #2 |
| bronchial hyperresponsiveness allergic | #2 |
| negative volatile organic | #2 |
| association opposite direction | #2 |
| adult arm alliance | #2 |
| allergies genetic variation | #2 |
| bm190th | #2 |
| study design participation | #2 |
| wheeze bronchial responsiveness | #2 |
| dairying eczema | #2 |
| sensitized patients order | #2 |
| aa hc | #2 |
| newonset asthma symptoms | #2 |
| card4 association | #2 |
| animal exposure levels | #2 |
| childhood phase | #2 |
| farm milk pregnancy | #2 |
| alk samples | #2 |
| role helminths | #2 |
| gels bands | #2 |
| highrisk predictors | #2 |
| study participants fieldworkers | #2 |
| asthma symptoms eczema | #2 |
| life rural children | #2 |
| nocturnal symptoms spirometry | #2 |
| farming environment allergies | #2 |
| consumption unprocessed | #2 |
| childhood obesoty | #2 |
| allele card4 21596 | #2 |
| allergic disorders children | #2 |
| allergic asthma degradation | #2 |
| followup university | #2 |
| siblings atopic children | #2 |
| eczema conjunctivitis eczema | #2 |
| microbial exposure study | #2 |
| maternal immunity gondii | #2 |
| tirana mumbai | #2 |
| symptom control bmi | #2 |
| consumption farm | #2 |
| breathomics asthma | #2 |
| asthma hygiene hypothesis | #2 |
| cats eczema | #2 |
| hlx1 gene variants | #3 |
| markers fetal growth | #3 |
| hygiene hypothesis | #3 |
| lukas2 birth | #3 |
| microorganisms dust | #3 |
| life development | #3 |
| questionnaires physical examination | #3 |
| atopy dresden | #3 |
| paf allergic | #3 |
| microbiota farm | #3 |
| disequilibrium rhinitis allergic | #3 |
| allergic inflammation polymorphisms | #3 |
| children african ancestry | #3 |
| allergic disequilibrium rhinitis | #3 |
| life allergic diseases | #3 |
| stat1 gene variations | #3 |
| paf sensitisation | #3 |
| eosinophil pathway genes | #3 |
| atopic mothers | #3 |
| pcdh1 polymorphisms associations | #3 |
| col29a1 eczema | #3 |
| mmp9 variants risk | #3 |
| onset asthma child | #3 |
| eosinophil pathway | #3 |
| paracetamol risk | #3 |
| pcdh1 asthma | #3 |
| dresden odds ratio | #3 |
| asthma endotoxin levels | #3 |
| sensitisation affluent countries | #3 |
| cd14 association | #3 |
| ile117thr | #3 |
| germany west german | #3 |
| col29a1 polymorphisms eczema | #3 |
| farms asthma | #3 |
| 45yearold children | #3 |
| mmp9 influence development | #3 |
| eczema international study | #3 |
| endotoxin levels asthma | #3 |
| children bronchial hyperreactivity | #3 |
| stat6 haplotype | #3 |
| hlx1 gene | #3 |
| young adult europe | #3 |
| asthma subphenotypes | #3 |
| atopic dermatitis aor | #3 |
| wheeze allergy | #3 |
| 1q31 locus dennd1b | #3 |
| affluent countries atopy | #3 |
| gni measurements | #3 |
| persistent flexural eczema | #3 |
| rhinitis increased risk | #3 |
| farm animals farm | #3 |
| isaac polymorphisms | #3 |
| individual level questionnaires | #3 |
| farming farm | #3 |
| g1258a | #3 |
| t3085 | #3 |
| polymorphisms gm csf | #3 |
| col29a1 expression eczema | #3 |
| experimental asthma progeny | #3 |
| food year | #3 |
| blatella | #3 |
| farm contact | #3 |
| c2892 | #3 |
| cohort alliance | #3 |
| german children munich | #3 |
| moraxella colonization | #3 |
| asthma tolllike receptors | #3 |
| cowshed dust | #3 |
| network construction | #3 |
| 1000 enfants | #3 |
| col29a1 variants eczema | #3 |
| dennd1b asthma | #3 |
| allergyprotective | #3 |
| 1431c | #3 |
| il15 associations | #3 |
| puberty risk factors | #3 |
| ferme | #3 |
| increased treg cells | #3 |
| 95ci nonatopic asthma | #3 |
| protective farm | #3 |
| 1431c specific ige | #3 |
| monocytes lps stimulation | #3 |
| jobrelated chronic stress | #3 |
| children negative spts | #3 |
| doctors diagnosis | #3 |
| animal sheds | #3 |
| amino acid cx3cr1 | #3 |
| asthma pcdh1 | #3 |
| hygiene hypothesis development | #3 |
| il5 c746t | #3 |
| rural dwellings | #3 |
| occurrence rhinitis | #3 |
| role atopic sensitization | #3 |
| dogs exposure | #3 |
| protein rhinitis | #3 |
| auc asthma | #3 |
| dcs a20 induction | #3 |
| susceptibility col29a1 expression | #3 |
| eczema col29a1 | #3 |
| atopic female germany | #3 |
| crth2 influences development | #3 |
| rare tlr2 mutations | #3 |
| farming status | #3 |
| children isaac phase | #3 |
| today1 | #3 |
| bhr haplotypes humans | #3 |
| eczema isaac phase | #3 |
| wheezing neutrophils | #3 |
| asthma genetic association | #3 |
| sod3 variants | #3 |
| rural areas europe | #3 |
| role adam33 polymorphisms | #3 |
| asthma snp rs2786098 | #3 |
| asthma bordetella | #3 |
| asthma 1431c | #3 |
| tlr2 amino acid | #3 |
| stat6 gene regulation | #3 |
| bias asthma bias | #3 |
| prevalence asthma | #3 |
| countries endotoxin levels | #3 |
| growing farm | #3 |
| throat microbiota asthma | #3 |
| european ancestry asthma | #3 |
| il5 c746 allergic | #3 |
| t12888c | #3 |
| allergic phenotypes correction | #3 |
| bavaria obesity | #3 |
| substances protection | #3 |
| samples 1q31 locus | #3 |
| prevalence allergies | #3 |
| protocadherin‐1 | #3 |
| united kingdom albania | #3 |
| effects single snps | #3 |
| rhinoconjunctivitis conjunctivitis | #3 |
| breastfeeding overweight | #3 |
| bhr pcdh1 polymorphisms | #3 |
| rhinoconjunctivitis paf | #3 |
| biomaterial collection | #3 |
| tlr2 polymorphisms | #3 |
| phase international study | #3 |
| endotoxin dust samples | #3 |
| arabinogalactan isolated | #3 |
| il15 gene asthma | #3 |
| 280met | #3 |
| dennd1b chromosome | #3 |
| severity moisture damage | #3 |
| col29a1 genetic variants | #3 |
| asthma amino acid | #3 |
| sige asthma | #3 |
| domestic asthma | #3 |
| nonatopic asthma 95ci | #3 |
| overweight germany | #3 |
| 53152 | #3 |
| protection development | #3 |
| parent prevalence | #3 |
| progeny asthma | #3 |
| duration prevalence | #3 |
| asthma genetic severity | #3 |
| domestic arthritis | #3 |
| col29a1 polymorphisms | #3 |
| polymorphisms hlx1 gene | #3 |
| atopic sensitisation | #3 |
| il15 gene variants | #3 |
| seasonal allergens atopy | #3 |
| pcr sscp analysis | #3 |
| environmental dusts | #3 |
| european science foundation | #3 |
| adam33 snps | #3 |
| asthma major | #3 |
| age 7–10 years | #3 |
| anthroposophic children | #3 |
| population german | #3 |
| role neu5gc | #3 |
| protection contre | #3 |
| allergic phenotype polymorphism | #3 |
| c39134a | #3 |
| current asthma rhinoconjunctivitis | #3 |
| 1q31 locus | #3 |
| munich polymorphism | #3 |
| gni rho | #3 |
| responses innate | #3 |
| asthma farming environment | #3 |
| bacterial diversity asthma | #3 |
| cx3cr1 polymorphisms atopy | #3 |
| sod3 extracellular matrix | #3 |
| vivo expression irf1 | #3 |
| il15 il15 associations | #3 |
| 3099 children | #3 |
| c746t | #3 |
| risk nonatopic asthma | #3 |
| locus dennd1b | #3 |
| perennial allergens paf | #3 |
| prenatal protection | #3 |
| organic waste storage | #3 |
| endotoxin milk | #3 |
| allergy a20 induction | #3 |
| c1407t | #3 |
| exposure helminths | #3 |
| lwoffii f78 | #3 |
| eosinophils matrix metalloproteinase | #3 |
| atopic asthma effects | #3 |
| f78 | #3 |
| maternal tlr | #3 |
| prenatal protection asthma | #3 |
| atopic diseases mutations | #3 |
| eczema farmers | #3 |
| regular contact | #3 |
| nf kappa polymorphism | #3 |
| populations illness surveys | #3 |
| col29a1 polymorphisms susceptibility | #3 |
| allergic asthmatics aa | #3 |
| culture techniques study | #3 |
| characteristics respiratory | #3 |
| rhinoconjunctivitis atopic eczema | #3 |
| il5 il5 c746 | #3 |
| genetic variation crth2 | #3 |
| cx3cr1 polymorphisms polymorphism | #3 |
| work work overload | #3 |
| irf1 interferon expression | #3 |
| allergy protection | #3 |
| crude measure | #3 |
| prenatal asthma protection | #3 |
| female fetus immunity | #3 |
| farm dwellings | #3 |
| ppg expression | #3 |
| adam33 polymorphisms asthma | #3 |
| conjunctivitis paf | #3 |
| farm dust endotoxin | #3 |
| asthma cattle | #3 |
| 9 mmp9 mmp9 | #3 |
| treatment asthma phenotypes | #3 |
| eczema strong association | #3 |
| food correction | #3 |
| associations pcdh1 | #3 |
| blood allergen | #3 |
| tlr2 receptor function | #3 |
| individual level centers | #3 |
| asthma protection progeny | #3 |
| cowshed dust extract | #3 |
| paf seasonal allergens | #3 |
| cytokine cluster bhr | #3 |
| asthma atopic sensitization | #3 |
| albania antibody specificity | #3 |
| role asthma prevalence | #3 |
| mmp9 variants mmp9 | #3 |
| putative functional role | #3 |
| forward initiative | #3 |
| asthma identified | #3 |
| —study | #3 |
| bdnf polymorphisms asthma | #3 |
| crosssectional population | #3 |
| children farming | #3 |
| allergic diseases children | #3 |
| childhood asthma community | #3 |
| fever aor | #3 |
| hlx1 gene development | #3 |
| adult lung disease | #4 |
| cheese consumption | #4 |
| stables farm milk | #4 |
| dietary habits children | #4 |
| agreement spt | #4 |
| allergic il5 | #4 |
| n2267 | #4 |
| participants fieldworkers | #4 |
| wheezing onset | #4 |
| asthma phenotype children | #4 |
| doctors diagnosis asthma | #4 |
| leisure time activity | #4 |
| tlr2 mutations | #4 |
| a20 induction | #4 |
| antibiotics antipyretics | #4 |
| incident sensitization | #4 |
| common sensitizations | #4 |
| lrti asthma | #4 |
| lower risk allergy | #4 |
| study centers phase | #4 |
| groups taxa | #4 |
| children maternal overweight | #4 |
| eczema questionnaires adolescent | #4 |
| gabriel advanced | #4 |
| genes il4r | #4 |
| benzene no2 | #4 |
| 99th dahlem conference | #4 |
| minimum battery | #4 |
| life childhood | #4 |
| childhood protect | #4 |
| birthcohort study | #4 |
| fever 17 | #4 |
| prenatal asthma | #4 |
| crp blood leukocytes | #4 |
| indoor pollen | #4 |
| children farms | #4 |
| asthma medication exposure | #4 |
| genetic nod1 | #4 |
| birth atopic dermatitis | #4 |
| aetiology asthma | #4 |
| t2high asthma | #4 |
| farm environment development | #4 |
| lifetime prevalence asthma | #4 |
| predictor wheezing | #4 |
| cats pregnancy | #4 |
| risk atopic dermatitis | #4 |
| 5 13 years | #4 |
| ilc2s human asthma | #4 |
| questionnaires adolescent eczema | #4 |
| exposure cats | #4 |
| fever year | #4 |
| asthma snps | #4 |
| environmental dust samples | #4 |
| adolescents duration | #4 |
| bacillus licheniformis spores | #4 |
| c746 | #4 |
| neonatal window | #4 |
| ige levels associations | #4 |
| current asthma bhr | #4 |
| asthma symptoms association | #4 |
| rs2786098 | #4 |
| permanovas | #4 |
| risk factor symptoms | #4 |
| il4r tlr4 | #4 |
| occupational allergy risks | #4 |
| cd4cd25hi tregs | #4 |
| h20like homeobox | #4 |
| microbes asthma | #4 |
| rare tlr2 | #4 |
| factors wheeze | #4 |
| atopic dermatitis birth | #4 |
| allergies children | #4 |
| microbial compounds | #4 |
| sas genetics | #4 |
| parent odds ratio | #4 |
| current symptoms asthma | #4 |
| alliance cohort | #4 |
| promoter region arg130gln | #4 |
| early identification atopy | #4 |
| asthma auc | #4 |
| pro27ser | #4 |
| feeding prevalence | #4 |
| 95 gene expression | #4 |
| asthma current symptoms | #4 |
| col29a1 expression | #4 |
| asthma symptoms adults | #4 |
| environmental factors development | #4 |
| tolllike receptors receptor | #4 |
| children munich | #4 |
| gene expression receptors | #4 |
| allergic ecuador eczema | #4 |
| infections early | #4 |
| genetic rhinitis allergic | #4 |
| anthroposophic families | #4 |
| childhood asthma | #4 |
| immunity receptors | #4 |
| eczema flg mutations | #4 |
| allergic dermatitis allergic | #4 |
| particle boluses | #4 |
| heating prevalence | #4 |
| high‐sensitivity c‐reactive protein | #4 |
| spt sige | #4 |
| predictors visits | #4 |
| inhalant patients | #4 |
| allergy international study | #4 |
| fever eczema | #4 |
| east germany bhr | #4 |
| human genetic nod1 | #4 |
| asthma 3 | #4 |
| lukas2 | #4 |
| asthma induction | #4 |
| increase eczema prevalence | #4 |
| asthma atopic diseases | #4 |
| secretory receptors allergic | #4 |
| parental allergic rhinitis | #4 |
| wheeze bhr | #4 |
| asthma hygiene | #4 |
| endotoxin relation | #4 |
| late phenotype | #4 |
| fatty acids allergic | #4 |
| questionnaires eczema | #4 |
| mother role | #4 |
| candidate genes wheeze | #4 |
| nonfarming | #4 |
| wheeze ige levels | #4 |
| cromolyns | #4 |
| cough bronchitis | #4 |
| sounds rhinitis | #4 |
| questionnaires populations | #4 |
| cord blood lipid | #4 |
| exposure microbial | #4 |
| licheniformis spores | #4 |
| phase 2 allergies | #4 |
| prevalence random | #4 |
| cowsheds | #4 |
| children mattresses | #4 |
| fetal growth asthma | #4 |
| occurrence atopic dermatitis | #4 |
| stable dust | #4 |
| cx3cr1 polymorphisms | #4 |
| col29a1 gene | #4 |
| genotypes cd14 | #4 |
| allergic diseases humans | #4 |
| development atopic sensitization | #4 |
| early life basis | #4 |
| initial data analysis | #4 |
| dust personal | #4 |
| glu420lys | #4 |
| flexural eczema | #4 |
| german children bavaria | #4 |
| development atopic | #4 |
| adulthood asthma | #5 |
| cd14 gene expression | #5 |
| puberty menarche | #5 |
| il13cd4 cells | #5 |
| tbx21 combination | #5 |
| parental reports asthma | #5 |
| ors positive association | #5 |
| severe atopy | #5 |
| timing exposures | #5 |
| genetic variants tbx21 | #5 |
| ornonaffluent | #5 |
| cow milk samples | #5 |
| hlx1 polymorphisms development | #5 |
| hlx1 variants | #5 |
| pregnancy year | #5 |
| asthma girls | #5 |
| atopic eczema allergic | #5 |
| cats risk factor | #5 |
| linkage development | #5 |
| sensitization atopic | #5 |
| milk exposure | #5 |
| milk odds | #5 |
| risk atopic | #5 |
| cowshed | #5 |
| 26 farms | #5 |
| popular terms | #5 |
| combination hlx1 variants | #5 |
| moulds actinomycetes | #5 |
| atopic sensitization asthma | #5 |
| n1046 | #5 |
| participation behaviour | #5 |
| atopic dermatitis age | #5 |
| taxa groups | #5 |
| disinfectants asthma | #5 |
| il13cd4 | #5 |
| c2892t | #5 |
| airway responsiveness age | #5 |
| allergic rhinitis wheeze | #5 |
| nonfarmers children | #5 |
| farming mothers | #5 |
| mmp9 influence | #5 |
| agriculture animals | #5 |
| phänotypen | #5 |
| hyperreactivity child | #5 |
| 95 reverse causation | #5 |
| helsinki alert | #5 |
| asthma endotoxins | #5 |
| dresden | #5 |
| life questionnaires switzerland | #5 |
| young adults methods | #5 |
| allergic diseases exposure | #5 |
| jf1 msf | #5 |
| verlaufsformen | #5 |
| genetic asthma | #5 |
| environmental dust | #5 |
| ige regulation | #5 |
| thr280met | #5 |
| atopy flexural eczema | #5 |
| subtypes risk | #5 |
| tbx21 gene variants | #5 |
| inverse association overweight | #5 |
| associations wheeze | #5 |
| 2q14 | #5 |
| endotoxin protection | #5 |
| cd4cd25hi | #5 |
| duration jobs | #5 |
| combination hlx1 polymorphisms | #5 |
| nod1 variation | #5 |
| west german children | #5 |
| trigger factors asthma | #5 |
| female germany allergic | #5 |
| milk consumption age | #5 |
| delayed manifestation | #5 |
| children validity | #5 |
| incident wheeze | #5 |
| mechanism environmental factors | #5 |
| rhinitis increase | #5 |
| moisture mold problems | #5 |
| rural subjects | #5 |
| communitybased random sample | #5 |
| pattern sensitization | #5 |
| rs3771300 | #5 |
| 14452 | #5 |
| current symptoms rhinoconjunctivitis | #5 |
| visits predictors | #5 |
| tests bronchitis | #5 |
| tnc nps | #5 |
| children current wheeze | #5 |
| allergystudy | #5 |
| asthma medication 95 | #5 |
| influence ige | #5 |
| allergen 95 | #5 |
| lung health disease | #5 |
| childhood isaac phase | #5 |
| neu5gc mice | #5 |
| 95 populationattributable risk | #5 |
| tbx21 promoter activity | #5 |
| consumption 4 years | #5 |
| ormdl3 gsdma | #5 |
| 2nd followup | #5 |
| processing intensity | #5 |
| wisconsin infant | #5 |
| receptors innate immunity | #5 |
| atopy airway hyperresponsiveness | #5 |
| tbx21 polymorphisms development | #5 |
| flexural eczema strength | #5 |
| asthma child dust | #5 |
| exposure rhinitis | #5 |
| ors atopy | #5 |
| eczema relation | #5 |
| dogs symptoms | #5 |
| responders frequency | #6 |
| protection allergies | #6 |
| tests asthma | #6 |
| tlr1 tlr10 | #6 |
| oropharyngeal microbiota | #6 |
| primary preventive strategies | #6 |
| rora npsr1 | #6 |
| abschnitten | #6 |
| natural atopic dermatitis | #6 |
| childhood aa | #6 |
| asthma context | #6 |
| nonaffluent | #6 |
| lifestyle factors symptoms | #6 |
| sscp method | #6 |
| complete screening | #6 |
| allergy tests children | #6 |
| deubiquitinating enzyme tao | #6 |
| allergic diseases | #6 |
| childhood asthma phenotypes | #6 |
| pair deubiquitinating enzyme | #6 |
| progression asthma | #6 |
| children farming environment | #6 |
| inversely asthma | #6 |
| onset disease germany | #6 |
| overweight data | #6 |
| hypertonic skin tests | #6 |
| food allergy 95 | #6 |
| 16q12 region | #6 |
| current contact | #6 |
| polymorphisms stat6 gene | #6 |
| fever wheezing | #6 |
| rhinoconjunctivitis eczema | #6 |
| allergic epistasis | #6 |
| strategies disease | #6 |
| fever atopy | #6 |
| data 7 years | #6 |
| countries albania | #6 |
| german nationality | #6 |
| sensitisation exposure | #6 |
| nd132656 | #6 |
| lung barrier | #6 |
| allergoprotective properties | #6 |
| 11094 | #6 |
| distinct underlying mechanisms | #6 |
| asthma authors | #6 |
| pair male nod2 | #6 |
| genetic variants 17q12q21 | #6 |
| systemic inflammation age | #6 |
| children positive spt | #6 |
| central europe interactions | #6 |
| susceptibility gene asthma | #6 |
| il33 17q12q21 | #6 |
| asthma genotypes | #6 |
| lowgrade inflammation hscrp | #6 |
| prevent allergic | #6 |
| childhood asthma genes | #6 |
| tripeptidylpeptidases subunit p40 | #6 |
| children east germany | #6 |
| 17q12q21 earlier onset | #6 |
| asthma allergic sensitisation | #6 |
| pierced ears | #6 |
| allergens needed | #6 |
| allergic immunologic receptors | #6 |
| parsifal | #6 |
| atemwegserkrankungen | #6 |
| 939 children | #6 |
| interactions farm exposures | #6 |
| genetic variants time | #6 |
| dust collection | #6 |
| sounds surveys | #6 |
| study rarer snps | #6 |
| bavarian preschool children | #6 |
| 5 regions tao | #6 |
| no2 current asthma | #6 |
| dipeptidyl peptidases tripeptidylpeptidases | #6 |
| allergic markers | #6 |
| microorganisms samples | #6 |
| asthma transition | #6 |
| new locus time | #6 |
| eating environmental | #6 |
| comprehensive questionnaires | #6 |
| steiner schools | #6 |
| 14 genes tripeptidylpeptidases | #6 |
| european dairy farms | #6 |
| devenues | #6 |
| 7 years association | #6 |
| farm nonfarm | #6 |
| dogs environmental exposure | #6 |
| central europe asthma | #6 |
| asthma austria | #6 |
| yearly interviews | #6 |
| isaac programme | #6 |
| longitudinal populations | #6 |
| rhinoconjunctivitis atopic | #6 |
| bolus dispersion | #6 |
| cold air challenge | #6 |
| grass rphl | #7 |
| childhoodonset disease | #7 |
| farm exposure | #7 |
| secretory receptors | #7 |
| interleukin4 sequence analysis | #7 |
| pregnancy atopic dermatitis | #7 |
| infantis populations | #7 |
| hutterite children | #7 |
| foxp3 blood | #7 |
| symptoms adulthood | #7 |
| juvenile inflammatory | #7 |
| functional phenotypes | #7 |
| indoor moisture | #7 |
| breastfeeding prevalence | #7 |
| questionnaires allergic | #7 |
| stat1 gene | #7 |
| questionnaires phase | #7 |
| adult farmers | #7 |
| children regular contact | #7 |
| centers increase | #7 |
| fever atopic asthma | #7 |
| biomarker immune activation | #7 |
| levels farm | #7 |
| pasture birth | #7 |
| fieldworkers | #7 |
| child dust | #7 |
| strategies asthma | #7 |
| nonfarm homes | #7 |
| childrens bedrooms | #7 |
| fetal development allergic | #7 |
| cells dust | #7 |
| seasonal sensitivity allergic | #7 |
| perennial allergen | #7 |
| children breast | #7 |
| steiner school | #7 |
| polymorphisms il4 gene | #7 |
| association cord blood | #7 |
| amish children | #7 |
| viral infections development | #7 |
| inhalant age | #7 |
| 5 harmonization | #7 |
| isaac eczema | #7 |
| pasture study | #7 |
| atopic europe | #7 |
| aerosol bolus dispersion | #7 |
| allergy antibiotics | #7 |
| genetic predisposition role | #7 |
| preanalytix | #7 |
| highrisk occupations | #7 |
| farm life | #7 |
| influence neonatal | #7 |
| large centres | #7 |
| 95 endotoxin | #7 |
| european science | #7 |
| wheeze atopy | #7 |
| children prognosis | #7 |
| level variety | #7 |
| murine offspring | #7 |
| hypersensitivity male | #7 |
| exposure farms | #7 |
| chemokine cx3cl1 cx3cr1 | #7 |
| endotoxin allergen | #7 |
| environmental factors children | #7 |
| infectious diseases phenotype | #7 |
| paracetamol year | #7 |
| asthma fever | #7 |
| environmental exposure endotoxin | #7 |
| children international study | #7 |
| steiner school children | #7 |
| farm homes | #7 |
| log2fold | #7 |
| hypertonic sensitivity | #7 |
| lymphoid cells asthma | #7 |
| diversity introduction | #7 |
| immunologic receptors allergic | #7 |
| allergic atopic embryonic | #7 |
| birth cohorts report | #7 |
| school age asthma | #7 |
| exposure neu5gc | #7 |
| atopic dermatitis association | #7 |
| pbmcs asthmatics | #7 |
| lung sod3 | #7 |
| lower risk asthma | #7 |
| asthma school age | #7 |
| 15245 | #7 |
| inverse association consumption | #7 |
| invading microorganism | #7 |
| reference exposure | #7 |
| wheeze 12 months | #7 |
| bhr current asthma | #7 |
| asthma environmental factors | #7 |
| birth function | #7 |
| rhinitis early childhood | #7 |
| antibiotics year | #8 |
| chromosome 2q14 | #8 |
| asthma child conjunctivitis | #8 |
| asthma birth weight | #8 |
| ppg stimulation | #8 |
| asthmaprotective | #8 |
| repeats sequence homology | #8 |
| 17q12q21 | #8 |
| asthma maternal smoking | #8 |
| il13 variants | #8 |
| age positive spts | #8 |
| cows milk age | #8 |
| genetic risk asthma | #8 |
| proteins dendritic cells | #8 |
| asthma 08 | #8 |
| eczema asthma child | #8 |
| sensitization patterns | #8 |
| crohns disease polymorphisms | #8 |
| inhalant europe | #8 |
| asthma analyses | #8 |
| 3113 children | #8 |
| gabriela study | #8 |
| austrian schoolchildren | #8 |
| lipid peptidoglycan | #8 |
| current asthma data | #8 |
| children anthroposophic | #8 |
| p11×10−8 | #8 |
| university work | #8 |
| age 911 years | #8 |
| invertedu shape | #8 |
| highthroughput sequencing data | #8 |
| mice children | #8 |
| allergies childhood | #8 |
| igg1 galactosylation | #8 |
| early age exposure | #8 |
| factor analysis factor | #8 |
| chromosome childhoodonset disease | #8 |
| fever atopic sensitisation | #8 |
| amino acid asthma | #8 |
| il15 snps | #8 |
| international variations | #8 |
| gabriela | #8 |
| children anthroposophic families | #8 |
| association wheeze | #8 |
| asthma bias | #8 |
| surveyed children | #8 |
| atopic sensitization prevalence | #8 |
| children reference | #8 |
| hlx1 | #8 |
| bronchial histamine challenge | #8 |
| allergy epidemiology | #8 |
| study rural | #8 |
| dogs risk factor | #8 |
| hrqol questions | #8 |
| childhood asthma atopy | #8 |
| association food diversity | #8 |
| 824 children | #8 |
| immunity gene expression | #8 |
| diversity year | #8 |
| asthma atopic sensitisation | #8 |
| asthma physiciandiagnosed asthma | #8 |
| airwayrelated symptoms | #8 |
| p4×10−9 | #8 |
| p7×10−14 | #8 |
| indoor microbiota | #8 |
| exposure dogs | #8 |
| finlande | #8 |
| p3×10−9 | #8 |
| 95 food allergy | #8 |
| sensitization mite | #8 |
| childhoodonset disease elevation | #8 |
| allergy study | #8 |
| th2 cells ilc2s | #8 |
| rs8076131 | #8 |
| c4ma3 | #8 |
| influence cytokine | #8 |
| agmr | #8 |
| amish child | #8 |
| diet year | #8 |
| asthma early life | #9 |
| ausprägungen | #9 |
| symptoms 12 months | #9 |
| clinical response score | #9 |
| fcer1a susceptibility locus | #9 |
| regular exposure | #9 |
| asthma antibiotics | #9 |
| association stat6 variation | #9 |
| microbial exposure | #9 |
| regulatory th17 cells | #9 |
| prevalence atopic | #9 |
| allergic phenotypes | #9 |
| ribosomal 16s risk | #9 |
| random subsample | #9 |
| unprocessed milk | #9 |
| asthma symptoms baseline | #9 |
| life ahr | #9 |
| relation asthma | #9 |
| asthma risk | #9 |
| germany munich | #9 |
| exposure farming environments | #9 |
| allergic preschool conjunctivitis | #9 |
| asthma infant | #9 |
| rural farm | #9 |
| eczema weight | #9 |
| teenagers asthma | #9 |
| allergic inflammation patients | #9 |
| animals supplementation | #9 |
| asthma child | #9 |
| partial nonresponders | #9 |
| dennd1b | #9 |
| 1314 children | #9 |
| asthma respiratory conditions | #9 |
| bronchial hyper‐responsiveness | #9 |
| polymorphisms development | #9 |
| drug development strategies | #9 |
| relation environment | #9 |
| cord blood cytokines | #9 |
| autriche | #9 |
| 1314yrolds | #9 |
| farming environment | #9 |
| ige levels gwas | #9 |
| chromosome ige levels | #9 |
| npsr1 snps | #9 |
| ecuador eczema | #9 |
| cytokines environmental | #9 |
| levels allergens | #9 |
| asthma allergy symptoms | #9 |
| skinprick | #9 |
| microbial substances | #9 |
| igg4 ige | #9 |
| association wheezing | #9 |
| life female germany | #9 |
| 105 years age | #9 |
| atopic sensitization children | #9 |
| positive spts | #9 |
| conjunctivitis cross | #9 |
| kazal type | #9 |
| rad50 gene chromosome | #9 |
| asthma child child | #9 |
| life prenatal exposure | #9 |
| allergic seasonal risk | #9 |
| 1 npsr1 | #9 |
| gwas approaches | #9 |
| longitudinal follow‐up | #9 |
| role human asthma | #9 |
| subspecies bifidobacterium | #9 |
| low levels hscrp | #9 |
| n7498 | #9 |
| tbx21 promoter | #9 |
| col29a1 variants | #9 |
| 5 european | #9 |
| study asthma | #9 |
| young german | #9 |
| factors sensitization | #9 |
| young german adults | #10 |
| centers prevalence rates | #10 |
| study occupational | #10 |
| house dust endotoxin | #10 |
| production cord blood | #10 |
| humans hypersensitivity | #10 |
| endotoxin muramic acid | #10 |
| farm exposures asthma | #10 |
| asthma nocturnal | #10 |
| 45 saline | #10 |
| bhr prevalence | #10 |
| context eczema | #10 |
| consumption raw | #10 |
| phase protocol | #10 |
| farm children children | #10 |
| receptors immunity | #10 |
| mechanisms oral tolerance | #10 |
| life allergen | #10 |
| bdnf gene variants | #10 |
| ige levels asthma | #10 |
| mattress dust | #10 |
| hormonal factors role | #10 |
| substances development | #10 |
| infection allergic | #10 |
| early life immunity | #10 |
| international study asthma | #10 |
| n1138 | #10 |
| prevalence differences | #10 |
| gabriel advanced studies | #10 |
| new zealand bhr | #10 |
| asthma chromosome | #10 |
| airway hyperresponsiveness children | #10 |
| rural school children | #10 |
| predictors health utilization | #10 |
| leipzig east germany | #10 |
| urban rural area | #10 |
| genetic probability receptors | #10 |
| countries centres | #10 |
| atopic dermatitis 95 | #10 |
| latex children | #10 |
| interrelations risk factors | #10 |
| bias exposure | #10 |
| blood samples tubes | #10 |
| reservoir method | #10 |
| 1992–2001 | #10 |
| ilt3 ilt4 | #10 |
| association new onset | #10 |
| association atopic | #10 |
| new onset rhinitis | #10 |
| indoor heating | #10 |
| adult cases controls | #10 |
| mothers contact | #10 |
| ratio asthma | #10 |
| missing values paper | #10 |
| blood foxp3 | #11 |
| farm buildings | #11 |
| children school entry | #11 |
| early life development | #11 |
| allergy risks | #11 |
| asthma bacterial | #11 |
| school beginners | #11 |
| newborn male polymorphism | #11 |
| active smoking association | #11 |
| lebensbedingungen | #11 |
| german schoolchildren | #11 |
| factors agriculture | #11 |
| npsr1 polymorphisms | #11 |
| atopic dust | #11 |
| samples persons | #11 |
| subsequent development asthma | #11 |
| farm exposures | #11 |
| health outcomes countries | #11 |
| atopy | #11 |
| microbiome lung | #11 |
| pregnancy early life | #11 |
| occupational disinfectants | #11 |
| reduced risk asthma | #11 |
| association respiratory health | #11 |
| cytokines allergic inflammation | #11 |
| allergic disease children | #11 |
| genotyped polymorphisms | #11 |
| persistent uncontrolled asthma | #11 |
| wheeze year | #11 |
| overweight body mass | #11 |
| fetal ige | #11 |
| symptoms allergic rhinoconjunctivitis | #11 |
| children rural | #11 |
| asthma lower | #11 |
| transient wheezing | #11 |
| tbx21 polymorphisms | #11 |
| tuberculosis notification rates | #11 |
| protective development | #11 |
| ige measurements | #11 |
| asthma risk participants | #11 |
| allergic asthma conjunctivitis | #11 |
| parsifal study | #11 |
| wheeze aor | #11 |
| ige grass | #12 |
| farm | #12 |
| increase prevalence | #12 |
| dermatitis phenotypes | #12 |
| children exposed children | #12 |
| asthma disease humans | #12 |
| exposure asthma symptoms | #12 |
| rural environments | #12 |
| asthma parent | #12 |
| polymorphisms bdnf gene | #12 |
| birth cohorts asthma | #12 |
| male respiratory | #12 |
| standard deviation skewness | #12 |
| female humans hypersensitivity | #12 |
| young adults school | #12 |
| incident asthma 95 | #12 |
| munich west germany | #12 |
| child environmental | #12 |
| damage mold | #12 |
| healthy children asthma | #12 |
| backgroundasthma | #12 |
| east germany munich | #12 |
| cattle child | #12 |
| asthma epidemic | #12 |
| children low levels | #12 |
| doctor asthma | #12 |
| current paracetamol | #12 |
| children background | #12 |
| mattress dust samples | #12 |
| multicentre allergy | #12 |
| management childhood asthma | #12 |
| fever exposure | #12 |
| german multicentre | #12 |
| overweight breast | #12 |
| infection analyses | #12 |
| symptoms atopic | #12 |
| early priming | #12 |
| participants allergic rhinitis | #12 |
| association moisture | #12 |
| validated questions | #12 |
| sensitization birth | #12 |
| stepwise protocol | #12 |
| hypersensitivity immunity | #12 |
| skin prick testing | #12 |
| asthma candidate gene | #12 |
| pet contact | #12 |
| age 105 years | #12 |
| 7 years data | #12 |
| polymorphism asthma | #12 |
| bhr wheeze | #12 |
| 95 nox | #12 |
| transient wheeze | #12 |
| asthmatic cohort | #12 |
| polymorphisms influence | #13 |
| asthma mental health | #13 |
| asthma outcomes patients | #13 |
| hygiene hypersensitivity | #13 |
| wheezing ages | #13 |
| sx1 | #13 |
| groups phenotype | #13 |
| allergic sensitisation children | #13 |
| asthma rhinoconjunctivitis | #13 |
| occupational exposure disinfectants | #13 |
| asthma snp | #13 |
| eastern western germany | #13 |
| rhinitis allergens | #13 |
| ibd sle | #13 |
| antibiotic exposure pregnancy | #13 |
| childhood allergy | #13 |
| children inhaled steroids | #13 |
| northern indiana | #13 |
| nod1 gene | #13 |
| spt specific ige | #13 |
| asthma bronchial | #13 |
| th1cells | #13 |
| childhood isaac | #13 |
| children polymorphisms | #13 |
| children raised | #13 |
| farm animal contact | #13 |
| local immunity | #13 |
| developing microbiota | #13 |
| farm dust | #13 |
| asthma community | #13 |
| npsr1 | #13 |
| cord adult blood | #13 |
| switzerland children | #13 |
| atopic eczema symptoms | #13 |
| subjects jobs | #13 |
| rural schoolchildren | #13 |
| asthma nocturnal symptoms | #13 |
| expression ormdl3 | #13 |
| dresden germany | #13 |
| n349 | #13 |
| farming exposures | #13 |
| introduction complementary food | #14 |
| allergic sensitization age | #14 |
| innate infant | #14 |
| nonaffluent countries | #14 |
| exacerbations fev1 | #14 |
| fx5 | #14 |
| breast feeding children | #14 |
| atopic environmental | #14 |
| upper respiratory symptoms | #14 |
| increased risk age | #14 |
| 7 polymorphisms | #14 |
| incidence rhinitis | #14 |
| delayed introduction solids | #14 |
| air challenge | #14 |
| role lung microbiome | #14 |
| positive spts age | #14 |
| polymorphisms ormdl3 | #14 |
| preventive development | #14 |
| farm rural | #14 |
| rhinitis conjunctivitis | #14 |
| burden prevalence | #14 |
| maternal sensitization | #14 |
| farming lifestyle | #14 |
| diabimmune study | #14 |
| standardised questionnaires | #14 |
| asthma1 | #14 |
| 3099 | #14 |
| mrna expression vivo | #14 |
| detailed questionnaires | #14 |
| th2 commitment | #14 |
| changing gender | #14 |
| german children | #14 |
| cross environmental exposure | #14 |
| 10‐year‐old children | #14 |
| late introduction | #14 |
| asthma step | #14 |
| asthma bronchial hyperresponsiveness | #14 |
| symptoms rhinoconjunctivitis | #14 |
| diseases atopic | #14 |
| respiratory atopic | #14 |
| untypical | #14 |
| il15 gene | #14 |
| bronchial hyperreactivity | #15 |
| children early | #15 |
| epidemiological studies exposure | #15 |
| factors bronchial | #15 |
| allele evidence | #15 |
| ω3 polyunsaturated | #15 |
| rhinitis puberty | #15 |
| street residence | #15 |
| sensitization indoor allergens | #15 |
| respective tlrs | #15 |
| children allele | #15 |
| diabimmune | #15 |
| association asthma symptoms | #15 |
| puberty rhinitis | #15 |
| contact farm animals | #15 |
| skin prick tests | #15 |
| pregnancy protective | #15 |
| immunity asthma | #15 |
| allele2 | #15 |
| 17q21 locus | #15 |
| mold problems | #15 |
| asthma allergy | #15 |
| bronchial responsiveness children | #15 |
| ahr male mice | #15 |
| unpasteurized | #15 |
| dogs children | #15 |
| allergy risk | #15 |
| nocturnal symptoms | #15 |
| polymorphisms atopy | #16 |
| burden childhood asthma | #16 |
| multi‐centre study | #16 |
| clinical response measures | #16 |
| lung microbiome health | #16 |
| asthma asthma risk | #16 |
| chronic asthma children | #16 |
| exposure atopic | #16 |
| n1133 | #16 |
| wheeze trajectories | #16 |
| seasonal surveys questionnaires | #16 |
| asthma farm | #16 |
| association atopy | #16 |
| 7 year | #16 |
| microbial exposures | #16 |
| newborn phenotype | #16 |
| nonatopic asthma children | #16 |
| hutterite | #16 |
| allergic diseases childhood | #16 |
| bacteria respiratory tract | #16 |
| sas institute | #16 |
| childhood asthma asthma | #16 |
| endotoxin house | #16 |
| 80 chromosomes | #16 |
| microbial environment | #16 |
| diseases allergy | #16 |
| protocadherin1 | #16 |
| 9 11 | #16 |
| increased food | #16 |
| levels microbial | #17 |
| factors atopic | #17 |
| asthma immune responses | #17 |
| allergic asthma aa | #17 |
| asthma associations | #17 |
| epidemiologic dermatitis | #17 |
| single microbial | #17 |
| eczema exposure | #17 |
| asthma biomarkers humans | #17 |
| asthma environment | #17 |
| asthma 95 | #17 |
| rhinoconjunctivitis | #17 |
| dust extract | #17 |
| munich | #17 |
| child allergic | #17 |
| humans preschool haemophilus | #17 |
| aerosol bolus | #17 |
| animals domestic | #17 |
| bavarian | #17 |
| ga2len skin | #17 |
| function school | #17 |
| pregnancy gene expression | #17 |
| respiratory health children | #17 |
| age 7 years | #17 |
| neuropeptide receptor npsr1 | #17 |
| munich germany | #17 |
| atopy childhood | #17 |
| persistent sensitization | #17 |
| variants increase | #17 |
| cb production | #18 |
| increase childhood | #18 |
| protective microbiota | #18 |
| 7 yrs | #18 |
| pregnancy 6 years | #18 |
| german populations | #18 |
| children german | #18 |
| phenotypes children | #18 |
| trajectories asthma | #18 |
| type employment | #18 |
| edna concentrations | #18 |
| female humans asthma | #18 |
| underlying responses | #18 |
| meat children | #18 |
| current wheezers | #18 |
| ormdl3 gene | #18 |
| maternal contact | #18 |
| preschool dna ribosomal | #18 |
| eczema 95 | #18 |
| measles infection | #18 |
| childrens mattresses | #18 |
| asthma 6 years | #18 |
| wheeze | #18 |
| immune adaptation | #18 |
| col29a1 | #18 |
| cbmcs | #18 |
| asthma exposure | #18 |
| atopy rhinitis | #18 |
| polymorphism genetic receptors | #18 |
| mef75 | #18 |
| maternallyacquired mice mice | #18 |
| asthma phenotyping | #18 |
| anthroposophic lifestyle | #18 |
| linkage disequilibrium polymorphisms | #19 |
| children current | #19 |
| life diversity | #19 |
| newonset symptoms | #19 |
| susceptibility human | #19 |
| tcell phenotypes | #19 |
| expression treg | #19 |
| regulatory tolllike receptor | #19 |
| seasonal risk | #19 |
| developing asthma | #19 |
| innate mice models | #19 |
| life exposures | #19 |
| asthma | #19 |
| disease atopic | #19 |
| german center | #19 |
| farming activities | #19 |
| receptors innate immune | #19 |
| arg130gln | #19 |
| crp levels age | #19 |
| life asthma risk | #19 |
| symptoms asthma | #19 |
| asthma report | #19 |
| viable bacterial counts | #19 |
| asthma bronchiale | #19 |
| ilt4 | #19 |
| sounds risk | #19 |
| higher levels endotoxin | #19 |
| poor symptom control | #19 |
| receptors innate | #19 |
| 3 years life | #19 |
| cary | #19 |
| birth 13 years | #19 |
| child crosssectional studies | #19 |
| atopy phenotypes | #19 |
| rural children | #19 |
| microbial association networks | #19 |
| asthma allergy development | #19 |
| atopic dermatitis studies | #19 |
| hscrp age | #19 |
| gene expression measurements | #20 |
| symptoms wheeze | #20 |
| life farm | #20 |
| atopy snps | #20 |
| asthma nonatopic asthma | #20 |
| animal exposure | #20 |
| haplotype studies | #20 |
| gender ratio | #20 |
| unboiled | #20 |
| farm environments | #20 |
| pvalues patients | #20 |
| asthma trajectories | #20 |
| adults childhood | #20 |
| school university | #20 |
| breast feeding risk | #20 |
| children living | #20 |
| stables | #20 |
| allergic disease prevalence | #20 |
| specific ige food | #20 |
| westernized countries | #20 |
| disease germany | #20 |
| persistent uncontrolled | #20 |
| dermatitis early | #20 |
| infant colonization | #20 |
| 6 haplotype | #20 |
| unhygienic | #20 |
| mice sod3 | #20 |
| dust female humans | #20 |
| inbred balb spores | #20 |
| isaac | #20 |
| npsr1 nps | #20 |
| eczema atopy | #21 |
| plasma erythrocyte membranes | #21 |
| tlr2 receptor | #21 |
| prevalence rates symptoms | #21 |
| pseudocroup | #21 |
| pregnancy production | #21 |
| gstm1 deficiency | #21 |
| environmental microbiome | #21 |
| farm environment | #21 |
| atopic asthma children | #21 |
| studies eczema | #21 |
| patients degradation | #21 |
| current asthma wheeze | #21 |
| markers early | #21 |
| bifidobacterium colonization | #21 |
| environment lifestyle | #21 |
| turkish children | #21 |
| children inhaled | #21 |
| c589t | #21 |
| children east | #21 |
| childhood background | #21 |
| tripeptidylpeptidases | #21 |
| asthma review | #21 |
| unremitting | #21 |
| development allergic diseases | #21 |
| n1062 | #21 |
| ige igg4 | #21 |
| bhr 95 | #21 |
| germany humans germany | #21 |
| hypersensitivity infant | #21 |
| rora | #21 |
| network differences | #21 |
| living germany | #22 |
| npsr1 gene | #22 |
| exposure germany | #22 |
| gabriel | #22 |
| samples dust | #22 |
| seasonal risk factors | #22 |
| alleles asthma | #22 |
| β1→3glucans | #22 |
| endotoxin house dust | #22 |
| asthmatic phenotypes | #22 |
| highschool | #22 |
| childhood atopy | #22 |
| respiratory diseases children | #22 |
| 17q21 asthma | #22 |
| lower prevalences | #22 |
| isaac childhood | #22 |
| food diversity | #22 |
| immune maturation | #22 |
| effective airway | #22 |
| crth2 th2 cells | #22 |
| lps risk | #22 |
| neonatal immune responses | #22 |
| feeding obesity | #22 |
| chromosome asthma | #22 |
| muramic acid | #22 |
| allergic rhinitis 95 | #22 |
| 95 prenatal exposure | #22 |
| objective sought | #22 |
| r753q | #22 |
| child cross | #23 |
| association atopic asthma | #23 |
| childhood allergies | #23 |
| nonfarm | #23 |
| asthma cats | #23 |
| asthma agents | #23 |
| traffic counts | #23 |
| new onset | #23 |
| gross national | #23 |
| fecal microbiota children | #23 |
| children adulthood | #23 |
| rapid alternative | #23 |
| bronchial challenge tests | #23 |
| 7 prevalence | #23 |
| single taxa | #23 |
| breast feeding asthma | #23 |
| farm childhood | #23 |
| symptoms atopic eczema | #23 |
| southern bavaria | #23 |
| isaac phase | #23 |
| nonlinear relations | #23 |
| microbiota respiratory | #23 |
| asthma 12 months | #23 |
| hillerød | #23 |
| wheeze symptoms | #24 |
| haying | #24 |
| children indoor | #24 |
| dust endotoxin | #24 |
| west german | #24 |
| doctor diagnosed | #24 |
| current symptoms | #24 |
| asthma age | #24 |
| countrys | #24 |
| allergic respiratory symptoms | #24 |
| eczema susceptibility | #24 |
| asthma early | #24 |
| contact livestock | #24 |
| 2fold risk | #24 |
| tobit regression | #24 |
| 4 phenotypes | #24 |
| differences asthma prevalence | #24 |
| gene expression immunity | #24 |
| allergic dermatitis | #24 |
| exposure road traffic | #24 |
| bronchitis child | #24 |
| asthma bhr | #24 |
| asthma prevention | #24 |
| phenotypes childhood | #24 |
| asthma cross | #24 |
| asthma aa | #24 |
| asthma 5 years | #24 |
| environmental determinants | #25 |
| il13 pathway | #25 |
| antibiotic year | #25 |
| 5030 | #25 |
| farm animals | #25 |
| methods association | #25 |
| expression ige | #25 |
| exposure paracetamol | #25 |
| igg1 ige | #25 |
| cytokines children | #25 |
| prevention asthma | #25 |
| sensitization early | #25 |
| car traffic | #25 |
| 2 12 months | #25 |
| risk atopic diseases | #25 |
| early atopic | #26 |
| levels mite | #26 |
| early phenotypes | #26 |
| environmental asthma | #26 |
| allergen sensitisation | #26 |
| child conjunctivitis | #26 |
| blood samples children | #26 |
| 3rd year | #26 |
| trendwise | #26 |
| farms humans | #26 |
| risk allergic sensitization | #26 |
| 5 european countries | #26 |
| increased treg | #26 |
| card4 | #26 |
| risk factors probability | #26 |
| wheezing childhood | #26 |
| written questionnaire | #26 |
| clinical phenotypes children | #26 |
| fev1 bhr | #26 |
| sputum eosinophils feno | #26 |
| microbiota asthma | #26 |
| asthma syndrome | #26 |
| asthma childhood | #27 |
| asthma child cross | #27 |
| allergens europe | #27 |
| childhood origins | #27 |
| visible mould | #27 |
| ilt3 | #27 |
| children parental asthma | #27 |
| association childhood asthma | #27 |
| single snps | #27 |
| muramic | #27 |
| wheeze childhood | #27 |
| npsr1 asthma | #27 |
| specific ige levels | #27 |
| prevention allergic diseases | #27 |
| factors year | #27 |
| prevalence fever | #27 |
| respiratory infections year | #27 |
| asthma environmental | #27 |
| children asthma symptoms | #27 |
| consumption raw milk | #27 |
| asthmatic participants | #27 |
| prevalence atopic eczema | #27 |
| 035 iu | #27 |
| 9 11 years | #27 |
| childhood asthma risk | #28 |
| analysis lca | #28 |
| atopic phenotypes | #28 |
| weekly diaries | #28 |
| levels sensitization | #28 |
| higher hrqol | #28 |
| 10 years data | #28 |
| dust children | #28 |
| ige therapy | #28 |
| il13 polymorphisms | #28 |
| gene asthma | #28 |
| early identification children | #28 |
| immune phenotypes | #28 |
| feno fev1 | #28 |
| host factors infection | #28 |
| east germany | #28 |
| recurrence persistence | #28 |
| pregnancy increase | #28 |
| centers prevalence | #29 |
| pblc | #29 |
| anthroposophy | #29 |
| vivo age | #29 |
| adult agriculture | #29 |
| acinetobacter lwoffii | #29 |
| women males | #29 |
| pediatric asthma patients | #29 |
| dust indoor | #29 |
| farming | #29 |
| enhanced expression genes | #29 |
| early years life | #29 |
| bioair | #29 |
| polymorphisms identified | #29 |
| mite sensitization | #29 |
| questionnaires urban | #29 |
| preschool environmental | #29 |
| polymorphisms il13 | #29 |
| primary prevention asthma | #29 |
| rad50 gene | #29 |
| dismutase 3 | #30 |
| incidence recurrence | #30 |
| affluent | #30 |
| biodiversity child | #30 |
| viral infections asthma | #30 |
| boys asthma | #30 |
| effective ways | #30 |
| il10 snps | #30 |
| asthma childhood asthma | #30 |
| questionnaires asthma | #31 |
| persons european ancestry | #31 |
| children diagnosed asthma | #31 |
| card4 nod1 | #31 |
| enhancer marks | #31 |
| ribosomal preschool dna | #31 |
| childhood infectious | #31 |
| traditional farming | #31 |
| il10 polymorphisms | #31 |
| atopic food | #31 |
| atopy children | #31 |
| probability persistence | #31 |
| centres countries | #31 |
| moisture damage | #31 |
| bronchial obstruction | #31 |
| asthma atopic | #31 |
| atopic diseases | #32 |
| gata3 gene | #32 |
| preschool day | #32 |
| epidemiology asthma | #32 |
| allergic diseases age | #32 |
| huge burden | #32 |
| association paracetamol | #32 |
| rural regions | #32 |
| microbial components | #32 |
| susceptibility asthma | #32 |
| asthma odds ratio | #32 |
| prick tests | #32 |
| studies dermatitis | #32 |
| african ancestry asthma | #32 |
| transferase deficiency | #32 |
| germany leipzig | #32 |
| infants countries | #32 |
| r2447x | #32 |
| obese children age | #32 |
| living environments | #32 |
| doctordiagnosed | #32 |
| microbial environments | #32 |
| symptoms childhood | #32 |
| disease childhood | #32 |
| linked polymorphisms | #32 |
| européens | #32 |
| cohorts asthma | #32 |
| asthma associations loci | #33 |
| allergic genetic epigenesis | #33 |
| genetic epigenesis allergic | #33 |
| immune cell enhancer | #33 |
| bhr fev1 | #33 |
| eczema prevalence | #33 |
| imputation data | #33 |
| multiancestry association | #33 |
| specificity skin tests | #33 |
| multiancestry association study | #33 |
| dust microbiota | #34 |
| asthma atopic eczema | #34 |
| asthma risk children | #34 |
| health utilization children | #34 |
| development atopy | #34 |
| tests surveys | #34 |
| participants questionnaire | #34 |
| bacterial farms | #34 |
| studies dust | #34 |
| pattern frequency | #34 |
| new onset symptoms | #34 |
| clec4e | #34 |
| curve asthma | #34 |
| participants childhood | #34 |
| endotoxins environmental | #34 |
| pregnancy maternal health | #34 |
| fascinating | #34 |
| mite allergen exposure | #34 |
| infant contact | #34 |
| year life | #34 |
| indoor mould | #34 |
| bradykinin receptor gene | #34 |
| western lifestyle | #35 |
| feno lung function | #35 |
| farms female | #35 |
| anthroposophic | #35 |
| 95 atopic dermatitis | #35 |
| western germany | #35 |
| asthma asthma phenotypes | #35 |
| risk asthma | #35 |
| urbanrural differences | #35 |
| diseases rhinitis | #35 |
| prick testing | #35 |
| tagging polymorphisms | #35 |
| children cross | #35 |
| nonatopic mothers | #35 |
| preschool fatty acids | #35 |
| germany haplotypes | #35 |
| analysis steps | #35 |
| asthma conjunctivitis | #35 |
| endotoxin levels | #35 |
| wingedhelix | #35 |
| raw cows milk | #35 |
| maternal vitamin intake | #36 |
| 1 stimulation | #36 |
| exposure genetic | #36 |
| asthma dendritic cells | #36 |
| prevalence childhood asthma | #36 |
| chapter 1 epidemiology | #36 |
| skin test reactivity | #36 |
| tolerance biomarkers | #36 |
| leipzig | #36 |
| 16s rrna data | #36 |
| maternal exposures | #36 |
| nasal samples | #37 |
| lifestyle environment | #37 |
| asthma candidate | #37 |
| allemagne | #37 |
| ril33 | #37 |
| 8263 | #37 |
| case status | #37 |
| incidence persistence | #37 |
| native milk | #37 |
| earlylife exposures | #37 |
| ormdl3 expression | #38 |
| maximum expiratory flow | #38 |
| recurrence risk factors | #38 |
| nps npsr1 | #38 |
| life increased | #38 |
| association ndvi | #38 |
| asthma cough | #38 |
| foxp3 levels | #38 |
| development allergic | #38 |
| reverse causation | #38 |
| atopy prevalence | #38 |
| mouse model asthma | #38 |
| innate immunity genes | #38 |
| amish | #38 |
| endotoxin asthma | #38 |
| asthma allergens | #38 |
| allergy birth | #38 |
| wisc | #38 |
| dust asthma | #38 |
| eczema environmental | #38 |
| itchy | #38 |
| levels house | #39 |
| diversity environmental | #39 |
| igg nglycosylation | #39 |
| polymorphisms asthma | #39 |
| ige switching | #39 |
| traffic asthma | #39 |
| c589 | #39 |
| seasonal perennial | #39 |
| wheezing phenotypes | #39 |
| genetic rhinitis | #39 |
| allergic symptoms children | #39 |
| protect children | #39 |
| degradation patients | #39 |
| maternal health pregnancy | #39 |
| adulthood risk factors | #39 |
| haploview | #39 |
| mite exposure | #40 |
| symptoms allergic | #40 |
| antibiotics development | #40 |
| children bronchial | #40 |
| 4606 | #40 |
| isolated polysaccharides | #40 |
| eczema | #40 |
| animal farms | #40 |
| preschool conjunctivitis | #40 |
| biodiversity health | #40 |
| transcription 6 | #40 |
| crosssectional studies | #40 |
| allergic child | #41 |
| small airway dysfunction | #41 |
| eczema phenotypes | #41 |
| asthma wheeze | #41 |
| treg cells patients | #41 |
| risk factors health | #41 |
| stress young | #41 |
| allergens age | #41 |
| german cities | #41 |
| farm residence | #41 |
| discotheques | #41 |
| effects asthma | #41 |
| 95 antibiotics | #42 |
| food questionnaire | #42 |
| dust female | #42 |
| pcdh1 | #42 |
| international patterns | #42 |
| polymorphism single nucleotide | #42 |
| microbiome data | #42 |
| onset year | #42 |
| bronchiale | #42 |
| increased regulatory | #43 |
| subspecies infantis | #43 |
| treg th17 cells | #43 |
| asthma onset | #43 |
| time asthma | #43 |
| dermatitis food | #43 |
| worldwide variations | #43 |
| sensitized subjects | #43 |
| asthma food | #43 |
| asthma food allergy | #44 |
| work overload | #44 |
| sequential switching | #44 |
| early childhood infections | #44 |
| diseases childhood | #44 |
| increased risk symptoms | #44 |
| 97th | #44 |
| national institute allergy | #44 |
| cells cord | #44 |
| gsdma | #44 |
| developing countries children | #44 |
| wide variations | #44 |
| atopic diseases asthma | #44 |
| prevalence symptoms | #44 |
| asthma cystic fibrosis | #44 |
| followup physical activity | #44 |
| facklamia | #44 |
| microbiome asthma | #44 |
| atp2a3 | #44 |
| sensitization inhalant | #45 |
| 7445 | #45 |
| animals pregnancy | #45 |
| questionnaire responses | #45 |
| bamse | #45 |
| phenotype respiratory | #45 |
| fever 95 | #45 |
| traffic exposure | #45 |
| antiasthma drugs | #45 |
| biodiversity hypothesis | #45 |
| dust endotoxins | #45 |
| exposure early life | #45 |
| severe atopic eczema | #45 |
| birth 12 months | #45 |
| control physical | #46 |
| asthma gwas | #46 |
| farm animal | #46 |
| receptor tolllike receptors | #46 |
| prevalence bhr | #46 |
| adolescence differences | #46 |
| improvement reduction | #46 |
| prevalence diseases | #46 |
| spt reactivity | #46 |
| atopic diseases children | #46 |
| prevalence current wheeze | #46 |
| asthma cluster | #46 |
| evidence gene | #46 |
| humans hygiene | #46 |
| tirana | #47 |
| germany east | #47 |
| wheeze phenotypes | #47 |
| franche | #47 |
| factors asthma | #47 |
| analysis step | #47 |
| efraim | #47 |
| 95 eczema | #47 |
| prevalence rhinoconjunctivitis | #47 |
| children atopic disease | #47 |
| international study | #47 |
| asthma risk loci | #48 |
| lung function spirometry | #48 |
| fungal flora | #48 |
| parental interviews | #48 |
| prevalences asthma | #48 |
| cluster children | #48 |
| frequent wheeze | #48 |
| doctordiagnosed asthma | #48 |
| halle | #48 |
| perennial allergens | #48 |
| asthma adjusted | #48 |
| polymorphisms il4 | #48 |
| breath volatile | #48 |
| wheeze age | #48 |
| airways diseases | #48 |
| asthma biological | #48 |
| children female humans | #49 |
| chromosome susceptibility | #49 |
| milk farm | #49 |
| risk factors incidence | #49 |
| fcer1a | #49 |
| children paracetamol | #49 |
| n228 | #49 |
| pcrsscp | #50 |
| beta13glucans | #50 |
| unpasteurized milk | #50 |
| exposures asthma | #50 |
| physiciandiagnosed | #50 |
| longum subsp infantis | #50 |
| diversity food | #50 |
| bacterial markers | #50 |
| background atopic | #50 |
| common chronic disease | #51 |
| igg1 igg4 | #51 |
| association atopic dermatitis | #51 |
| maintenant | #51 |
| conjugated mice mice | #51 |
| asthma dust | #51 |
| lwoffii | #51 |
| allergy symptoms | #51 |
| microbial burden | #51 |
| asthma maternal | #51 |
| populationattributable risk | #51 |
| association allergic | #51 |
| identified polymorphisms | #51 |
| children cities | #51 |
| country prevalence | #51 |
| bmi asthma | #52 |
| wheeze cough | #52 |
| age wheezing | #52 |
| epidemiologischen | #52 |
| 9357 | #52 |
| sensitization children | #52 |
| prevalence wheeze | #52 |
| geneenvironment interactions | #52 |
| milk consumption | #52 |
| infant study | #52 |
| indoor endotoxin | #52 |
| ige sige | #52 |
| specific protective | #52 |
| gpra | #52 |
| itchy rash | #52 |
| doctor diagnosis | #52 |
| eczema childhood | #52 |
| atopic eczema children | #53 |
| adam33 asthma | #53 |
| ige children | #53 |
| early life exposure | #53 |
| outdoor pollution | #53 |
| il13 gene | #53 |
| 2q32 | #53 |
| life exposure | #53 |
| children current asthma | #53 |
| cross sectional studies | #54 |
| prevalence wheezing | #54 |
| nonmicrobial | #54 |
| asthma odds | #54 |
| estonian children | #54 |
| male prevalence | #54 |
| animals asthma | #54 |
| female germany life | #54 |
| bacterial microbiota | #55 |
| year asthma | #55 |
| samples farm | #55 |
| stepwise procedure | #55 |
| prevalence association | #55 |
| cough wheeze | #55 |
| visible mold | #56 |
| atopy development | #56 |
| alex study | #56 |
| immunoglobulin interleukin13 | #56 |
| tuberculosis notification | #56 |
| random samples | #56 |
| asthma atopy | #56 |
| cd14 tolllike receptor | #56 |
| adult asthma patients | #56 |
| maternal ige | #56 |
| strong protective | #56 |
| 3785 | #57 |
| member 1 polymorphism | #57 |
| derp1 | #57 |
| diseases methods | #57 |
| eczema flg | #57 |
| adam33 polymorphisms | #57 |
| atopy wheeze | #57 |
| prevention allergic | #57 |
| pollutant exposure | #57 |
| mef50 | #57 |
| life atopic dermatitis | #57 |
| asthma allergic rhinoconjunctivitis | #57 |
| mononuclear lipid | #57 |
| specificity asthma | #58 |
| early asthma | #58 |
| reported parents | #58 |
| total serum | #58 |
| stat6 gene | #58 |
| hypersensitivity immunoglobulin | #58 |
| diseases children | #58 |
| eczema female | #58 |
| th17 lineage | #59 |
| german participants | #59 |
| finland estonia | #59 |
| asthma morbidity children | #59 |
| farm families | #59 |
| 1q31 | #59 |
| milk cla | #59 |
| 6 years age | #59 |
| beta 2agonists | #60 |
| development childhood | #60 |
| iedap | #60 |
| rna yield | #60 |
| predictors incidence | #60 |
| preschool wheezing | #60 |
| allergic surveys | #60 |
| birth school age | #60 |
| breastfed children | #61 |
| atopy eczema | #61 |
| implicated genes | #61 |
| species colonization | #61 |
| seasonal skin tests | #61 |
| exposure asthma | #61 |
| life immune | #62 |
| respiratory sounds | #62 |
| development airway hyperresponsiveness | #62 |
| large german | #62 |
| persistence asthma | #62 |
| asthma birth | #62 |
| childhoodonset asthma | #62 |
| immunoglobulin infant | #62 |
| estonia finland | #62 |
| endotoxin level | #63 |
| indoor allergen exposure | #63 |
| children regions | #63 |
| total quantity | #63 |
| asthma breast | #63 |
| dermatitis risk | #63 |
| atopic | #63 |
| hyperreactivity bronchial | #63 |
| children role | #63 |
| cystic fibrosis abpa | #63 |
| exposure assessed | #63 |
| dust parameters | #64 |
| differential networks | #64 |
| no2 benzene | #64 |
| helminth ascariasis ascaris | #64 |
| allergenspecific ige | #64 |
| newborn lymphocyte | #64 |
| children centers | #64 |
| healthy controls children | #65 |
| risk wheezing | #65 |
| animal contact | #65 |
| childhood allergic diseases | #65 |
| umc | #66 |
| allergic rhinitis age | #66 |
| immunological data | #66 |
| prevalence current asthma | #66 |
| dust extracts | #66 |
| sensitization allergic | #66 |
| living area | #66 |
| atopic symptoms | #66 |
| ga²len | #66 |
| preschool haemophilus humans | #66 |
| pa obesity | #67 |
| respiratory allergies | #67 |
| ige expression | #67 |
| maternal atopy | #67 |
| biomarkers predictors | #67 |
| 2 questionnaires | #67 |
| mère | #68 |
| early wheeze | #68 |
| antibiotic sales | #68 |
| weight boys | #68 |
| ige allergens | #69 |
| hypersensitivity immunization | #70 |
| atopic disease children | #70 |
| allergic disorders | #70 |
| asthma complex | #70 |
| sod3 | #70 |
| suisse | #70 |
| gene gene interaction | #70 |
| unprocessed | #71 |
| small airway function | #71 |
| occurrence progression | #71 |
| prenatal vitamin | #71 |
| barns | #71 |
| tlr2 tlr1 | #71 |
| allergic sensitization children | #71 |
| atopic rhinitis | #71 |
| breathomics | #71 |
| factor asthma | #72 |
| molecular fingerprinting | #72 |
| children wheeze | #72 |
| association occupational exposure | #72 |
| 158 95 | #72 |
| infantis | #72 |
| persistent asthma children | #72 |
| european ancestry association | #73 |
| sounds respiratory | #73 |
| onset allergic | #73 |
| gni | #73 |
| ormdl3 | #73 |
| food allergy asthma | #74 |
| risk wheeze | #74 |
| exposure europe | #74 |
| health services children | #74 |
| severe eczema | #74 |
| west humans | #74 |
| asthma genome | #75 |
| chromosome 17q21 | #75 |
| asthmatic mothers | #75 |
| total serum ige | #75 |
| rfel | #75 |
| standardized procedure | #75 |
| maternal immunity | #75 |
| children hrqol | #75 |
| allergy childhood | #76 |
| food inhalant | #76 |
| microbial molecules | #76 |
| symptoms eczema | #76 |
| rural differences | #76 |
| asthma case | #76 |
| wheezing | #76 |
| eczema children | #76 |
| hyperresponsiveness bhr | #77 |
| 9 mmp9 | #77 |
| asthma healthy | #77 |
| diversity microbial | #77 |
| sexspecific association | #77 |
| turkish origin | #78 |
| findings prevalence | #78 |
| wheezing illnesses | #78 |
| childhood | #78 |
| edta tubes | #78 |
| rhinitis atopic | #78 |
| blood cytokines | #78 |
| sensitisation children | #78 |
| mothers asthma | #78 |
| years odds | #78 |
| 6399 | #78 |
| neuropeptide receptor | #79 |
| interactions snps | #79 |
| seasonal asthma | #79 |
| milk yoghurt | #79 |
| 95 protection | #79 |
| genes innate immunity | #79 |
| cats child | #80 |
| dander | #80 |
| ige skin | #80 |
| symptoms 12 | #81 |
| prevalence respiratory | #81 |
| forkhead box protein | #81 |
| lower prevalence | #81 |
| development atopic dermatitis | #81 |
| microbial agents | #81 |
| childhood wheeze | #81 |
| bacterial viral infections | #82 |
| children european | #82 |
| age 45 | #82 |
| introduction solids | #82 |
| 13 14 | #82 |
| concentrations so2 | #82 |
| ribosomal pcr | #82 |
| age prevalence | #82 |
| laryngitis | #82 |
| total fat content | #83 |
| study pcr | #83 |
| hypersensitivity risk | #83 |
| microbial stimulation | #83 |
| study population patients | #83 |
| cleanliness | #83 |
| gut commensals | #83 |
| reporter genetic predisposition | #83 |
| children siblings | #83 |
| current wheezing | #83 |
| 4732 | #84 |
| new asthma | #84 |
| tests child | #84 |
| control pa | #84 |
| specific exposures | #84 |
| oligoarticular juvenile | #84 |
| bronchial responsiveness | #85 |
| n134 | #85 |
| single nucleotide rna | #85 |
| atopy risk | #85 |
| α1 antitrypsin | #85 |
| européenne | #85 |
| comté | #86 |
| truck traffic | #86 |
| children feeding | #86 |
| bifidobacterium species | #86 |
| infant inflammation | #86 |
| wheeze prevalence | #86 |
| hyper responsiveness | #86 |
| arabinogalactan | #86 |
| ige levels | #86 |
| genes asthma | #87 |
| exposure associations | #87 |
| influential factors | #87 |
| age asthma | #87 |
| visits asthma | #87 |
| 95 fever | #87 |
| analysis respiratory | #87 |
| asthma polymorphisms | #88 |
| exposure tobacco smoke | #88 |
| tolllike receptors tlrs | #88 |
| allergy tests | #88 |
| pollution allergens | #88 |
| rhinitis risk | #88 |
| asthma phenotypes | #89 |
| aged 6 | #89 |
| asthma children | #89 |
| rphl | #89 |
| bronchial hyper | #89 |
| critical time window | #90 |
| children area | #90 |
| current exposure | #90 |
| allergic seasonal surveys | #90 |
| newborn limit | #91 |
| newborn leukocytes | #91 |
| joint workshop | #91 |
| filaggrin mutations | #91 |
| asthma school | #91 |
| development eczema | #91 |
| sensitisation | #92 |
| mononuclear polymorphism | #92 |
| previous studies association | #93 |
| rs2305480 | #93 |
| preschool haemophilus | #93 |
| geführt | #93 |
| south germany | #93 |
| allergic rhinitis symptoms | #93 |
| experimental asthma | #93 |
| low levels exposure | #93 |
| east west germany | #93 |
| pertussis infection | #94 |
| zpbp2 | #94 |
| tregulatory cells | #94 |
| asthma common | #95 |
| nickel allergy | #95 |
| fed children | #95 |
| greater consumption | #95 |
| 16q12 | #95 |
| asthma loci | #95 |
| university life | #95 |
| eczema symptoms | #95 |
| international variation | #95 |
| expression toll | #95 |
| trigger factors | #96 |
| anaphylaxie | #96 |
| lps recognition | #96 |
| dust environmental | #96 |
| dysbalance | #96 |
| expression th1 | #96 |
| cumulative prevalence | #96 |
| onset wheeze | #96 |
| airway dysfunction | #96 |
| allergic sensitisation | #96 |
| nonfarmers | #96 |
| 95 overweight | #97 |
| city air | #97 |
| regulatory treg | #97 |
| indoor factors | #97 |
| inhalant allergens | #97 |
| schoolchildren aged | #97 |
| background asthma | #98 |
| age 3 years | #98 |
| childhood adulthood | #98 |
| seasonal sensitivity | #98 |
| factors school | #98 |
| children germany | #98 |
| tlr1 tlr2 | #98 |
| asthma inflammation | #99 |
| comprehensive questionnaire | #99 |
| children atopic | #99 |
| years aor | #99 |
| current wheeze | #99 |
| seasonal surveys | #99 |
| earlyonset asthma | #99 |
| eastern germany | #99 |
| rural school | #99 |
| isaac questionnaire | #100 |
| preschool crosssectional studies | #100 |
| childhood atopic dermatitis | #100 |
| genetic factors susceptibility | #101 |
| weight girls | #101 |
| mef25 | #101 |
| raw cow | #101 |
| expression measurements | #101 |
| summarised | #101 |
| ige concentrations | #102 |
| risk factors persistence | #102 |
| tenascin tnc | #102 |
| factors wheezing | #102 |
| effects respiratory | #102 |
| retinoid acid | #102 |
| 4264 | #103 |
| irf1 gene | #103 |
| years early | #103 |
| hdm exposure | #103 |
| sensitization eczema | #103 |
| children increased risk | #103 |
| children relation | #104 |
| sensitization childhood | #104 |
| exposure milk | #104 |
| arabinogalactans | #105 |
| high‐sensitivity | #105 |
| hutterites | #105 |
| hyperreactivity | #105 |
| pollen concentration | #105 |
| wheezing disorders | #106 |
| physiciandiagnosed asthma | #106 |
| questionnaires switzerland | #106 |
| animal dander | #106 |
| children contact | #106 |
| blood ige | #106 |
| prevalence atopy | #106 |
| underlying factor | #107 |
| detailed questionnaire | #107 |
| socs4 | #107 |
| puberty age | #107 |
| breast feeding | #108 |
| fever episodes | #108 |
| inverse associations | #108 |
| overweight 95 | #108 |
| allergic perennial rhinitis | #109 |
| complex syndrome | #109 |
| healthy children children | #109 |
| air pollution children | #109 |
| moulds | #109 |
| publication air pollution | #109 |
| asthma wheezing | #109 |
| folgenden | #110 |
| atopic eczema humans | #110 |
| p≤003 | #110 |
| rs7216389 | #110 |
| genotype germany | #110 |
| female germany | #110 |
| parental questionnaire | #111 |
| il4ra | #111 |
| tbox transcription factor | #112 |
| female histones | #112 |
| environmental study | #112 |
| 1314 | #112 |
| olive pollen | #112 |
| milk samples | #112 |
| phenotypes asthma | #113 |
| risk allergic | #113 |
| indoor asthma | #113 |
| experimental allergic asthma | #113 |
| allergic | #113 |
| flg variants | #113 |
| asthma sensitization | #114 |
| occupational allergy | #114 |
| allergic disease | #114 |
| challenge data | #114 |
| parent reported | #114 |
| mould exposure | #114 |
| tests bronchial | #114 |
| cord blood ige | #115 |
| igg4 responses | #115 |
| cough children | #115 |
| notification rates | #115 |
| foxp3 locus | #115 |
| increased diversity | #115 |
| immune responsiveness | #116 |
| exclusive breast feeding | #116 |
| aged 9 | #116 |
| regulatory th17 | #116 |
| psychosocial characteristics | #117 |
| children underwent | #117 |
| glutathione transferase gst | #117 |
| indoor microbial | #118 |
| reference children | #118 |
| living rural | #118 |
| skinprick tests | #118 |
| allergic sensitization | #118 |
| germany humans | #118 |
| ratio prevalence | #118 |
| west germany | #118 |
| skin prick | #119 |
| ancestry asthma | #119 |
| switching immunoglobulin | #119 |
| children wheezing | #119 |
| delayed introduction | #119 |
| association chromosome | #120 |
| environment children | #120 |
| levels endotoxin | #120 |
| fibrolysis | #120 |
| childhood risk factors | #120 |
| dampness | #121 |
| symptom control | #121 |
| lung function measurements | #121 |
| factors rural | #121 |
| vitamin supplementation pregnancy | #121 |
| common aeroallergens | #121 |
| allergens asthma | #121 |
| aliments | #121 |
| life early | #122 |
| preventive potential | #122 |
| tlr10 | #122 |
| 300 people | #122 |
| urban traffic | #123 |
| hayfever | #123 |
| frequency pattern | #123 |
| active asthma | #124 |
| passive smoke exposure | #124 |
| germany prevalence | #124 |
| atopic manifestations | #124 |
| severe eosinophilic asthma | #124 |
| il18r1 | #125 |
| immunologic tolllike receptor | #125 |
| common inhalant | #125 |
| potted plants | #125 |
| paediatric studies | #126 |
| exposure pets | #126 |
| sensitization development | #126 |
| prevalence allergic diseases | #126 |
| effects prevalence | #126 |
| asthma background | #126 |
| 3 infections | #126 |
| await | #126 |
| eczema patients | #126 |
| parent questionnaire | #127 |
| caspase recruitment domain | #127 |
| test reactivity | #127 |
| exposure endotoxin | #127 |
| prävalenz | #127 |
| 95 ors | #127 |
| adaptive cells | #127 |
| allergens child | #127 |
| environmental allergens | #127 |
| bdnf polymorphisms | #128 |
| bdnf gene | #129 |
| receptors male | #129 |
| microbial markers | #129 |
| medall | #130 |
| protein allergy | #131 |
| respiratory symptoms children | #131 |
| sensitization allergens | #131 |
| hypersensitivity respiratory | #131 |
| asthma objective | #131 |
| test study | #131 |
| factors allergens | #131 |
| common allergens | #131 |
| severe eosinophilic | #131 |
| effects development | #132 |
| diseases asthma | #132 |
| asthma adolescent | #132 |
| male occupational | #132 |
| expression receptors | #132 |
| immunoglobulin inflammation | #132 |
| bavaria | #133 |
| pollen prevalence | #133 |
| early age | #133 |
| understanding natural | #133 |
| age 7 | #133 |
| allergy | #134 |
| dpp10 | #134 |
| 7 years age | #134 |
| childhood risk | #135 |
| body composition bmi | #135 |
| 95 ages | #135 |
| crth2 | #135 |
| prevalence rhinitis | #135 |
| allergic phenotype | #136 |
| eczema risk | #136 |
| bronchial response | #136 |
| 60 iu | #136 |
| asthma young | #136 |
| 6 7 | #137 |
| mechanisms asthma | #137 |
| snps asthma | #137 |
| exposure children | #137 |
| ms4a2 | #137 |
| ga2len | #137 |
| actinomycetes | #137 |
| asthma development | #138 |
| asthma atopic dermatitis | #138 |
| régions | #138 |
| reduced prevalence | #138 |
| mattress | #138 |
| pollutants allergens | #138 |
| sensitized children | #138 |
| snps interactions | #138 |
| milk animals | #139 |
| sebacate | #139 |
| pollution asthma | #139 |
| listeria spp | #139 |
| allergen levels | #139 |
| 3 14 | #139 |
| serum ige | #139 |
| exposure symptoms | #140 |
| largest reduction | #140 |
| tregs foxp3 | #140 |
| pasture | #140 |
| microbiota children | #140 |
| duration type | #140 |
| asthma genes | #141 |
| exposure indoor | #141 |
| age 6 years | #141 |
| questionnaires illness surveys | #142 |
| asthma bronchitis | #142 |
| cla content | #142 |
| indoor allergens | #142 |
| n183 | #142 |
| susceptibility children | #142 |
| factors difference | #142 |
| unifrac | #143 |
| pregnancy early | #143 |
| inconclusive | #144 |
| snps chromosome | #144 |
| asthma defined | #144 |
| exposure year | #144 |
| pet exposure | #144 |
| replication association | #144 |
| incident asthma | #144 |
| dermatitis asthma | #145 |
| onset menarche | #145 |
| children allergy | #145 |
| expositions | #145 |
| lower airways | #146 |
| prematurely born children | #146 |
| prevalence skin | #146 |
| interleukin13 interleukin4 | #146 |
| allergy testing | #146 |
| airway mechanics | #146 |
| health outcomes children | #146 |
| original article | #147 |
| biomarkers child | #147 |
| study centers | #147 |
| children 6 | #148 |
| germany west | #148 |
| association early | #148 |
| feno patients | #148 |
| early immune | #149 |
| atopic outcomes | #149 |
| indoor allergen | #149 |
| perennial rhinitis allergic | #150 |
| fall fev1 | #150 |
| pregnancy respiratory | #150 |
| 105 years | #151 |
| confer protection | #151 |
| wheezing children | #151 |
| prevalence childhood | #151 |
| wheeze children | #151 |
| profound differences | #151 |
| distribution asthma | #152 |
| children review | #152 |
| environmental exposure | #152 |
| immunomodulatory molecules | #152 |
| established asthma | #152 |
| exposure increased | #152 |
| consumption dairy products | #152 |
| bhr | #152 |
| hens egg | #153 |
| common respiratory | #153 |
| asthma dermatitis | #153 |
| function measurements | #153 |
| tagging single | #153 |
| wheeze asthma | #153 |
| cd28null | #154 |
| hormonal factors | #154 |
| onset association | #155 |
| neighboring countries | #155 |
| bronchial challenge | #155 |
| tests sex factors | #155 |
| association asthma | #156 |
| atopic children | #156 |
| neu5gc | #157 |
| development allergy | #157 |
| severity frequency | #157 |
| gene 3 | #157 |
| absolute levels | #157 |
| positive spt | #157 |
| paediatric asthma | #158 |
| lower diversity | #158 |
| bacterial lysates | #158 |
| asthma females | #158 |
| early environmental | #158 |
| children asthma | #159 |
| patients controlled asthma | #159 |
| prevention allergy | #159 |
| developing immune | #159 |
| microbiome diversity | #160 |
| children homes | #160 |
| children rhinitis | #160 |
| german adults | #160 |
| reported prevalence | #160 |
| allergic seasonal | #160 |
| spts | #160 |
| atopy asthma | #161 |
| asthma presence | #161 |
| preventive measure | #161 |
| wheeze rhinitis | #161 |
| newborn longitudinal | #161 |
| parental asthma | #162 |
| female humans allergic | #162 |
| children lower | #162 |
| immune pathways | #162 |
| specific ige | #163 |
| perennial rhinitis | #163 |
| environmental associations | #163 |
| exposure prevalence | #163 |
| kindl | #164 |
| sscp | #164 |
| sensitised | #164 |
| atopic dermatitis | #165 |
| asthma ige | #165 |
| children sensitized | #165 |
| atopic eczema | #165 |
| infant respiratory | #166 |
| ige asthma | #166 |
| illness surveys questionnaires | #166 |
| 5q31 | #166 |
| epidemiologie | #166 |
| feeding child | #166 |
| preschool cross | #167 |
| disease life | #167 |
| adolescent allergens | #167 |
| studies exposure | #167 |
| air pollutant concentrations | #167 |
| preadolescent children | #167 |
| current asthma | #168 |
| years lung | #168 |
| year children | #168 |
| workplace young | #169 |
| 2688 | #169 |
| airway size | #169 |
| stratification patients | #169 |
| regulatory treg cells | #169 |
| chronic inflammatory disease | #170 |
| sensitization pollen | #171 |
| nucleotide rna | #171 |
| inhalant | #171 |
| aged 13 | #171 |
| adolescent analysis | #171 |
| studien | #172 |
| skin prick test | #172 |
| ifnγ levels | #172 |
| endotoxins female | #172 |
| prevalence current | #172 |
| nucleotide pregnancy | #172 |
| sheds | #172 |
| unifying concept | #173 |
| risk score model | #173 |
| antipyretics | #174 |
| risk atopy | #174 |
| female humans questionnaires | #175 |
| mice asthma | #175 |
| small airway | #175 |
| patients nocturnal | #175 |
| school level | #176 |
| asthma attack | #176 |
| repeated infections | #176 |
| sensitization common | #176 |
| serine protease inhibitor | #176 |
| sensitization pattern | #177 |
| life respiratory function | #177 |
| wheezers | #177 |
| situ hybridization infant | #177 |
| aa patients | #178 |
| childhood infections | #178 |
| genetic severity | #178 |
| 9p24 | #178 |
| sensitization asthma | #178 |
| nocturnal asthma | #179 |
| sputum neutrophils | #179 |
| childhood adolescence | #179 |
| studies environmental | #179 |
| objective measurements | #179 |
| traffic characteristics | #179 |
| w12 | #179 |
| standardized methodology | #179 |
| asthma genetic | #180 |
| socks | #180 |
| breastfed infant | #180 |
| children environmental | #181 |
| environmental predictors | #181 |
| mattresses | #181 |
| bacterial count | #181 |
| lung function testing | #181 |
| differences hrqol | #182 |
| immunemediated diseases | #182 |
| dermatitis children | #182 |
| dust levels | #182 |
| vitamin asthma | #182 |
| tlr signaling | #183 |
| children levels | #183 |
| mögliche | #183 |
| vocational training | #183 |
| environmental microbiology | #183 |
| german population | #183 |
| exposure humans | #183 |
| school district | #185 |
| incidence allergic | #185 |
| life prevalence | #185 |
| work asthma | #186 |
| protein child | #187 |
| environmental exposures | #188 |
| asthma body | #188 |
| development allergic disease | #188 |
| selfselection | #188 |
| qpcrs | #188 |
| childhood early adulthood | #188 |
| tests children | #188 |
| jf1 | #189 |
| tlr genes | #189 |
| mother pregnancy | #190 |
| wheezing age | #190 |
| type duration | #190 |
| muscle mass patients | #190 |
| bacterial groups | #190 |
| early wheezing | #190 |
| association antibiotic | #190 |
| inversely | #190 |
| dry cough | #191 |
| atopic dermatitis children | #191 |
| blood gene | #191 |
| cd14 gene | #191 |
| longum subsp | #192 |
| pyroglyphidae | #192 |
| adjusted irr | #192 |
| cε | #193 |
| adam33 | #193 |
| milk serum | #193 |
| model allergic | #193 |
| prevalence severity | #195 |
| estonian | #195 |
| eosinophilic asthma | #195 |
| caspase recruitment | #196 |
| review asthma | #197 |
| germany switzerland | #197 |
| enthusiasm | #197 |
| earlylife | #198 |
| questionnaire data | #198 |
| decreased prevalence | #199 |
| representative population | #199 |
| rhinitis eczema | #199 |
| upper lower airways | #200 |
| bacteria role | #202 |
| allergy infectious diseases | #202 |
| complex interplay | #202 |
| patients europe | #203 |
| paediatrician | #203 |
| bronchial hyperresponsiveness bhr | #203 |
| phenotyped | #204 |
| patients aa | #204 |
| difference prevalence | #204 |
| amebocyte | #205 |
| new locus | #205 |
| dermatitis atopic | #205 |
| 13 years age | #205 |
| 3034 | #206 |
| allergen specific | #206 |
| asthma respiratory symptoms | #207 |
| factors atopy | #207 |
| asthma methods | #207 |
| karelia | #208 |
| studies germany | #208 |
| male phenotype | #208 |
| allergic asthmatics | #208 |
| diagnosed asthma | #208 |
| newborn logistic | #209 |
| col4a3 | #209 |
| sensitization age | #209 |
| studies cytokines | #209 |
| prevalence obesity | #209 |
| glycolylneuraminic acid | #209 |
| innate adaptive immunity | #209 |
| higher diversity | #209 |
| epithelial barrier function | #210 |
| bhr asthma | #210 |
| core microbiome | #210 |
| bronchial provocation | #210 |
| symptoms children | #210 |
| low prevalence | #211 |
| exposure sensitization | #211 |
| cats dogs | #211 |
| influence development | #211 |
| methodssubjects | #212 |
| asthma animals | #212 |
| atopic dermatitis asthma | #212 |
| tlr4 cd14 | #212 |
| birth 6 | #212 |
| asthma allergic | #212 |
| distinct clusters | #213 |
| exposure allergens | #213 |
| cohort methods | #213 |
| 1872 | #213 |
| patients uncontrolled asthma | #213 |
| 00035 | #214 |
| rural environment | #214 |
| reverse causality | #214 |
| asthma allergic diseases | #214 |
| prevalence allergic | #214 |
| workplace exposure | #214 |
| expression cd14 | #214 |
| life allergic | #215 |
| mast cell chymase | #216 |
| obesity overweight | #216 |
| regulatory responses | #216 |
| il2rb | #218 |
| atopic female | #218 |
| geneticist | #219 |
| microbial products | #219 |
| child dna | #219 |
| causation | #219 |
| disinfectants | #219 |
| variants asthma | #220 |
| pierced | #220 |
| allergy development | #220 |
| steiner | #220 |
| schistosoma schistosomiasis | #221 |
| method participants | #221 |
| homogenised | #221 |
| 90 children | #222 |
| increased asthma | #222 |
| sensitization rates | #222 |
| symptoms baseline | #223 |
| environmental epidemiology | #223 |
| groups asthma | #224 |
| sibship size | #225 |
| german study | #225 |
| conjunctivitis allergic | #226 |
| alpha1 antitrypsin | #226 |
| sensitization allergen | #226 |
| german | #226 |
| provocative concentration | #227 |
| school age | #227 |
| allergic diseases asthma | #228 |
| data asthma | #228 |
| test spt | #228 |
| lung health | #228 |
| 95 obesity | #228 |
| specific stimulation | #228 |
| understanding asthma | #229 |
| wheezing asthma | #229 |
| tuberculosis prevalence | #229 |
| road traffic | #229 |
| healthy worker | #229 |
| asthma phenotype | #230 |
| cord blood cells | #230 |
| asthma allergic rhinitis | #230 |
| umwelt | #230 |
| butyryl | #230 |
| cord blood cb | #231 |
| allergy prevention | #231 |
| discontent | #232 |
| living conditions | #232 |
| 20 fall | #232 |
| health variables | #232 |
| subgroup children | #232 |
| nonallergic asthma | #232 |
| lively | #233 |
| innate leukocytes | #233 |
| prevalence overweight | #233 |
| complementary food | #234 |
| hyperreactive | #234 |
| dermatophagoides pteronyssinus | #234 |
| n144 | #235 |
| fourth grade | #235 |
| resequenced | #236 |
| specific allergen | #236 |
| levels asthma | #236 |
| exposure pregnancy | #236 |
| finland france | #238 |
| puberty girls | #238 |
| strategies prevention | #239 |
| incidence asthma | #239 |
| neutrophilic asthma | #240 |
| preschool cytokines | #241 |
| regulatory th1 | #242 |
| age exposure | #243 |
| th2 immunity | #243 |
| immune development | #243 |
| adjusted odds ratio | #245 |
| receptor 1 | #245 |
| adaptor protein polymorphism | #245 |
| muropeptides | #246 |
| fungal dna ribosomal | #246 |
| prick test | #247 |
| role development | #247 |
| nasal microbiota | #247 |
| fever asthma | #247 |
| patients healthcare | #248 |
| children analysis | #248 |
| baseline incidence | #249 |
| class analysis | #249 |
| factors allergic | #249 |
| clinical science | #250 |
| therapy severe | #250 |
| biological therapy | #251 |
| tlr2 gene | #251 |
| communism | #252 |
| china factors | #253 |
| asthma symptoms | #253 |
| contact animals | #253 |
| cold air | #253 |
| hormonal influences | #254 |
| atopic disease | #255 |
| lowgrade inflammation | #255 |
| preschool dermatitis | #256 |
| h4 acetylation | #256 |
| low pa | #256 |
| human asthma | #257 |
| 454pyrosequencing | #257 |
| adolescent asthma | #257 |
| body mass children | #257 |
| association expression | #258 |
| niaid | #258 |
| epidemiological studies | #259 |
| airborne fungi | #259 |
| prediction quality | #259 |
| life asthma | #260 |
| 2051 | #260 |
| rhinitis allergic | #260 |
| age 6 | #260 |
| exposure early | #260 |
| life symptoms | #260 |
| early life | #261 |
| westernization | #261 |
| eczema atopic | #261 |
| discriminate | #261 |
| utilization health services | #262 |
| spink5 | #262 |
| interferon expression | #262 |
| milk pregnancy | #263 |
| physician diagnosed | #263 |
| development immune | #263 |
| alpha1antitrypsin | #263 |
| protein 15 | #263 |
| children associations | #264 |
| tightly linked | #265 |
| exposure traffic | #265 |
| latex sensitization | #265 |
| indoor exposures | #265 |
| nox concentrations | #266 |
| increase asthma | #266 |
| early work | #267 |
| age 13 years | #267 |
| settled dust | #267 |
| pollen sensitization | #268 |
| rhinitis | #269 |
| prick | #269 |
| fever children | #269 |
| allergen extracts | #270 |
| symptom prevalence | #270 |
| hypersensitivity immune | #270 |
| conditions asthma | #271 |
| relation body mass | #272 |
| child chromosomes | #272 |
| study centres | #273 |
| dipeptidyl peptidases | #273 |
| asthma control patients | #274 |
| objective markers | #274 |
| inflammatory properties | #275 |
| exposure female | #276 |
| host microbiome | #276 |
| extracellular polysaccharides | #277 |
| future asthma | #277 |
| male microbiota | #277 |
| dust samples | #277 |
| increased exposure | #278 |
| study birth | #279 |
| remedy | #280 |
| hire | #280 |
| tests allergens | #280 |
| questionnaires adolescent | #281 |
| adolescent animals | #282 |
| child dermatitis | #282 |
| 6 years | #282 |
| allergies asthma | #282 |
| impulse oscillometry | #284 |
| collection methods | #284 |
| randomeffects | #284 |
| 17 children | #285 |
| population burden | #285 |
| allergic symptoms | #286 |
| tests respiratory | #287 |
| cells ilc2s | #287 |
| differences asthma | #287 |
| gg 95 | #288 |
| geometric ratio | #288 |
| pollution air | #289 |
| epidemiological surveys | #289 |
| hdms | #289 |
| risk factors children | #290 |
| role asthma | #290 |
| data normalization | #290 |
| allergic manifestations | #291 |
| asthma increased | #291 |
| asthma factors | #292 |
| eczema food | #292 |
| environnement | #293 |
| indoor exposure | #293 |
| answered | #293 |
| longitudinal cohort study | #293 |
| recruitment domain | #293 |
| exposure environmental | #293 |
| cohort participants | #293 |
| allergic perennial | #293 |
| asthma data | #294 |
| cbmc | #294 |
| mucosal surfaces | #296 |
| smoke pollution | #297 |
| pollution respiratory | #297 |
| global synthesis | #298 |
| bifidobacterium | #298 |
| paxgene | #299 |
| exposure benzene | #299 |
| obesity asthma | #299 |
| nonatopic | #299 |
| exposure allergic | #299 |
| unification | #299 |
| infancy development | #300 |
| risk allergy | #303 |
| asthma drugs | #306 |
| reported association | #307 |
| lumbricoides | #307 |
| analysis phase | #307 |
| severe exacerbations | #308 |
| antigens dermatophagoides | #308 |
| mucosal microbiota | #309 |
| 2623 | #309 |
| messenger tlymphocytes | #309 |
| neonatal immune | #309 |
| ige sensitization | #309 |
| exposure childhood | #309 |
| controlled asthma | #311 |
| factors early | #311 |
| midexpiratory | #312 |
| atopic march | #312 |
| birth cohort studies | #312 |
| asthma inflammatory | #313 |
| allergy age | #313 |
| skin examination | #314 |
| signal transducer activator | #314 |
| genotyping data | #315 |
| bacillus spores | #315 |
| variance animals antigens | #315 |
| jusqu | #315 |
| 2 toll | #316 |
| independent study | #316 |
| older siblings | #317 |
| pregnancy expression | #318 |
| adjustment covariates | #318 |
| child comorbidity | #318 |
| compared children | #319 |
| bmi united states | #320 |
| fpr2 | #320 |
| il5 il13 | #320 |
| chronic airway inflammation | #321 |
| mfi20 | #321 |
| moisturizer | #323 |
| children birth | #324 |
| maximal expiratory | #325 |
| ige responses | #325 |
| stratified sample | #326 |
| airway hyperresponsiveness ahr | #326 |
| 2 yrs | #326 |
| flg mutations | #327 |
| ichthyosis vulgaris | #327 |
| selfadministered questionnaire | #328 |
| bedrooms | #328 |
| recurrent wheeze | #328 |
| active smoking | #328 |
| extracellular dna | #329 |
| male milk | #330 |
| glycolylneuraminic | #330 |
| reference equations | #331 |
| accuracy analysis | #331 |
| pollutant levels | #331 |
| floor dust | #331 |
| demethylation | #331 |
| dermatophagoides asthma | #331 |
| asthma biomarkers | #333 |
| streptococcaceae | #333 |
| onset asthma | #333 |
| upper respiratory | #334 |
| development sensitization | #334 |
| reduced lung function | #334 |
| children controls | #335 |
| asthma china | #336 |
| boluses | #336 |
| predictive risk factors | #337 |
| prevalence surveys | #337 |
| 1st year | #337 |
| risk current | #337 |
| 3113 | #338 |
| childhood atopic | #338 |
| risk eczema | #339 |
| respiratory outcomes | #339 |
| asthma parents | #340 |
| medical advice | #340 |
| humans prevalence | #341 |
| adultonset asthma | #341 |
| exposure development | #341 |
| filaggrin gene | #342 |
| persistent wheeze | #342 |
| kitchen | #342 |
| nonatopic asthma | #343 |
| age introduction | #343 |
| age 9 | #344 |
| breast fed | #345 |
| stat6 transcription | #346 |
| hypersensitivity | #346 |
| 90th | #348 |
| childhood onset | #349 |
| increasing prevalence | #350 |
| rates asthma | #350 |
| exposed children | #350 |
| prevalence | #350 |
| factors surveys | #351 |
| th1 th2 cells | #353 |
| activator transcription | #354 |
| repeated episodes | #356 |
| freeways | #358 |
| purposepatients | #359 |
| genetic interaction | #359 |
| kazal | #360 |
| subsequent asthma | #360 |
| regression approach | #360 |
| eurotium | #361 |
| children cohort | #361 |
| strength association | #361 |
| asthma disease | #361 |
| age 3 | #363 |
| cord blood | #363 |
| expression asthma | #363 |
| allergic outcomes | #364 |
| farming practices | #364 |
| food sensitization | #364 |
| annual concentrations | #365 |
| austria germany | #365 |
| children reported | #366 |
| chronic inflammatory disorders | #366 |
| lactadherin | #368 |
| atopic status | #369 |
| expression tlr2 | #370 |
| adolescent air | #370 |
| earlylife exposure | #370 |
| single snp | #370 |
| conclusionwe | #371 |
| austria switzerland | #371 |
| 1159 | #371 |
| testing procedures | #371 |
| east west | #373 |
| time activity | #373 |
| obesity prevalence | #373 |
| 22 countries | #374 |
| asthmatic symptoms | #374 |
| performance accuracy | #374 |
| paragraphs | #374 |
| asthma current | #374 |
| foxp3 tregs | #375 |
| smoking asthma | #375 |
| upper respiratory tract | #376 |
| asthma cases | #376 |
| cows milk | #377 |
| positional cloning | #377 |
| statistical approaches | #377 |
| associations exposure | #377 |
| population studies | #379 |
| parental reports | #379 |
| mite allergens | #379 |
| dietary strategies | #381 |
| pieces | #382 |
| inverse association | #383 |
| measles vaccination | #384 |
| preschool cohort studies | #384 |
| unifying | #384 |
| normal lung function | #385 |
| impaired lung function | #386 |
| latex | #386 |
| chronic asthma | #386 |
| bronchial | #386 |
| alliance | #388 |
| gene environment | #389 |
| allergie | #390 |
| critical window | #391 |
| potential association | #391 |
| immunological analysis | #391 |
| haplotype analyses | #391 |
| 11 year | #392 |
| cde | #393 |
| mmp9 gene | #394 |
| risk sensitization | #394 |
| early feeding | #394 |
| 14 year | #394 |
| linear regressions | #395 |
| polymorphism gene | #395 |
| increased risk asthma | #395 |
| immunological mechanisms | #396 |
| th2 th1 | #398 |
| respiratory health | #399 |
| salmeterol xinafoate | #399 |
| study polymorphisms | #399 |
| receptor cx3cr1 | #400 |
| antiviral responses | #401 |
| 2033 | #402 |
| receptor polymorphisms | #402 |
| regions countries | #402 |
| exposure animals | #403 |
| length time | #403 |
| analysis asthma | #403 |
| plea | #404 |
| study agreement | #405 |
| allergens | #405 |
| timothy grass | #405 |
| production ifngamma | #406 |
| cells asthma | #406 |
| allergen exposure | #406 |
| mugwort | #407 |
| 071 | #407 |
| childhood allergic | #407 |
| data cohort | #409 |
| geneenvironment interaction | #409 |
| mold exposure | #410 |
| endotoxin exposure | #411 |
| common occurrence | #411 |
| living room | #411 |
| blood cb | #413 |
| blood rna | #413 |
| gene variations | #413 |
| ige synthesis | #414 |
| germany | #415 |
| childhood exposure | #416 |
| mite allergen | #416 |
| facemasks | #416 |
| house dust | #417 |
| illness asthma | #418 |
| 7 years | #418 |
| bronchial hyperresponsiveness | #418 |
| extended haplotypes | #419 |
| population sample | #420 |
| age 2 years | #420 |
| alimentary | #420 |
| halfwidth | #421 |
| prenatal factors | #421 |
| confers protection | #424 |
| tnc | #424 |
| cytokine secretion | #426 |
| asthma eczema | #427 |
| parasitic infections | #427 |
| asthma treatment | #428 |
| childhood eczema | #429 |
| duration breastfeeding | #429 |
| childrens hospitals | #430 |
| tlr1 | #430 |
| allergic conditions | #431 |
| clinical examinations | #432 |
| risk overweight | #433 |
| 441 | #433 |
| specific sensitization | #434 |
| respiratory allergic | #434 |
| tobit | #438 |
| age odds ratio | #438 |
| decrements | #438 |
| allergy diagnosis | #438 |
| conundrum | #440 |
| asthma gene | #441 |
| annual prevalence | #441 |
| population asthma | #442 |
| inception | #443 |
| male odds | #443 |
| chronic inflammatory diseases | #443 |
| fecal microbiota | #443 |
| cell phenotypes | #444 |
| asthma effects | #444 |
| persisting | #444 |
| increase bmi | #445 |
| observed differences | #445 |
| specific serum | #446 |
| asthma respiratory | #446 |
| exposure respiratory | #448 |
| ethnic origin | #449 |
| allergic rhinoconjunctivitis | #449 |
| 033 | #450 |
| allergy food | #450 |
| adult asthmatics | #451 |
| n149 | #452 |
| associations asthma | #452 |
| including asthma | #455 |
| school entry | #456 |
| pregnancy increased risk | #457 |
| dermatophagoides farinae | #457 |
| germany health | #458 |
| mice role | #460 |
| external environment | #460 |
| allergic risk | #460 |
| provocation tests | #460 |
| airway hyper | #462 |
| westernized | #463 |
| asthma higher | #464 |
| rural health | #464 |
| asthma control test | #465 |
| environmental factors | #466 |
| postal questionnaire | #467 |
| cells innate | #467 |
| opposite effects | #467 |
| severity asthma | #468 |
| alex | #468 |
| immunocap | #468 |
| so2 concentrations | #469 |
| early identification | #470 |
| nod1 signaling | #470 |
| clinical asthma | #470 |
| emphasised | #471 |
| exposure | #471 |
| microbial counts | #471 |
| asthma rhinitis | #471 |
| fodder | #473 |
| birth cohorts | #473 |
| antibiotics children | #473 |
| yrs | #474 |
| 1133 | #474 |
| champ | #476 |
| cross sectional survey | #476 |
| exposure antibiotics | #477 |
| early exposure | #481 |
| risk severity | #482 |
| childhood environment | #483 |
| asthma association | #484 |
| total immunoglobulin | #484 |
| subphenotypes | #485 |
| atopic disorders | #486 |
| children | #486 |
| immunity genes | #486 |
| phenotypes | #487 |
| prospective birth cohort | #487 |
| potential confounding | #489 |
| exposure data | #489 |
| genes environment | #490 |
| studies rhinitis | #490 |
| multicenter cohort | #491 |
| snp association | #494 |
| polymorphisms association | #495 |
| uncontrolled asthma | #495 |
| lifestyles | #496 |
| age 10 | #496 |
| southern germany | #497 |
| housing animal | #497 |
| children jia | #497 |
| phenotype polymorphism | #498 |
| individual level | #498 |
| asthma severe | #498 |
| omega6 fatty acids | #500 |
| respiratory hypersensitivity | #500 |
| birth age | #501 |
| lung function children | #503 |
| asthma susceptibility | #503 |
| sensitizations | #504 |
| diet diversity | #505 |
| white children | #505 |
| methods studies | #505 |
| tests specific | #505 |
| ranks | #508 |
| allergy children | #508 |
| rna samples | #509 |
| prevalence rates | #509 |
| childhood respiratory | #509 |
| housing humans | #510 |
| perennial | #511 |
| stimulation lps | #511 |
| il15 | #513 |
| europe female | #514 |
| age 10 years | #514 |
| asthma prevalence | #515 |
| children exposed | #515 |
| asthma bronchiolitis | #516 |
| receptor tlr | #516 |
| levels children | #516 |
| infections asthma | #516 |
| cities china | #516 |
| cd4cd25high | #517 |
| dpps | #518 |
| th2 immune | #519 |
| atopic conditions | #519 |
| haplotype association | #520 |
| neutrophils eosinophils | #522 |
| eczema asthma | #522 |
| risk factors asthma | #523 |
| p0041 | #523 |
| age 1 year | #523 |
| children maternal | #523 |
| polymorphisms snps | #523 |
| rural areas | #524 |
| time window | #524 |
| adolescence age | #525 |
| maternal vitamin | #525 |
| trans fatty acids | #526 |
| bmi increased risk | #528 |
| baseline participants | #528 |
| obesity body mass | #528 |
| allergens animals | #529 |
| blood humans | #529 |
| 117 95 | #529 |
| c‐reactive protein | #529 |
| edifice | #530 |
| persistent asthma | #530 |
| obesity smoking | #531 |
| environmental bacteria | #531 |
| protect | #532 |
| samples children | #532 |
| oral tolerance | #533 |
| allergic airway inflammation | #534 |
| children methods | #535 |
| immune stimulation | #536 |
| topic rhinitis | #537 |
| il4r | #538 |
| blood eosinophil counts | #539 |
| industrialised | #540 |
| human microbiota | #541 |
| adolescence early adulthood | #541 |
| airway symptoms | #542 |
| rubella virus | #543 |
| immunological markers | #543 |
| lipopolysaccharide receptors | #543 |
| pregnancy asthma | #543 |
| cypress | #544 |
| pathomechanisms | #545 |
| regulatory cell | #546 |
| 17q12 | #547 |
| antitrypsin alpha | #547 |
| greenness | #548 |
| oligoarticular | #549 |
| floorcoverings | #549 |
| hypersensitivity humans | #550 |
| epidemic proportions | #553 |
| association children | #553 |
| isotype switching | #553 |
| lung microbiome | #554 |
| multidisciplinary study | #554 |
| children parental | #555 |
| mental health patients | #555 |
| asthma status | #556 |
| overweight prevalence | #556 |
| allergic rhinitis asthma | #558 |
| aqlq | #558 |
| 1129 | #559 |
| letzten | #560 |
| blood eosinophils | #560 |
| activity body | #561 |
| reduced exposure | #564 |
| inhaled steroids | #566 |
| hormonal contraceptives | #566 |
| 2 immunity | #566 |
| 077 | #567 |
| immune regulatory | #569 |
| initial observations | #570 |
| exposure matrix | #570 |
| tripeptidyl | #570 |
| asthma symptom | #571 |
| health urban | #571 |
| diseases prevalence | #575 |
| affluence | #575 |
| hcs patients | #575 |
| levels total | #575 |
| creactive protein levels | #579 |
| atopic asthma | #579 |
| oro | #580 |
| followups | #580 |
| association obesity | #581 |
| age controls | #581 |
| asthma population | #582 |
| fdr | #582 |
| flanking regions | #582 |
| asthma severity | #584 |
| tlr6 | #584 |
| uht | #584 |
| function asthma | #585 |
| bacterial microbiome | #588 |
| gsdmb | #589 |
| n63 | #590 |
| longum | #590 |
| skin test | #591 |
| 1 antitrypsin | #592 |
| holiday | #593 |
| endotoxin concentrations | #593 |
| gasdermin | #596 |
| factors respiratory | #596 |
| il1rl1 | #596 |
| model asthma | #597 |
| zeigen | #598 |
| total specific | #598 |
| advising | #598 |
| pathogenesis asthma | #598 |
| galactosylation | #600 |
| genetic environmental | #600 |
| active immunity | #601 |
| factors humans | #602 |
| 048 | #603 |
| pregnancy maternal | #603 |
| humans human | #604 |
| statistical analyses | #604 |
| hladqa1 | #604 |
| sensitization | #606 |
| agents asthma | #606 |
| microbes | #606 |
| microbiome studies | #607 |
| ige production | #608 |
| 2 inflammation | #610 |
| allergic rhinitis | #610 |
| infant feeding practices | #611 |
| regulatory molecules | #612 |
| work life | #612 |
| bolus | #612 |
| 11–13 | #612 |
| pollen allergens | #616 |
| chronic stress | #619 |
| albania | #619 |
| aged allergens | #619 |
| urban populations | #620 |
| body plethysmography | #621 |
| life age | #621 |
| arthropod proteins | #621 |
| deep phenotyping | #622 |
| unstimulated | #623 |
| radioallergosorbent | #623 |
| functional features | #625 |
| endotoxin | #627 |
| data prevalence | #627 |
| 779 | #627 |
| protective properties | #629 |
| crosssectional | #629 |
| school children | #632 |
| smoking surveys | #632 |
| models asthma | #633 |
| exacerbating | #635 |
| settled | #635 |
| feeding patterns | #635 |
| child asthma | #636 |
| children atopic dermatitis | #637 |
| standardized questionnaire | #637 |
| lifetime prevalence | #638 |
| european children | #639 |
| igg glycosylation | #639 |
| factors urban | #639 |
| clustering approach | #641 |
| grass pollen | #642 |
| innate immunity | #642 |
| humans microbiota | #643 |
| years increased | #645 |
| symptoms | #646 |
| innate lung | #647 |
| pollen concentrations | #648 |
| kindern | #650 |
| life children | #650 |
| participation rates | #650 |
| health rural | #650 |
| pets | #650 |
| glucocorticoid induced | #652 |
| helsinki | #653 |
| comprehensive analysis | #654 |
| dermatitis allergic | #654 |
| prospective studies association | #656 |
| 16 countries | #658 |
| common chronic | #659 |
| latent classes | #662 |
| age 1 | #662 |
| conclusion data | #663 |
| cd14 expression | #664 |
| hygiene | #665 |
| di2ethylhexyl | #665 |
| abpa | #665 |
| pvalues | #666 |
| hypertonic saline | #667 |
| chemokine cx3cl1 | #668 |
| adult lung | #669 |
| standardized questionnaires | #670 |
| birth cohort | #671 |
| central european | #672 |
| susceptibility locus | #672 |
| cellules | #673 |
| études | #674 |
| jobs | #676 |
| ilc2s | #677 |
| age 45 years | #679 |
| common infections | #680 |
| protective | #681 |
| female forced | #681 |
| random sample | #681 |
| dairy farm | #681 |
| egg allergy | #682 |
| cohorte | #683 |
| recurrent wheezing | #685 |
| dietary habits | #685 |
| childhood experiences | #686 |
| factors air | #688 |
| european community | #692 |
| major gene | #693 |
| doctor | #693 |
| turkish | #694 |
| factors skin | #695 |
| physical examination | #699 |
| rhinitis symptoms | #702 |
| microbial flora | #703 |
| risk obesity | #703 |
| sensitization food | #703 |
| hypersensitivity inflammation | #703 |
| tao | #707 |
| dramatic increase | #708 |
| microbial interactions | #708 |
| 459 | #708 |
| immune activation | #709 |
| perpetuation | #709 |
| immunologic tlymphocytes | #712 |
| population surveys | #712 |
| children time | #713 |
| pregnancy children | #718 |
| bacterial spores | #720 |
| mediated diseases | #721 |
| allergy asthma | #722 |
| ratio aor | #724 |
| sensitized patients | #727 |
| function children | #727 |
| 95 males | #734 |
| alias | #734 |
| il4 il13 | #738 |
| population adolescent | #741 |
| linkage chromosome | #741 |
| fractional exhaled | #742 |
| nonasthmatic | #742 |
| farms | #743 |
| treg cell | #745 |
| type 5 | #748 |
| traffic air | #748 |
| ifih1 | #749 |
| children low | #753 |
| earlier study | #754 |
| total lung | #755 |
| h20 | #758 |
| environment interactions | #758 |
| aeroallergens | #759 |
| moderate levels | #764 |
| indoor dust | #766 |
| air trapping | #768 |
| edn1 | #768 |
| hscrp levels | #769 |
| pulmonary function tests | #769 |
| allergists | #769 |
| hyperresponsiveness | #770 |
| pattern recognition receptors | #770 |
| blood leukocytes | #770 |
| asthma adults | #771 |
| strabismus surgery | #772 |
| term impact | #773 |
| incidence longitudinal | #773 |
| nucleotide receptors | #773 |
| volume humans | #777 |
| rhinitis children | #781 |
| studies asthma | #784 |
| new associations | #784 |
| factors incidence | #785 |
| children allergic | #785 |
| nonallergic | #788 |
| factors tobacco | #788 |
| shortness breath | #789 |
| asthma therapy | #791 |
| gis | #793 |
| male metaanalysis | #793 |
| children health | #794 |
| βdiversity | #795 |
| airway hyperresponsiveness | #795 |
| distinct trajectories | #796 |
| natural habitat | #796 |
| personalization | #798 |
| pc20 | #798 |
| card15 | #799 |
| protective effects | #799 |
| 45 years | #800 |
| pair 1 chromosomes | #801 |
| confer | #802 |
| allergen | #805 |
| age 4 years | #806 |
| infant food | #807 |
| dairy farms | #808 |
| bifidobacterium longum | #810 |
| tenascin | #810 |
| exposure age | #810 |
| subclinical inflammation | #811 |
| pteronyssinus | #811 |
| bacillus licheniformis | #813 |
| peak flow | #813 |
| boiled | #814 |
| initial data | #814 |
| onset age | #815 |
| foe | #816 |
| foxp3 | #817 |
| brevibacterium | #818 |
| positive skin | #819 |
| 0053 | #820 |
| food infant | #821 |
| breastfeeding duration | #822 |
| skin tests | #822 |
| spt | #827 |
| studies respiratory | #830 |
| trier | #830 |
| prevention strategies | #831 |
| asthma health | #832 |
| current analysis | #833 |
| rad50 | #833 |
| promoter polymorphisms | #834 |
| snps haplotypes | #835 |
| igg4 | #835 |
| regularly | #835 |
| farinae | #835 |
| adolescent age | #837 |
| cx3cr1 | #838 |
| exhaled breath | #838 |
| parental smoking | #839 |
| asthma bronchi | #839 |
| toll receptors | #839 |
| public health problem | #839 |
| subsequent development | #840 |
| cladosporium | #841 |
| chronification | #844 |
| fetal blood | #845 |
| modifies | #845 |
| innate | #849 |
| potted | #849 |
| bacterial endotoxin | #850 |
| maternal exposure | #850 |
| allergen sensitization | #852 |
| inspections | #854 |
| 17q | #855 |
| infant health | #856 |
| provocation | #856 |
| infant infant | #858 |
| repeatedly | #861 |
| age 5 | #861 |
| paracetamol | #862 |
| asthma lung | #864 |
| receptors tlrs | #864 |
| questionnaires young adult | #864 |
| volatile organic | #865 |
| birth cohort study | #866 |
| ige | #866 |
| airway eosinophilia | #866 |
| cumulative incidence | #874 |
| outdoor air pollution | #874 |
| latent class analysis | #875 |
| dermatitis | #878 |
| hmos | #878 |
| microbiome humans | #879 |
| 057 | #880 |
| 1940 | #880 |
| 12q | #884 |
| ifngamma tnfalpha | #886 |
| brink | #888 |
| 856 | #888 |
| oscillometry | #890 |
| european populations | #891 |
| bacterial counts | #892 |
| subsample | #895 |
| exposure study | #895 |
| asthma incidence | #896 |
| esl | #896 |
| impact asthma | #900 |
| inflammation airway | #902 |
| immunoglobulin ige | #902 |
| breastfed | #904 |
| respiration disorders | #905 |
| allergen induced | #907 |
| shortness | #908 |
| adult asthma | #908 |
| children overweight | #910 |
| microbiome composition | #910 |
| microbiota development | #912 |
| complex disease | #917 |
| cow milk | #917 |
| immunity innate | #919 |
| peripheral blood samples | #920 |
| 710 | #920 |
| methods cross | #920 |
| estonia | #923 |
| prospective birth | #927 |
| sounds | #928 |
| sectional population | #928 |
| ilcs | #929 |
| biomérieux | #929 |
| participants baseline | #932 |
| 026 | #939 |
| lactococcus lactis | #939 |
| dermatophagoides | #940 |
| 13 years | #940 |
| potential confounders | #940 |
| floors | #942 |
| life style | #944 |
| microbiome host | #949 |
| 055 | #950 |
| identification genes | #952 |
| environmental effects | #952 |
| 454 pyrosequencing | #953 |
| solids | #954 |
| 1120 | #954 |
| polymorphisms | #954 |
| genotyped | #954 |
| asthma exercise | #954 |
| human life | #955 |
| infections child | #957 |
| children countries | #959 |
| fever | #959 |
| domestic | #961 |
| rhinitis asthma | #961 |
| exposures | #961 |
| disease asthma | #964 |
| nasal secretions | #964 |
| cytokines female | #965 |
| immunoglobulin male | #965 |
| obesity children | #966 |
| innsbruck | #970 |
| readings | #971 |
| immunization immunoglobulin | #973 |
| fev | #973 |
| onset child child | #974 |
| teenagers | #975 |
| orphan receptor | #976 |
| gondii infection | #976 |
| bmi physical activity | #977 |
| nucleotide promoter | #978 |
| respiratory conditions | #979 |
| xinafoate | #981 |
| receptor gene | #981 |
| 682 | #981 |
| yearly | #982 |
| 1333 | #983 |
| small effects | #984 |
| child cohort | #986 |
| adolescents asthma | #987 |
| 12 months age | #990 |
| 068 | #991 |
| pasteurization | #991 |
| c3h hej | #991 |
| asthma humans | #992 |
| function development | #992 |
| hercules | #992 |
| sectional | #994 |
| design methods | #994 |
| immunoglobulin class | #995 |
| diagnosis asthma | #998 |
| respiratory symptoms | #1001 |
| bradykinin receptors | #1003 |
| yoghurt | #1005 |
| maternally | #1006 |
| rural population | #1006 |
| ppg | #1006 |
| linens | #1009 |
| preventive measures | #1010 |
| pt15 | #1012 |
| asthma outcomes | #1014 |
| timeframe | #1016 |
| phytohemagglutinin | #1017 |
| 039 | #1017 |
| association physical activity | #1018 |
| median levels | #1019 |
| strongest associations | #1020 |
| asthma medication | #1021 |
| western countries | #1022 |
| sought | #1024 |
| raw milk | #1027 |
| asthma adult | #1029 |
| outcome variables | #1030 |
| upper airways | #1031 |
| 096 | #1033 |
| genomewide association | #1033 |
| asthmatic children | #1035 |
| veillonella | #1037 |
| cell child | #1038 |
| breastmilk | #1039 |
| dairying | #1039 |
| nod1 | #1042 |
| milieu | #1046 |
| disease children | #1046 |
| missing values | #1047 |
| exposure conditions | #1048 |
| controls age | #1051 |
| severe allergic | #1057 |
| il5 | #1058 |
| hobbies | #1059 |
| infant gut | #1059 |
| metalloprotease | #1060 |
| pregnancy prospective | #1062 |
| class switching | #1064 |
| signaling adaptor | #1065 |
| rural | #1066 |
| predictor | #1066 |
| 8 12 | #1068 |
| skin sensitization | #1068 |
| gnp | #1069 |
| moraxella | #1070 |
| margarine | #1070 |
| central europe | #1070 |
| prevalence prospective | #1071 |
| expression humans | #1072 |
| interrelation | #1075 |
| large population | #1077 |
| cross sectional study | #1077 |
| box transcription | #1079 |
| west east | #1079 |
| trflp | #1080 |
| factors child | #1081 |
| risk development | #1081 |
| life respiratory | #1082 |
| allergic airway | #1083 |
| cells tregs | #1083 |
| study areas | #1083 |
| children prevalence | #1086 |
| sufferers | #1086 |
| maternal asthma | #1089 |
| lca | #1090 |
| gene expression data | #1090 |
| exposure delayed | #1091 |
| longduration | #1094 |
| disintegrin | #1095 |
| proteins polymorphism | #1096 |
| nationality | #1096 |
| 930 | #1097 |
| supplementary data | #1098 |
| overweight bmi | #1101 |
| forkhead | #1103 |
| enfants | #1103 |
| conjunctivitis | #1104 |
| studies evidence | #1104 |
| adolescence adulthood | #1105 |
| cd14 | #1106 |
| weight risk | #1116 |
| 248 | #1116 |
| characteristically | #1117 |
| risk gene | #1117 |
| associations observed | #1118 |
| meat consumption | #1119 |
| prevalences | #1122 |
| association exposure | #1123 |
| intermediate phenotypes | #1125 |
| newonset | #1126 |
| sscp analysis | #1127 |
| lung function decline | #1127 |
| il12b | #1127 |
| based clustering | #1128 |
| endotoxins | #1130 |
| taxonomies | #1130 |
| expiratory flow | #1132 |
| age birth | #1132 |
| 859 | #1134 |
| based birth | #1136 |
| log2 | #1144 |
| pet ownership | #1144 |
| gondii | #1145 |
| allergic asthma | #1145 |
| patients severe asthma | #1146 |
| pediatric asthma | #1146 |
| 837 | #1152 |
| skewness | #1152 |
| humans respiratory | #1153 |
| environmental tobacco | #1154 |
| regions china | #1154 |
| dust mite | #1156 |
| disease cohort | #1156 |
| 862 | #1158 |
| deciphering | #1159 |
| countries prevalence | #1160 |
| epidemiological evidence | #1164 |
| 027 | #1165 |
| anti ige | #1165 |
| rarer | #1168 |
| preschool cohort | #1169 |
| inbred balb receptors | #1172 |
| crowding | #1173 |
| genomewide | #1176 |
| receptors ige | #1178 |
| farmers | #1179 |
| phase behaviour | #1180 |
| croup | #1183 |
| contre | #1184 |
| serum immunoglobulin | #1184 |
| food allergens | #1186 |
| new paradigm | #1189 |
| asthma bronchodilator | #1189 |
| levels measured | #1190 |
| exhaled | #1194 |
| respiratory tract | #1196 |
| censored | #1197 |
| children association | #1200 |
| management children | #1206 |
| rorc | #1207 |
| bacterial taxa | #1208 |
| fungi humans | #1211 |
| sedentary lifestyle | #1211 |
| risk childhood | #1214 |
| flg | #1215 |
| regulatory cells tregs | #1216 |
| food hypersensitivity | #1218 |
| risk children | #1218 |
| orphan | #1219 |
| bradykinin | #1220 |
| eosinophilic inflammation | #1221 |
| day life | #1223 |
| factor activity | #1225 |
| 047 | #1229 |
| male pregnancy | #1233 |
| balb ovalbumin | #1234 |
| th1 th2 | #1236 |
| age menarche | #1236 |
| gene variants | #1236 |
| adult allergens | #1240 |
| european population | #1241 |
| antitrypsin | #1243 |
| small children | #1243 |
| ulm | #1247 |
| protective factors | #1250 |
| objective aim | #1251 |
| early years | #1252 |
| pertussis | #1252 |
| peripheral blood leukocytes | #1253 |
| airway hyperreactivity | #1253 |
| food items | #1253 |
| shop | #1256 |
| questionnaires | #1256 |
| debated | #1257 |
| telephone interviews | #1260 |
| lung function | #1260 |
| mite | #1262 |
| studies gene | #1263 |
| disease case | #1264 |
| yogurt | #1267 |
| temperature humidity | #1268 |
| overweight children | #1274 |
| occupational exposures | #1277 |
| fev1 forced | #1281 |
| pollution indoor | #1281 |
| children exposure | #1282 |
| infections risk | #1284 |
| shannon | #1284 |
| diseases occupational | #1289 |
| immunomodulating | #1289 |
| pollution exposure | #1292 |
| potential risk factors | #1293 |
| 182 | #1295 |
| body sites | #1296 |
| tests risk | #1299 |
| age baseline | #1301 |
| gme | #1302 |
| explain | #1303 |
| topic polymorphism | #1303 |
| venipuncture | #1306 |
| endotypes | #1309 |
| lymphocytes regulatory | #1312 |
| factor development | #1312 |
| th1 cytokines | #1314 |
| industrially | #1314 |
| 038 | #1318 |
| sought determine | #1320 |
| harmonization | #1322 |
| cell numbers | #1322 |
| epidemiological survey | #1322 |
| objective investigate | #1327 |
| neuraminic | #1329 |
| cleaning | #1329 |
| lrti | #1330 |
| concerted | #1330 |
| prevalence rural | #1331 |
| zusammenfassung | #1331 |
| gambia | #1332 |
| respiratory allergy | #1332 |
| induced sputum | #1335 |
| sponsorship | #1335 |
| loft | #1337 |
| passive smoking | #1340 |
| 897 | #1342 |
| mass breast | #1343 |
| multiple testing | #1346 |
| puberty | #1347 |
| airway function | #1349 |
| th2 cells | #1351 |
| irf1 | #1353 |
| expired | #1353 |
| oxide feno | #1353 |
| atopic humans | #1354 |
| toxoplasma gondii | #1355 |
| 267 | #1357 |
| 16 18 | #1358 |
| reduction risk | #1358 |
| asthmatics | #1359 |
| science foundation | #1359 |
| 2 innate | #1360 |
| lung microbiota | #1363 |
| france germany | #1366 |
| 279 | #1366 |
| maternal immune | #1367 |
| asthma female | #1369 |
| innate lymphoid | #1374 |
| whey proteins | #1378 |
| preventive strategies | #1381 |
| austria | #1382 |
| common forms | #1383 |
| total ige | #1383 |
| lactococcus | #1386 |
| studies lung | #1387 |
| management asthma | #1388 |
| environmental | #1389 |
| disagreement | #1389 |
| childhood adult | #1390 |
| early intervention | #1395 |
| milk proteins | #1403 |
| q21 | #1404 |
| risk developing | #1404 |
| severe atopic | #1404 |
| fef25 | #1406 |
| airway inflammation | #1407 |
| air samples | #1410 |
| indoor | #1412 |
| dust exposure | #1415 |
| sige | #1417 |
| baseline followup | #1417 |
| bronchodilators | #1418 |
| immune mechanisms | #1418 |
| microbial | #1419 |
| il13 | #1421 |
| hapmap | #1421 |
| longitudinal cohort | #1422 |
| bronchitis | #1422 |
| male multivariate | #1427 |
| pulmonary eosinophilia | #1429 |
| pair 17 | #1429 |
| asthmatic | #1433 |
| timepoint | #1433 |
| chronic inflammatory | #1435 |
| exhaled nitric | #1440 |
| irak4 | #1442 |
| induced airway | #1443 |
| inflammatory pathways | #1444 |
| centres | #1444 |
| overweight | #1445 |
| studies europe | #1445 |
| age 5 years | #1446 |
| bronchodilator response | #1448 |
| airway responses | #1451 |
| factors prevalence | #1454 |
| asthma clinical | #1460 |
| agricultural workers | #1460 |
| unique opportunity | #1461 |
| infancy | #1461 |
| immunizations | #1463 |
| barcelona | #1464 |
| 706 | #1464 |
| a20 | #1466 |
| hand eczema | #1468 |
| association polymorphism | #1468 |
| recognition receptors | #1470 |
| surveys questionnaires | #1470 |
| asthma compared | #1472 |
| immunity | #1473 |
| leur | #1474 |
| operating characteristics | #1474 |
| adolescence | #1475 |
| nod2 signaling | #1476 |
| 362 | #1477 |
| innate immune responses | #1478 |
| 1 levels | #1478 |
| meeting | #1479 |
| dgge | #1480 |
| otitis | #1482 |
| paediatricians | #1490 |
| immunologic mechanisms | #1493 |
| strongest predictor | #1494 |
| peptidases | #1494 |
| populationbased cohort | #1504 |
| ionomycin | #1505 |
| flexural | #1505 |
| tlr2 | #1506 |
| birch pollen | #1507 |
| structured interviews | #1508 |
| tlr2 tlr4 | #1509 |
| igg1 | #1511 |
| understood | #1512 |
| bacterial composition | #1514 |
| sulphur dioxide | #1514 |
| ergosterol | #1515 |
| epidemiological data | #1517 |
| living environment | #1517 |
| moderate asthma | #1517 |
| pasteurized | #1518 |
| latent class | #1520 |
| child welfare | #1521 |
| pollution levels | #1524 |
| rôle | #1524 |
| hladq | #1527 |
| 153 | #1527 |
| respiratory tract infections | #1530 |
| differences prevalence | #1533 |
| underlying mechanisms | #1536 |
| jia | #1536 |
| dust | #1542 |
| 245 | #1551 |
| factors development | #1552 |
| wisconsin | #1555 |
| previous 12 months | #1558 |
| birthday | #1558 |
| children aged | #1564 |
| children increased | #1566 |
| antibiotic exposure | #1567 |
| austrian | #1573 |
| born children | #1578 |
| china female humans | #1579 |
| licheniformis | #1584 |
| children risk | #1584 |
| current studies | #1588 |
| treatment asthma | #1595 |
| trans fatty | #1596 |
| explained | #1596 |
| breastfed infants | #1598 |
| study populations | #1599 |
| tract diseases | #1602 |
| development progression | #1603 |
| 775 | #1603 |
| air microbiology | #1604 |
| regulatory | #1605 |
| disease process | #1607 |
| ascariasis | #1610 |
| male prospective | #1611 |
| neuropeptide | #1612 |
| erythrocyte membranes | #1612 |
| cells1 | #1613 |
| peak expiratory | #1613 |
| familial aggregation | #1617 |
| candidate gene | #1622 |
| cells th2 | #1624 |
| ige antibodies | #1624 |
| early gene | #1626 |
| precision medicine | #1627 |
| short communication | #1627 |
| tolerogenic | #1628 |
| questionnaires young | #1632 |
| studies recurrence | #1634 |
| tcell responses | #1635 |
| gata3 | #1641 |
| newborn infants | #1641 |
| th2 cytokines | #1644 |
| th2 | #1645 |
| nutritional factors | #1647 |
| population based study | #1653 |
| style male | #1653 |
| topic surveys | #1653 |
| card | #1655 |
| traffic volume | #1656 |
| 034 | #1656 |
| microbial diversity | #1656 |
| smoke exposure | #1657 |
| cells transcription | #1661 |
| northern europe | #1661 |
| expiratory volume | #1664 |
| respiratory | #1666 |
| opportunity | #1667 |
| linear discriminant analysis | #1671 |
| followup study | #1677 |
| asthmatic agents | #1678 |
| cheese | #1688 |
| epidemiologic evidence | #1688 |
| employment | #1692 |
| microbiome | #1693 |
| early introduction | #1694 |
| innate immune | #1694 |
| obesity risk | #1694 |
| gitr | #1696 |
| health‐related quality | #1697 |
| aux | #1701 |
| th2 th17 | #1702 |
| phenotyping | #1704 |
| gene interaction | #1704 |
| adulthood | #1706 |
| 476 | #1710 |
| fungal diversity | #1712 |
| provocative | #1716 |
| singlenucleotide polymorphisms | #1717 |
| house dust mite | #1718 |
| mere | #1718 |
| 029 | #1723 |
| life hrqol | #1730 |
| airflow obstruction | #1732 |
| gabon | #1733 |
| asthma control | #1733 |
| genotyping | #1734 |
| anti asthmatic | #1735 |
| innate adaptive | #1739 |
| factors breast | #1742 |
| cytokine genes | #1746 |
| factors children | #1746 |
| 5 7 | #1748 |
| helminth parasites | #1749 |
| inverse relationship | #1749 |
| preschool clinical trials | #1751 |
| inconsistencies | #1753 |
| molds | #1754 |
| male polymorphism | #1756 |
| masks | #1756 |
| gstm1 gstt1 | #1760 |
| fivefold | #1760 |
| refugees | #1761 |
| chronic airway | #1761 |
| bacterial diversity | #1764 |
| susceptibility gene | #1767 |
| street | #1768 |
| environmental tobacco smoke | #1769 |
| association body mass | #1772 |
| cells airway | #1778 |
| soot | #1778 |
| helminth infections | #1779 |
| peptidoglycan | #1782 |
| cd4cd25 | #1782 |
| occupational exposure | #1782 |
| allergic reaction | #1788 |
| exposure assessment | #1789 |
| nucleotide polymorphisms | #1799 |
| generations | #1800 |
| helminths | #1801 |
| 054 | #1801 |
| key feature | #1801 |
| rubella | #1807 |
| life factors | #1809 |
| single nucleotide receptors | #1812 |
| treg cells | #1812 |
| feno | #1817 |
| censoring | #1821 |
| protein 3 | #1821 |
| factors health | #1822 |
| dna fingerprinting | #1823 |
| breastfeeding | #1825 |
| signal transducer | #1828 |
| asthma morbidity | #1828 |
| 112 | #1831 |
| respiratory illnesses | #1831 |
| leisure time | #1834 |
| generational | #1837 |
| vocational | #1838 |
| foxp3 expression | #1841 |
| heterogeneous disease | #1843 |
| il4 | #1843 |
| regulatory cells | #1843 |
| otus | #1845 |
| fetal growth | #1845 |
| forkhead transcription | #1849 |
| sampling methods | #1854 |
| causally | #1855 |
| idiopathic arthritis | #1857 |
| 95 risk factors | #1859 |
| disease incidence | #1878 |
| hypertonic | #1879 |
| friend | #1884 |
| unraveling | #1886 |
| diseases lung | #1886 |
| interleukin33 | #1891 |
| predispose | #1892 |
| age 4 | #1893 |
| aor | #1894 |
| age 2 | #1895 |
| life | #1898 |
| microbe | #1899 |
| lung male | #1900 |
| population level | #1901 |
| interleukin5 | #1901 |
| hrqol | #1903 |
| occupational stress | #1904 |
| jedoch | #1908 |
| vital capacity | #1909 |
| brought | #1909 |
| predictive models | #1914 |
| feeding practices | #1917 |
| coeliac disease | #1918 |
| confounded | #1924 |
| weight breast | #1929 |
| basics | #1932 |
| experimental models | #1932 |
| p0012 | #1933 |
| helminthiasis | #1934 |
| pregnancy prevalence | #1936 |
| child humans | #1938 |
| barrier function | #1941 |
| european commission | #1944 |
| aetiology | #1945 |
| juvenile idiopathic | #1946 |
| percentiles | #1946 |
| cell markers | #1949 |
| galactans | #1951 |
| moisture | #1959 |
| raised | #1959 |
| asthmatic subjects | #1960 |
| invading | #1960 |
| blood eosinophil | #1960 |
| immune mediated | #1960 |
| lps stimulation | #1966 |
| child female | #1966 |
| regulatory region | #1973 |
| 658 | #1975 |
| phenomena infant | #1977 |
| dwellings | #1985 |
| children severe | #1991 |
| dollar | #1994 |
| natural environments | #1997 |
| helper type | #1998 |
| studie | #1999 |
| descriptions | #2000 |
| agriculture | #2000 |
| 041 | #2004 |
| respiratory viral | #2010 |
| infectious agents | #2011 |
| richness | #2012 |
| physical activity pa | #2014 |
| lower frequencies | #2015 |
| life risk | #2018 |
| postnatal exposure | #2019 |
| diary | #2020 |
| children data | #2020 |
| regulation genetic | #2020 |
| physician diagnosis | #2021 |
| bedding | #2024 |
| underline | #2025 |
| relate | #2026 |
| age | #2027 |
| 939 | #2030 |
| chymase | #2038 |
| bovine milk | #2038 |
| ige mediated | #2040 |
| outdoor air | #2041 |
| subsamples | #2046 |
| mass child | #2047 |
| conflicting | #2056 |
| cx3c | #2057 |
| 858 | #2059 |
| schoolage children | #2063 |
| peanuts | #2068 |
| association snps | #2070 |
| standardize | #2072 |
| asthma diagnosis | #2073 |
| bronchial epithelial cells | #2075 |
| early childhood | #2075 |
| polarizing | #2076 |
| discrepant | #2080 |
| asthma quality | #2086 |
| women association | #2087 |
| gastrointestinal microbiome | #2095 |
| confounders | #2097 |
| abstracts | #2098 |
| clinical phenotypes | #2098 |
| dusts | #2099 |
| environment interaction | #2100 |
| symptoms age | #2101 |
| male maternal | #2103 |
| 19th century | #2103 |
| disequilibrium | #2104 |
| tregs | #2109 |
| bacterial colonization | #2111 |
| reduced levels | #2111 |
| dairy products | #2114 |
| permutation | #2116 |
| alternata | #2118 |
| prevalence children | #2118 |
| children higher | #2121 |
| 5q | #2125 |
| child preschool | #2128 |
| protection | #2128 |
| glucans | #2132 |
| year | #2133 |
| th2 cell | #2134 |
| common disease | #2139 |
| mild asthma | #2141 |
| dietary interventions | #2142 |
| exhalation | #2145 |
| animals child | #2145 |
| indoors | #2149 |
| sibling | #2153 |
| offspring mothers | #2154 |
| epigenetic regulation | #2155 |
| schoolchildren | #2157 |
| immune modulation | #2157 |
| ionization time | #2158 |
| studies food | #2161 |
| interleukin4 | #2163 |
| blood samples | #2166 |
| food allergy | #2173 |
| blood sampling | #2175 |
| stat6 | #2178 |
| west | #2178 |
| consumption | #2180 |
| spirometry | #2181 |
| forced expiratory | #2184 |
| utero exposure | #2186 |
| industrialized | #2190 |
| children age | #2192 |
| subsequent risk | #2193 |
| respiratory infections | #2196 |
| topic united states | #2207 |
| occupational diseases | #2208 |
| actinomycetales | #2210 |
| acinetobacter | #2212 |
| communicable | #2213 |
| 146 | #2213 |
| lung epithelial cells | #2215 |
| indoor outdoor | #2215 |
| early development | #2220 |
| onset disease | #2220 |
| female finland | #2221 |
| lung mice | #2229 |
| guardians | #2231 |
| preschool | #2232 |
| 079 | #2234 |
| 18 months | #2236 |
| 12th | #2242 |
| diesel exhaust | #2242 |
| childhood overweight | #2245 |
| th17 cell | #2246 |
| bacteria fungi | #2247 |
| spirometric | #2247 |
| immune regulation | #2248 |
| whooping | #2249 |
| preventive | #2249 |
| bacterial load | #2251 |
| functional relevance | #2252 |
| bmi risk | #2257 |
| christianity | #2258 |
| 108 | #2259 |
| specific immunoglobulin | #2259 |
| patients responders | #2267 |
| résultats | #2268 |
| environmental influences | #2271 |
| decanoic | #2274 |
| consistently | #2277 |
| preventative | #2280 |
| cla | #2282 |
| commensals | #2282 |
| 031 | #2286 |
| objective measures | #2287 |
| association childhood | #2292 |
| foxp3 cells | #2293 |
| avenues | #2296 |
| gene interactions | #2299 |
| 11 years | #2301 |
| asthma study | #2312 |
| normal children | #2318 |
| receptor 2 | #2322 |
| box protein | #2325 |
| 0042 | #2326 |
| limulus | #2329 |
| 056 | #2334 |
| studies children | #2336 |
| methodsthe | #2338 |
| 064 | #2338 |
| variation genotype | #2341 |
| ascaris | #2349 |
| omega3 fatty acids | #2352 |
| 922 | #2353 |
| prrs | #2353 |
| spss | #2354 |
| 035 | #2358 |
| treg | #2361 |
| strongest | #2364 |
| adaptive immune response | #2366 |
| regular | #2368 |
| throat | #2371 |
| microbial composition | #2376 |
| viral respiratory | #2377 |
| populationbased cohort study | #2379 |
| diseases respiratory | #2380 |
| expiratory | #2386 |
| immunologically | #2386 |
| breath | #2395 |
| genetic variation | #2396 |
| human immune | #2397 |
| urban environments | #2401 |
| blood institute | #2402 |
| diaries | #2405 |
| bronchodilator agents | #2405 |
| models male | #2413 |
| cord | #2416 |
| adequately | #2417 |
| ripk1 | #2419 |
| 7000 | #2422 |
| finnish | #2423 |
| gstt1 | #2428 |
| pathway genes | #2430 |
| early adulthood | #2435 |
| african ancestry | #2443 |
| partly | #2445 |
| toll receptor | #2457 |
| attributable | #2459 |
| motor vehicles | #2461 |
| questionnaires sweden | #2462 |
| luciferase reporter | #2464 |
| disease review | #2468 |
| vitamin intake | #2468 |
| enhancer elements | #2474 |
| genetic ancestry | #2477 |
| crosssectional survey | #2479 |
| 095 | #2496 |
| peers | #2497 |
| case control study | #2498 |
| questionnaire | #2500 |
| cytokines humans | #2508 |
| children adolescent | #2508 |
| forkhead box | #2509 |
| tolllike receptors | #2512 |
| interleukin13 | #2525 |
| tolllike receptor | #2525 |
| airway responsiveness | #2525 |
| 239 | #2527 |
| common cold | #2528 |
| style | #2528 |
| artemisia | #2530 |
| uncontrolled | #2540 |
| forced expiratory volume | #2541 |
| young adulthood | #2552 |
| switzerland | #2553 |
| inverse | #2553 |
| modify | #2556 |
| european countries | #2564 |
| pregnancy prenatal | #2568 |
| 060 | #2569 |
| siblings | #2572 |
| th2 response | #2576 |
| activator | #2584 |
| suggested | #2584 |
| myristate | #2585 |
| sectional survey | #2586 |
| disease development | #2586 |
| human microbiome | #2588 |
| 030 | #2590 |
| ω3 | #2590 |
| air pollutant | #2602 |
| immunoglobulin levels | #2603 |
| damp | #2605 |
| large sample | #2608 |
| health children | #2616 |
| viral infections | #2623 |
| humans immunoglobulin | #2624 |
| 241 | #2625 |
| mold | #2626 |
| adverse health effects | #2628 |
| polymorphism | #2633 |
| chronic respiratory diseases | #2637 |
| prenatal exposure | #2638 |
| illness surveys | #2638 |
| translate | #2640 |
| molecular patterns | #2641 |
| imputation | #2641 |
| 141 | #2643 |
| cb | #2643 |
| early | #2646 |
| evenness | #2647 |
| life illness | #2651 |
| stockholm | #2652 |
| virus diseases | #2657 |
| exhaled nitric oxide | #2657 |
| groups children | #2665 |
| 739 | #2668 |
| urban rural | #2672 |
| il4 il5 | #2673 |
| gene expression levels | #2678 |
| confounder | #2678 |
| girls boys | #2684 |
| urgently | #2684 |
| onwards | #2687 |
| categorised | #2687 |
| positive association | #2689 |
| 0048 | #2696 |
| 061 | #2699 |
| host factors | #2699 |
| effects prenatal | #2700 |
| 793 | #2703 |
| 063 | #2712 |
| leukocytes mononuclear | #2717 |
| prenatally | #2721 |
| il23r | #2721 |
| respiratory function | #2731 |
| progression disease | #2732 |
| interaction genetic | #2738 |
| reaction polymorphism | #2739 |
| risk allele | #2739 |
| worldwide | #2739 |
| contacted | #2742 |
| 95 children | #2754 |
| preschool chromosomes | #2755 |
| complete data | #2756 |
| female fetal | #2760 |
| modern | #2764 |
| milk | #2766 |
| species level | #2770 |
| effects air | #2770 |
| potential benefits | #2771 |
| rhinovirus | #2775 |
| urban health | #2778 |
| centile | #2786 |
| messenger receptors | #2787 |
| gstm1 | #2787 |
| questionnaire study | #2796 |
| prematurely | #2800 |
| emergency department visits | #2801 |
| 893 | #2802 |
| prospective longitudinal | #2809 |
| functional variants | #2810 |
| personalized treatment | #2812 |
| 812 | #2815 |
| detailed | #2816 |
| package | #2826 |
| stat1 | #2827 |
| standardized | #2829 |
| nocturnal | #2831 |
| toll | #2843 |
| dietary factors | #2848 |
| asthma patients | #2853 |
| alternaria | #2854 |
| infant formula | #2856 |
| children mothers | #2861 |
| antibiotic treatment | #2871 |
| deubiquitinating | #2878 |
| tobacco smoke | #2878 |
| lci | #2886 |
| living | #2887 |
| respondent | #2888 |
| human bronchial | #2894 |
| persistence | #2899 |
| east | #2902 |
| complement receptors | #2906 |
| male parents | #2911 |
| intrapulmonary | #2914 |
| life span | #2915 |
| 3 mm | #2916 |
| epidemiologic methods | #2917 |
| 645 | #2919 |
| 913 | #2923 |
| transitioning | #2925 |
| male gender | #2928 |
| virtually | #2928 |
| il33 | #2940 |
| listeria | #2942 |
| matrix assisted | #2944 |
| antibiotic | #2947 |
| clinical manifestation | #2956 |
| pollen | #2957 |
| visiting | #2958 |
| reduced risk | #2961 |
| written | #2965 |
| notification | #2966 |
| 074 | #2968 |
| asthma management | #2969 |
| birth | #2974 |
| study prevalence | #2975 |
| mould | #2979 |
| 073 | #2982 |
| 8th | #2983 |
| patients asthma | #2985 |
| 804 | #2985 |
| primary prevention | #2989 |
| 2 months | #2990 |
| year age | #2996 |
| critical period | #2996 |
| forced vital | #3004 |
| 293 | #3010 |
| allergic inflammation | #3011 |
| genetic receptor | #3013 |
| tlr5 | #3022 |
| forced | #3024 |
| confounding factors | #3040 |
| methodological issues | #3047 |
| polymorphism single | #3050 |
| fungal dna | #3054 |
| frequency genetic | #3059 |
| 3 years | #3060 |
| epigenetic mechanisms | #3065 |
| doubt | #3065 |
| tlrs | #3068 |
| findings studies | #3069 |
| dna extraction | #3069 |
| snps genes | #3071 |
| vaccinations | #3079 |
| economic development | #3082 |
| adaptive immune responses | #3087 |
| preschool children | #3087 |
| rapid increase | #3089 |
| rural area | #3089 |
| viewpoints | #3090 |
| overweight obesity | #3093 |
| 066 | #3096 |
| genetic variations | #3098 |
| homes | #3099 |
| analysed | #3103 |
| malditof | #3106 |
| invited | #3110 |
| delayed effects | #3119 |
| environment | #3123 |
| 0036 | #3125 |
| inhalation exposure | #3126 |
| europe humans | #3126 |
| menarche | #3129 |
| hdm | #3131 |
| 12 months | #3141 |
| filaggrin | #3142 |
| cow | #3143 |
| preschool dna | #3154 |
| vital | #3157 |
| pha | #3159 |
| baseline follow | #3182 |
| multifaceted | #3184 |
| clarified | #3188 |
| distinct | #3192 |
| bronchodilator | #3194 |
| pleiotropy | #3196 |
| monitoring female | #3197 |
| genetic receptors | #3197 |
| aor 95 | #3198 |
| 037 | #3201 |
| development disease | #3206 |
| disease genotype | #3207 |
| volume 1 | #3208 |
| 069 | #3209 |
| suburban | #3211 |
| bronchial asthma | #3213 |
| surveys | #3214 |
| messages | #3216 |
| university students | #3218 |
| epidemiological | #3227 |
| housekeeping | #3227 |
| catarrhalis | #3235 |
| functional effects | #3245 |
| 050 | #3251 |
| agents child | #3252 |
| health surveys | #3257 |
| beds | #3257 |
| 08 | #3258 |
| 360 | #3259 |
| genetic epigenesis | #3260 |
| missing data | #3261 |
| systemic inflammation | #3261 |
| prospective cohort | #3264 |
| eventually | #3266 |
| enhanced expression | #3270 |
| spores | #3271 |
| automobiles | #3272 |
| 3rd | #3275 |
| nested case | #3280 |
| premature birth | #3283 |
| 4th | #3289 |
| appreciation | #3296 |
| 19th | #3300 |
| european ancestry | #3301 |
| 098 | #3306 |
| lab | #3308 |
| cells toll | #3314 |
| influential | #3317 |
| corynebacterium | #3318 |
| surveys humans | #3318 |
| weight children | #3327 |
| child | #3332 |
| idiotypic | #3338 |
| subtle | #3341 |
| logistic regression models | #3343 |
| th17 cells | #3349 |
| age children | #3352 |
| acid receptor | #3354 |
| noncommunicable diseases | #3354 |
| influencing | #3358 |
| 509 | #3361 |
| 086 | #3367 |
| ifn γ | #3371 |
| 166 | #3372 |
| manifests | #3374 |
| polymorphisms genes | #3377 |
| 566 | #3377 |
| genetic variants | #3379 |
| rooms | #3380 |
| gut microbiome | #3384 |
| genetic background | #3388 |
| differed | #3397 |
| 0004 | #3398 |
| genetic protein structure | #3408 |
| benzene | #3408 |
| turn | #3409 |
| protecting | #3409 |
| alternaria alternata | #3418 |
| gg | #3421 |
| tlr | #3421 |
| occupational asthma | #3423 |
| maternal health | #3433 |
| sociodemographics | #3436 |
| 092 | #3443 |
| air pollution | #3445 |
| factors smoking | #3445 |
| guangzhou | #3448 |
| epithelial barrier | #3461 |
| disease genetic | #3465 |
| trends prevalence | #3467 |
| airflow limitation | #3468 |
| 049 | #3468 |
| cytokine responses | #3469 |
| th2 cytokine | #3470 |
| omega6 | #3470 |
| rye | #3480 |
| 089 | #3484 |
| humans linkage | #3484 |
| 043 | #3484 |
| 18s | #3488 |
| ambient air pollution | #3494 |
| counselling | #3496 |
| skin patients | #3497 |
| aged children | #3500 |
| total population | #3501 |
| postal | #3507 |
| evidences | #3507 |
| raw | #3512 |
| heating | #3515 |
| onset symptoms | #3519 |
| 95th | #3523 |
| 032 | #3525 |
| respiratory mucosa | #3525 |
| analysing | #3529 |
| schoolaged children | #3540 |
| innate immune response | #3541 |
| older children | #3542 |
| microbiota | #3544 |
| 059 | #3548 |
| bronchial epithelial | #3550 |
| seasonal | #3551 |
| parent | #3557 |
| 5p | #3565 |
| molecular biomarkers | #3566 |
| microbiota composition | #3568 |
| 042 | #3570 |
| coevolution | #3578 |
| tract humans | #3594 |
| minor allele | #3596 |
| plausibility | #3603 |
| children parents | #3604 |
| birch | #3605 |
| parents children | #3606 |
| linkage disequilibrium | #3610 |
| cough | #3612 |
| association polymorphisms | #3618 |
| objectively | #3623 |
| genotype humans | #3626 |
| cats | #3627 |
| claimed | #3628 |
| relating | #3629 |
| environment female | #3630 |
| pollution | #3634 |
| risk alleles | #3638 |
| broad spectrum | #3641 |
| hej | #3643 |
| odds | #3644 |
| 0011 | #3652 |
| lung volume | #3654 |
| skewed | #3670 |
| contact | #3674 |
| publication child child | #3677 |
| resides | #3679 |
| complex diseases | #3680 |
| 251 | #3681 |
| 1995 | #3684 |
| toxoplasma | #3686 |
| genetic control | #3686 |
| disequilibrium male | #3686 |
| 046 | #3688 |
| monocytogenes | #3691 |
| adult blood | #3691 |
| host immune | #3691 |
| 655 | #3695 |
| gene frequency | #3697 |
| il17 | #3701 |
| biological agents | #3703 |
| gloves | #3704 |
| 456 | #3704 |
| study gwas | #3705 |
| cette | #3725 |
| mice models | #3726 |
| 577 | #3727 |
| allocate | #3730 |
| genetic gene | #3735 |
| desorption ionization | #3735 |
| hyper | #3748 |
| ovalbumin ova | #3753 |
| glutathione transferase | #3755 |
| 094 | #3755 |
| vehicle emissions | #3759 |
| helperinducer | #3763 |
| adaptive immunity | #3764 |
| coeliac | #3765 |
| regressions | #3766 |
| positive bacteria | #3766 |
| function decline | #3771 |
| 824 | #3786 |
| housing | #3795 |
| gm csf | #3797 |
| time trends | #3798 |
| sympathomimetics | #3802 |
| multicenter studies | #3807 |
| nutrition examination | #3820 |
| weight child | #3825 |
| tcells | #3832 |
| girls | #3834 |
| bethesda | #3837 |
| health problem | #3838 |
| relation | #3838 |
| receptors immunologic | #3843 |
| 076 | #3846 |
| models immunological | #3854 |
| exposure risk | #3861 |
| epistasis | #3865 |
| tremendous | #3867 |
| loci genetic | #3869 |
| utero | #3873 |
| immunoglobulin | #3873 |
| respiratory diseases | #3876 |
| berlin | #3876 |
| maternal smoking | #3881 |
| lymphoid cells | #3891 |
| parental | #3899 |
| positively | #3912 |
| 319 | #3920 |
| 368 | #3920 |
| colonisation | #3922 |
| volatile organic compounds | #3934 |
| confounding | #3940 |
| arthropod | #3942 |
| 051 | #3943 |
| maternal serum | #3946 |
| airway resistance | #3947 |
| maternal fetal | #3948 |
| human milk | #3950 |
| denaturing | #3950 |
| asthma exacerbations | #3957 |
| progeny | #3957 |
| faced | #3958 |
| genetic predisposition | #3958 |
| exacerbations | #3960 |
| epigenetic modifications | #3970 |
| culturing | #3971 |
| viable | #3982 |
| ecuador | #3991 |
| congresses | #3995 |
| health utilization | #3999 |
| ndvi | #4004 |
| 381 | #4005 |
| r5 | #4019 |
| newborn infant premature | #4023 |
| messenger reverse | #4026 |
| variation humans | #4026 |
| capita | #4029 |
| infant nutritional | #4032 |
| pellucida | #4033 |
| phase 2 | #4035 |
| environments | #4036 |
| ema | #4036 |
| single nucleotide | #4050 |
| occupational | #4052 |
| dipeptidyl | #4055 |
| genetic risk | #4060 |
| positive associations | #4061 |
| tlr9 | #4064 |
| humans polymorphism | #4069 |
| reverse | #4070 |
| prevotella | #4081 |
| dairy | #4093 |
| 493 | #4094 |
| 023 | #4107 |
| unbalanced | #4109 |
| clarification | #4112 |
| coding region | #4113 |
| chronic disease | #4118 |
| 052 | #4118 |
| effects exposure | #4120 |
| ethnically | #4120 |
| children 2 | #4126 |
| 087 | #4136 |
| positional | #4136 |
| salmeterol | #4139 |
| urban population | #4151 |
| luminex | #4154 |
| th17 | #4162 |
| chronic respiratory | #4163 |
| researcher | #4163 |
| 011 | #4170 |
| mrna expression | #4180 |
| husbandry | #4180 |
| sulfur dioxide | #4182 |
| th1 cells | #4183 |
| 424 | #4185 |
| rgs | #4187 |
| ruled | #4189 |
| respiratory infection | #4193 |
| protected | #4194 |
| zealand | #4204 |
| lifestyle | #4210 |
| risk loci | #4212 |
| finland | #4213 |
| preterm delivery | #4220 |
| populationbased sample | #4221 |
| growing body | #4222 |
| whey | #4236 |
| androstadienes | #4237 |
| inflammatory disease | #4243 |
| disease genotype humans | #4247 |
| body height | #4248 |
| adult onset | #4250 |
| increasing trend | #4252 |
| inhaled | #4253 |
| indoor environments | #4256 |
| participated | #4256 |
| neonatal mice | #4262 |
| children born | #4269 |
| healthy individuals | #4289 |
| metagenome | #4300 |
| ordinal | #4303 |
| influenced | #4314 |
| ephedrine | #4318 |
| cx3cl1 | #4318 |
| immunologic receptors | #4322 |
| activity pa | #4324 |
| 1 gene | #4337 |
| male mothers | #4339 |
| male obesity | #4345 |
| years life | #4346 |
| phytohemagglutinins | #4349 |
| nucleotide | #4353 |
| children study | #4356 |
| 093 | #4358 |
| diagnostics | #4359 |
| healthy children | #4370 |
| 410 | #4375 |
| urban area | #4379 |
| rationale | #4393 |
| poaceae | #4397 |
| protects | #4404 |
| age 12 | #4405 |
| fluticasone | #4405 |
| stratified | #4414 |
| lpa | #4417 |
| exposure levels | #4418 |
| cephalometry | #4418 |
| percentile | #4421 |
| hypopharynx | #4424 |
| 95ci | #4425 |
| female sex | #4428 |
| 15 years | #4429 |
| onset | #4434 |
| crohn disease | #4437 |
| participating | #4439 |
| pupils | #4442 |
| secondary prevention | #4449 |
| dr3 | #4449 |
| receptors protein | #4451 |
| chances | #4457 |
| rash | #4457 |
| goblet | #4459 |
| confers | #4461 |
| patients cystic fibrosis | #4466 |
| respiratory viruses | #4468 |
| increased prevalence | #4468 |
| 457 | #4474 |
| 0022 | #4496 |
| prevalence risk factors | #4499 |
| severe asthma | #4499 |
| culture techniques | #4499 |
| microorganisms | #4511 |
| genetic effects | #4516 |
| infant | #4517 |
| trajectories | #4530 |
| no2 | #4538 |
| inflammatory diseases | #4542 |
| statistical | #4545 |
| butter | #4551 |
| assisted laser | #4555 |
| gramnegative bacteria | #4558 |
| structural equation modeling | #4559 |
| receptor alpha | #4564 |
| control children | #4572 |
| 49 | #4573 |
| population prevalence | #4583 |
| ahr | #4583 |
| prevalence estimates | #4588 |
| 080 | #4591 |
| neutrophilic | #4598 |
| haplotypes humans | #4600 |
| adaptor protein | #4600 |
| airway | #4601 |
| knowledge gaps | #4603 |
| strikingly | #4630 |
| daily practice | #4632 |
| lactis | #4634 |
| detectability | #4660 |
| str | #4661 |
| random | #4676 |
| aiming | #4676 |
| pef | #4683 |
| 299 | #4688 |
| accumulating | #4695 |
| measles | #4697 |
| 1014 | #4699 |
| hscrp | #4700 |
| gstp1 | #4725 |
| current evidence | #4730 |
| tlc | #4741 |
| associations | #4745 |
| bacterial communities | #4747 |
| immune | #4749 |
| obstructive lung | #4753 |
| lactic acid bacteria | #4754 |
| genetic risk factors | #4755 |
| transcriptomics | #4768 |
| lifestyle factors | #4772 |
| pathophysiologic | #4775 |
| lung development | #4777 |
| unclear | #4782 |
| exposure air | #4785 |
| immune responses | #4795 |
| quantity | #4804 |
| pulmonary function | #4809 |
| filament proteins | #4812 |
| plateau | #4814 |
| helminth | #4821 |
| respects | #4823 |
| albuterol | #4823 |
| adult air | #4837 |
| 399 | #4838 |
| female food | #4841 |
| implicating | #4844 |
| pointed | #4848 |
| feeding | #4851 |
| new cases | #4858 |
| haplotype analysis | #4874 |
| ont | #4886 |
| hcs | #4889 |
| 624 | #4896 |
| occupations | #4896 |
| respiratory illness | #4897 |
| newborn male | #4902 |
| studies effects | #4919 |
| hyperventilation | #4927 |
| asthma chronic | #4928 |
| dans | #4930 |
| contributors | #4940 |
| postnatal development | #4944 |
| respective | #4955 |
| starts | #4964 |
| tolerance induction | #4965 |
| blood mononuclear | #4969 |
| natal | #4973 |
| 322 | #4975 |
| airway disease | #4975 |
| predisposition disease | #4986 |
| eosinophils | #4994 |
| potential effects | #5005 |
| explore | #5011 |
| adaptor | #5012 |
| epidemiology | #5018 |
| laser desorption | #5018 |
| serine protease | #5020 |
| functionality | #5023 |
| inbred c57bl models | #5024 |
| inhalation | #5049 |
| livestock | #5058 |
| 95 | #5062 |
| paediatric | #5065 |
| manifestation | #5069 |
| milk human | #5071 |
| inflammatory markers | #5072 |
| grass | #5072 |
| 219 | #5083 |
| genetic analyses | #5084 |
| covariates | #5089 |
| held | #5091 |
| hormonal | #5091 |
| alpha1 | #5092 |
| urgent | #5094 |
| unexposed | #5099 |
| habits | #5099 |
| 097 | #5100 |
| genomewide significance | #5100 |
| il3 | #5102 |
| highrisk | #5105 |
| lysate | #5106 |
| gwas | #5119 |
| latent | #5125 |
| smoke | #5126 |
| 103 | #5130 |
| crucial | #5133 |
| 12 years | #5134 |
| regional differences | #5144 |
| mononuclear | #5153 |
| decades | #5159 |
| traffic | #5159 |
| dysbiosis | #5183 |
| 383 | #5186 |
| lung epithelial | #5191 |
| fingerprinting | #5191 |
| reflect | #5193 |
| p40 | #5196 |
| butyrates | #5200 |
| 070 | #5204 |
| age onset | #5209 |
| airways | #5210 |
| window | #5232 |
| hallmarks | #5241 |
| taxa | #5242 |
| recruited | #5243 |
| bronchopulmonary | #5247 |
| isotype | #5247 |
| crp levels | #5256 |
| psychosocial factors | #5267 |
| quartile | #5274 |
| inflammatory disorders | #5279 |
| dietary supplementation | #5280 |
| gprotein | #5283 |
| international | #5289 |
| early phase | #5305 |
| 123 | #5306 |
| environmental variables | #5314 |
| cutoff | #5318 |
| coupled receptor | #5329 |
| excessive | #5333 |
| 136 | #5336 |
| comprehensively | #5339 |
| gene expression | #5348 |
| suppressive | #5348 |
| immunology | #5348 |
| meat | #5350 |
| disease susceptibility | #5359 |
| supernatants | #5369 |
| new strategies | #5380 |
| illumina | #5384 |
| serum proteins | #5392 |
| 233 | #5406 |
| substantial | #5412 |
| discussions | #5423 |
| smad3 | #5429 |
| vitamin supplementation | #5436 |
| sensitized | #5441 |
| certainty | #5443 |
| 337 | #5450 |
| geometric | #5456 |
| 224 | #5465 |
| marks | #5470 |
| hypothesis | #5473 |
| growing evidence | #5475 |
| challenge | #5476 |
| epidemiologic | #5476 |
| phenotype | #5481 |
| healthy control subjects | #5495 |
| floor | #5496 |
| cytokines disease | #5496 |
| 373 | #5496 |
| road | #5504 |
| aged asthma | #5537 |
| alter | #5539 |
| 556 | #5544 |
| term exposure | #5547 |
| 454 | #5550 |
| coexpression | #5570 |
| predisposition | #5574 |
| 512 | #5578 |
| 45 | #5580 |
| lose | #5584 |
| 321 | #5595 |
| figures | #5602 |
| methacholine | #5602 |
| 2nd | #5610 |
| 258 | #5610 |
| 062 | #5630 |
| ld | #5634 |
| 14 years | #5637 |
| airflow | #5642 |
| contribute | #5645 |
| aa | #5661 |
| bacterial species | #5667 |
| protein coupled | #5668 |
| 081 | #5668 |
| notable | #5679 |
| contraceptives | #5682 |
| hints | #5688 |
| cytokine expression | #5693 |
| prebiotics | #5694 |
| commission | #5700 |
| 134 | #5704 |
| offspring | #5704 |
| cows | #5713 |
| cytokine production | #5722 |
| tlr7 | #5725 |
| presentations | #5727 |
| stepwise | #5729 |
| fecal samples | #5753 |
| animal humans | #5764 |
| 021 | #5770 |
| house | #5777 |
| rna expression | #5788 |
| cold | #5790 |
| maternal | #5797 |
| predominance | #5812 |
| persists | #5817 |
| humans immunity | #5824 |
| comprehensive | #5824 |
| cholecalciferol | #5831 |
| snps | #5833 |
| hen | #5848 |
| commensal | #5856 |
| 384 | #5863 |
| mites | #5878 |
| 078 | #5881 |
| bangladesh | #5887 |
| study genotype | #5888 |
| drug development | #5891 |
| sleeping | #5898 |
| workplace | #5900 |
| immunoglobulin igg | #5902 |
| paf | #5910 |
| study associations | #5924 |
| adjust | #5930 |
| encourage | #5930 |
| helper | #5938 |
| differ | #5944 |
| western europe | #5945 |
| investigate association | #5947 |
| questionnaire survey | #5947 |
| male risk | #5953 |
| 0017 | #5958 |
| 216 | #5963 |
| eastern europe | #5978 |
| promoter polymorphism | #5989 |
| disease prevalence | #5991 |
| longitudinal data | #5995 |
| interleukin15 | #5996 |
| adaptive immune | #5999 |
| calling | #6002 |
| patients symptoms | #6008 |
| 367 | #6008 |
| panels | #6009 |
| doseresponse relationship | #6012 |
| box | #6020 |
| pathogen interactions | #6022 |
| immune tolerance | #6023 |
| tract infections | #6029 |
| adult population | #6032 |
| obese children | #6032 |
| diversity | #6047 |
| existing methods | #6054 |
| risk variants | #6060 |
| prevalent | #6063 |
| eastern | #6064 |
| gmcsf | #6064 |
| modifier | #6066 |
| persisted | #6067 |
| restricted | #6068 |
| comparability | #6070 |
| 122 | #6072 |
| implication | #6077 |
| unselected | #6082 |
| ors | #6082 |
| ovalbumin | #6086 |
| microflora | #6091 |
| interleukin17 | #6094 |
| time flight | #6103 |
| 099 | #6113 |
| conferred | #6117 |
| recruiting | #6117 |
| genetic polymorphisms | #6122 |
| causality | #6128 |
| repeated | #6132 |
| fev1 | #6134 |
| fecal | #6135 |
| ahead | #6140 |
| 24 years | #6146 |
| programme | #6152 |
| 16 years | #6157 |
| town | #6158 |
| intermediate filament | #6161 |
| avec | #6163 |
| welfare | #6164 |
| gathered | #6166 |
| keeping | #6173 |
| constituent | #6182 |
| toluene | #6192 |
| determining | #6193 |
| genomewide association study | #6196 |
| narcotic | #6202 |
| conferring | #6205 |
| gross | #6216 |
| genuine | #6233 |
| populations | #6233 |
| illnesses | #6241 |
| institute | #6243 |
| administration inhalation | #6246 |
| prematurity | #6246 |
| protease inhibitor | #6252 |
| odds ratio 95 | #6262 |
| parents | #6266 |
| indoor environment | #6270 |
| study groups | #6270 |
| proposal | #6285 |
| offers | #6287 |
| irr | #6291 |
| communicable diseases | #6301 |
| nested | #6303 |
| alpha 1 | #6304 |
| tests | #6307 |
| young age | #6316 |
| outdoor | #6321 |
| allele frequencies | #6326 |
| infrequent | #6326 |
| interferons | #6343 |
| peptidase | #6346 |
| immunity mucosal | #6349 |
| 067 | #6355 |
| lymphocytes helper | #6360 |
| studies association | #6370 |
| 090 | #6375 |
| adjustments | #6385 |
| bivariate | #6388 |
| protective factor | #6390 |
| iu | #6394 |
| levels serum | #6400 |
| decreased risk | #6401 |
| immunological | #6409 |
| selection bias | #6410 |
| cell subsets | #6411 |
| genetic determinants | #6417 |
| infant premature | #6418 |
| 119 | #6439 |
| questions | #6448 |
| hypothesized | #6466 |
| mmp9 | #6467 |
| adverse health | #6475 |
| lower respiratory | #6475 |
| 287 | #6486 |
| 274 | #6490 |
| premature | #6493 |
| omalizumab | #6501 |
| sleep disturbance | #6507 |
| 238 | #6507 |
| gst | #6507 |
| links | #6512 |
| murine model | #6515 |
| infant feeding | #6523 |
| adam | #6524 |
| repeated measurements | #6527 |
| increased expression | #6529 |
| fev1 fvc | #6530 |
| diseases risk | #6548 |
| implied | #6555 |
| centers | #6567 |
| 1012 | #6571 |
| statements | #6572 |
| completion | #6598 |
| disease onset | #6602 |
| 283 | #6602 |
| children adults | #6604 |
| pollutant | #6605 |
| hospital admissions | #6617 |
| promoter region | #6624 |
| consumed | #6647 |
| accessible | #6653 |
| host pathogen | #6653 |
| adjusted 95 | #6654 |
| intervention studies | #6660 |
| playing | #6672 |
| 138 | #6684 |
| candidate genes | #6684 |
| bacterium | #6709 |
| cell responses | #6711 |
| systematic search | #6715 |
| cytokines dendritic | #6716 |
| washout | #6720 |
| nod2 | #6730 |
| impulse | #6732 |
| haplotypes | #6732 |
| 0009 | #6734 |
| cells disease | #6734 |
| ova | #6739 |
| focuses | #6745 |
| 126 | #6750 |
| n10 | #6757 |
| cities | #6761 |
| quartiles | #6763 |
| height weight | #6765 |
| mumps | #6769 |
| plethysmography | #6771 |
| eosinophilic | #6783 |
| disease mechanisms | #6787 |
| 065 | #6794 |
| developing | #6798 |
| 330 | #6807 |
| remained | #6813 |
| chronic exposure | #6823 |
| microbiology | #6831 |
| elucidated | #6846 |
| growing | #6846 |
| mz | #6852 |
| microorganism | #6861 |
| 305 | #6868 |
| cream | #6874 |
| lower incidence | #6887 |
| functional studies | #6890 |
| beef | #6896 |
| incidences | #6900 |
| inert | #6911 |
| academia | #6924 |
| supplementary | #6934 |
| zona | #6939 |
| multivariate logistic | #6941 |
| tertiles | #6948 |
| specific effects | #6949 |
| 1 diabetes | #6962 |
| 044 | #6965 |
| pathogenic bacteria | #6972 |
| lung | #6972 |
| maturation | #6975 |
| specialists | #6986 |
| infections | #6991 |
| transducer | #6998 |
| obesity bmi | #6999 |
| attendance | #7012 |
| summarizes | #7024 |
| infectious diseases | #7025 |
| shaping | #7027 |
| ribosomal 16s | #7033 |
| organic compounds | #7037 |
| 231 | #7041 |
| 028 | #7042 |
| confirming | #7043 |
| evidence association | #7046 |
| explaining | #7053 |
| amelioration | #7060 |
| concert | #7095 |
| 313 | #7102 |
| 019 | #7109 |
| linoleic acid | #7111 |
| type 1 diabetes | #7111 |
| triggering | #7114 |
| breath tests | #7117 |
| serum total | #7117 |
| 164 | #7122 |
| increased incidence | #7128 |
| th1 | #7132 |
| homeobox | #7134 |
| male membrane | #7135 |
| health humans | #7136 |
| homozygote | #7150 |
| consenting | #7153 |
| compare | #7155 |
| daily life | #7165 |
| increased risks | #7167 |
| likewise | #7184 |
| agents anti | #7184 |
| spatial variation | #7197 |
| develop | #7209 |
| health nutrition | #7223 |
| irritable bowel syndrome | #7227 |
| helper cell | #7228 |
| discusses | #7228 |
| spore | #7229 |
| cohort | #7231 |
| grow | #7238 |
| 163 | #7243 |
| influences | #7244 |
| beta1 | #7244 |
| analyses | #7255 |
| 0015 | #7268 |
| standardised | #7277 |
| 058 | #7278 |
| 053 | #7283 |
| handling | #7288 |
| urbanization | #7299 |
| herpesviridae | #7299 |
| 022 | #7309 |
| internationality | #7310 |
| single nucleotide polymorphisms | #7317 |
| personalized | #7355 |
| attending | #7374 |
| air pollutants | #7376 |
| 199 | #7387 |
| rome | #7392 |
| university | #7411 |
| linoleic | #7424 |
| potential risk | #7443 |
| histories | #7457 |
| 9 months | #7467 |
| human body | #7474 |
| boiling | #7486 |
| stratification | #7488 |
| bronchi | #7493 |
| spp | #7515 |
| alps | #7515 |
| enrollment | #7519 |
| intestinal diseases | #7523 |
| pediatrics | #7535 |
| toxoplasmosis | #7551 |
| bowel diseases | #7561 |
| allele | #7582 |
| eosinophil | #7586 |
| oropharyngeal | #7591 |
| considerably | #7612 |
| overt | #7613 |
| diseases animals | #7613 |
| worked | #7643 |
| school | #7649 |
| 316 | #7658 |
| haemophilus | #7669 |
| health conditions | #7671 |
| peanut | #7684 |
| prenatal | #7684 |
| rna ribosomal | #7700 |
| 161 | #7725 |
| nox | #7726 |
| europe | #7728 |
| leukocytes | #7731 |
| population | #7736 |
| characterised | #7744 |
| vehicles | #7748 |
| 308 | #7763 |
| single | #7777 |
| flora | #7792 |
| clinical examination | #7797 |
| infant male | #7799 |
| attended | #7802 |
| sputum | #7804 |
| reader | #7805 |
| lymphocyte subsets | #7808 |
| 66 | #7809 |
| 171 | #7839 |
| pyrosequencing | #7845 |
| conjunction | #7848 |
| m3 | #7856 |
| pa | #7859 |
| participation | #7865 |
| 1996 | #7881 |
| investigators | #7882 |
| specific | #7895 |
| deficiencies | #7898 |
| asked | #7899 |
| specificities | #7907 |
| months age | #7912 |
| parasitic | #7915 |
| epigenesis genetic | #7919 |
| neisseria | #7922 |
| 160 | #7928 |
| protective role | #7929 |
| egg | #7933 |
| therapeutic intervention | #7939 |
| listeria monocytogenes | #7941 |
| pbmcs | #7944 |
| fall | #7947 |
| unresolved | #7949 |
| lockdown | #7950 |
| prevalence incidence | #7950 |
| immune function | #7953 |
| altering | #7959 |
| human subjects | #7966 |
| collecting | #7980 |
| explanatory | #7997 |
| fatty acid composition | #8002 |
| lacking | #8024 |
| 264 | #8040 |
| bordetella | #8049 |
| phorbol | #8077 |
| separately | #8084 |
| rising | #8086 |
| 304 | #8087 |
| helper inducer | #8091 |
| weight infant | #8101 |
| 088 | #8109 |
| determinants | #8119 |
| regarded | #8119 |
| multiple logistic | #8132 |
| career | #8149 |
| factor binding | #8160 |
| polymorphism genetic | #8162 |
| gene regulation | #8172 |
| etiologies | #8201 |
| omega3 | #8202 |
| mutually | #8209 |
| initiative | #8212 |
| sophisticated | #8214 |
| 140 | #8224 |
| community based | #8228 |
| epigenesis | #8236 |
| emerged | #8237 |
| 266 | #8255 |
| hypotheses | #8257 |
| cars | #8265 |
| examination | #8283 |
| modifiable | #8285 |
| adolescent | #8294 |
| 242 | #8295 |
| hc | #8303 |
| belonged | #8306 |
| humans immunization | #8308 |
| based cohort | #8312 |
| nights | #8331 |
| objectives | #8337 |
| critical roles | #8342 |
| 111 | #8348 |
| nasal mucosa | #8351 |
| nineteen | #8357 |
| genera | #8357 |
| pylori infection | #8359 |
| normal weight | #8367 |
| instillation | #8385 |
| interleukin10 | #8388 |
| relative abundance | #8412 |
| latest | #8415 |
| author | #8420 |
| spearman | #8422 |
| infant low | #8429 |
| covariate | #8435 |
| authorities | #8438 |
| aspergillosis | #8440 |
| reduce risk | #8441 |
| 16s | #8447 |
| 113 | #8460 |
| multifactorial | #8460 |
| anhydride | #8462 |
| syncytial | #8462 |
| contrasting | #8463 |
| similarities | #8478 |
| minor | #8478 |
| profound | #8479 |
| investigate | #8497 |
| asthmatic patients | #8506 |
| resembles | #8511 |
| mass body | #8521 |
| genetic factors | #8538 |
| relations | #8543 |
| cytokines | #8544 |
| so2 | #8558 |
| prospective cohort study | #8565 |
| extract | #8568 |
| 4 years | #8590 |
| inclusion | #8598 |
| genetic loci | #8618 |
| humidity | #8633 |
| facilitates | #8642 |
| strong evidence | #8645 |
| logistic | #8648 |
| animal | #8656 |
| dendritic cells dcs | #8665 |
| adaptive | #8676 |
| 101 | #8677 |
| oropharynx | #8681 |
| defines | #8685 |
| histamine | #8716 |
| responsiveness | #8726 |
| increased odds | #8730 |
| choosing | #8732 |
| prevention | #8737 |
| 193 | #8776 |
| exploring | #8780 |
| 30 years | #8799 |
| airborne | #8805 |
| vdr | #8811 |
| incidence infant | #8815 |
| integrates | #8824 |
| unknown | #8840 |
| alveoli | #8852 |
| antibody levels | #8861 |
| traditional | #8865 |
| 155 | #8867 |
| association analysis | #8868 |
| humans logistic | #8879 |
| burden disease | #8884 |
| ears | #8884 |
| cesarean | #8884 |
| utilization | #8888 |
| residence | #8903 |
| bdnf | #8911 |
| pools | #8916 |
| 273 | #8926 |
| processed | #8935 |
| reactive protein | #8944 |
| pattern recognition | #8957 |
| lipopolysaccharide lps | #8958 |
| olive | #8963 |
| phase | #8966 |
| 177 | #8983 |
| 194 | #8996 |
| 0007 | #8998 |
| underlying | #9006 |
| 172 | #9017 |
| preschool humans | #9028 |
| surveyed | #9029 |
| humans lung | #9031 |
| sequelae | #9032 |
| receptor 4 | #9040 |
| population surveillance | #9046 |
| transferase | #9049 |
| cytokine | #9057 |
| boys girls | #9070 |
| london | #9088 |
| lower risk | #9095 |
| median duration | #9096 |
| parturition | #9101 |
| flanking | #9109 |
| nutritional physiological | #9139 |
| determinant | #9154 |
| statistical methods | #9170 |
| differing | #9175 |
| study selection | #9180 |
| butyrate | #9182 |
| secretions | #9187 |
| food | #9198 |
| exert | #9209 |
| dogs | #9217 |
| fungi | #9222 |
| 186 | #9234 |
| accompanying | #9239 |
| pattern | #9248 |
| human skin | #9259 |
| popularity | #9269 |
| multivariate analyses | #9269 |
| 04 | #9278 |
| 275 | #9282 |
| counts | #9296 |
| quintile | #9297 |
| controversial | #9299 |
| tract | #9302 |
| 95 women | #9304 |
| haplotype | #9306 |
| allele frequency | #9306 |
| outcome measures | #9309 |
| 345 | #9313 |
| anova | #9328 |
| prospectively | #9334 |
| eosinophilia | #9338 |
| vocs | #9351 |
| logistic regression analysis | #9353 |
| funded | #9360 |
| responders | #9364 |
| olds | #9364 |
| proteinase | #9366 |
| urban | #9376 |
| tlr4 | #9383 |
| infantile | #9386 |
| numerous | #9388 |
| 232 | #9392 |
| maldi | #9404 |
| ages | #9407 |
| newborn | #9409 |
| incidence | #9412 |
| 286 | #9422 |
| 5000 | #9432 |
| streptococcus | #9438 |
| extrinsic | #9445 |
| sick | #9460 |
| countries | #9478 |
| 016 | #9481 |
| anthropometric | #9495 |
| worker | #9498 |
| fatty acids | #9509 |
| longitudinally | #9512 |
| comprise | #9517 |
| markers | #9532 |
| antigen presenting | #9554 |
| 256 | #9559 |
| body composition | #9561 |
| airway obstruction | #9573 |
| 165 | #9574 |
| pharyngeal | #9579 |
| global health | #9583 |
| social class | #9585 |
| ifn gamma | #9589 |
| actinobacteria | #9597 |
| nutritive | #9598 |
| replicated | #9599 |
| occurrence | #9605 |
| lessons | #9617 |
| increases risk | #9627 |
| substances | #9659 |
| mucous | #9666 |
| adult mice | #9669 |
| dietary supplements | #9672 |
| crude | #9672 |
| child child | #9678 |
| reference | #9687 |
| obesity | #9698 |
| common genetic | #9743 |
| diagnoses | #9743 |
| populationbased study | #9744 |
| 9 | #9746 |
| p004 | #9752 |
| mothers | #9753 |
| mononuclear cells | #9760 |
| il10 | #9761 |
| proinflammatory | #9761 |
| publications | #9772 |
| directly | #9772 |
| 1 protein | #9773 |
| obstruction | #9774 |
| body mass bmi | #9788 |
| reliable | #9790 |
| 158 | #9800 |
| electrophoretic | #9807 |
| therapeutic strategies | #9818 |
| prove | #9826 |
| 20th | #9843 |
| random allocation | #9844 |
| 102 | #9849 |
| cluster | #9849 |
| modifying | #9850 |
| rrna | #9873 |
| nps | #9884 |
| restrictive | #9899 |
| altogether | #9903 |
| reality | #9904 |
| receptors | #9909 |
| immunomodulatory | #9920 |
| tagging | #9925 |
| intranasal | #9929 |
| century | #9933 |
| 39 | #9935 |
| southern | #9938 |
| bacterial infections | #9964 |
| 1991 | #9964 |
| tnf α | #9973 |
| 0002 | #9995 |
| exclusively | #10002 |
| 152 | #10006 |
| lavage fluid | #10012 |
| presenting cells | #10012 |
| particulate matter | #10015 |
| mass bmi | #10020 |
| health outcomes | #10050 |
| reproducible | #10052 |
| 57 | #10065 |
| disappeared | #10087 |
| 87 | #10096 |
| elucidation | #10099 |
| parts | #10121 |
| superoxide dismutase | #10123 |
| immune cell | #10127 |
| 072 | #10143 |
| nasal | #10159 |
| exist | #10160 |
| bias | #10162 |
| expression genes | #10164 |
| ascertained | #10166 |
| sedentary behavior | #10168 |
| 4 months | #10169 |
| exclusions | #10169 |
| timing | #10174 |
| incidence prevalence | #10175 |
| discover | #10203 |
| western | #10210 |
| microbial communities | #10218 |
| fungal | #10222 |
| adaptor proteins | #10226 |
| alpha subunit | #10236 |
| weaker | #10259 |
| influenzae | #10264 |
| 212 | #10290 |
| study children | #10303 |
| ghana | #10324 |
| aim | #10332 |
| analyze | #10356 |
| interleukin12 | #10361 |
| factorial | #10361 |
| 142 | #10364 |
| concepts | #10386 |
| centrally | #10386 |
| methodologies | #10387 |
| ulcerative colitis | #10399 |
| respiratory disease | #10403 |
| 17 | #10408 |
| polyunsaturated | #10422 |
| parasites | #10430 |
| scientific | #10436 |
| modelled | #10448 |
| nose | #10465 |
| flow rate | #10471 |
| bronchiolitis | #10473 |
| exposed | #10477 |
| 07 | #10499 |
| realtime pcr | #10503 |
| c3h | #10522 |
| twothirds | #10527 |
| interquartile range | #10528 |
| adjusted | #10532 |
| acetates | #10561 |
| 94 | #10565 |
| new zealand | #10576 |
| 010 | #10595 |
| biodiversity | #10595 |
| societal | #10603 |
| france | #10605 |
| priming | #10614 |
| homeodomain | #10623 |
| time pcr | #10638 |
| boys | #10643 |
| indirectly | #10650 |
| bacteriological | #10653 |
| 206 | #10664 |
| 004 | #10665 |
| ribosomal | #10691 |
| vitamins | #10703 |
| bidirectional | #10706 |
| positivity | #10711 |
| possibilities | #10723 |
| 008 | #10728 |
| items | #10729 |
| newborn infant | #10763 |
| ancestry female | #10768 |
| nitrous | #10770 |
| swabs | #10771 |
| entered | #10774 |
| female gastrointestinal | #10776 |
| regulation humans | #10776 |
| responses | #10786 |
| skin | #10787 |
| transferases | #10789 |
| increased production | #10799 |
| national institute | #10805 |
| suppressing | #10825 |
| workshop | #10850 |
| physical activity | #10855 |
| postnatal | #10859 |
| prevent | #10862 |
| bronchoalveolar | #10864 |
| fvc | #10873 |
| km2 | #10911 |
| functional role | #10915 |
| standardization | #10926 |
| 2002 | #10934 |
| 036 | #10944 |
| carriers | #10949 |
| subclinical | #10957 |
| microbiological | #10968 |
| subsequent | #10971 |
| 16s rrna | #10983 |
| immunoglobulins | #10986 |
| lps | #10988 |
| 217 | #10992 |
| roc | #10992 |
| constituents | #10993 |
| 191 | #10993 |
| harm | #10994 |
| 197 | #10996 |
| aerosol | #11002 |
| swiss | #11006 |
| inconsistent | #11009 |
| chance | #11022 |
| poland | #11028 |
| antibody responses | #11043 |
| amniotic | #11054 |
| 6 12 | #11055 |
| low birth | #11092 |
| serology | #11092 |
| passive | #11120 |
| chromosomes human | #11127 |
| ulcerative | #11134 |
| disturbed | #11159 |
| 235 | #11177 |
| crohn | #11187 |
| community | #11188 |
| 144 | #11222 |
| gut | #11232 |
| il12 | #11233 |
| confined | #11247 |
| environmental pollutants | #11258 |
| fourth | #11270 |
| 157 | #11286 |
| rna messenger | #11289 |
| duration | #11314 |
| regulatory mechanisms | #11327 |
| highest risk | #11328 |
| intron | #11330 |
| studies diet | #11351 |
| persistent | #11353 |
| chronic diseases | #11376 |
| 040 | #11389 |
| birth weight | #11397 |
| juvenile | #11415 |
| nitrogen dioxide | #11427 |
| cell function | #11428 |
| modulate | #11435 |
| supplements | #11440 |
| 18 years | #11446 |
| discuss | #11455 |
| female | #11457 |
| 105 | #11459 |
| epigenetics | #11463 |
| gut microbiota | #11475 |
| quinolines | #11485 |
| genetic susceptibility | #11493 |
| 128 | #11502 |
| factor1 | #11515 |
| 86 | #11521 |
| haemophilus influenzae | #11522 |
| late onset | #11524 |
| helicobacter | #11533 |
| biomarker | #11536 |
| 012 | #11542 |
| cd28 | #11550 |
| interact | #11564 |
| 78 | #11583 |
| proteases | #11587 |
| households | #11587 |
| variant | #11588 |
| physiological phenomena | #11594 |
| healthy control | #11597 |
| 130 | #11601 |
| celiac | #11633 |
| risk disease | #11636 |
| dispersion | #11666 |
| narrative | #11668 |
| interquartile | #11709 |
| gene polymorphisms | #11736 |
| introduction | #11752 |
| trimester pregnancy | #11755 |
| confirmation | #11758 |
| harmful | #11806 |
| lipopolysaccharides | #11813 |
| 222 | #11824 |
| gram negative | #11824 |
| irrespective | #11831 |
| 075 | #11858 |
| subtypes | #11860 |
| episodes | #11867 |
| incident | #11881 |
| insight | #11899 |
| fetal | #11900 |
| 230 | #11904 |
| air | #11924 |
| started | #11931 |
| genetic | #11936 |
| ifn | #11939 |
| 1990 | #11944 |
| autoantigens | #11967 |
| natural | #11982 |
| lowest | #11990 |
| genetic association | #11992 |
| protein levels | #11997 |
| finding | #12007 |
| initially | #12014 |
| 151 | #12047 |
| solely | #12055 |
| quantifying | #12075 |
| pcr | #12106 |
| case control | #12121 |
| ultimately | #12124 |
| upregulation | #12127 |
| immunologic factors | #12176 |
| subsets | #12179 |
| estimating | #12184 |
| country | #12201 |
| young children | #12219 |
| 149 | #12221 |
| inflammatory response | #12238 |
| leukocyte count | #12248 |
| fish oil | #12249 |
| december | #12256 |
| sle | #12270 |
| shifted | #12297 |
| began | #12327 |
| relapsing | #12330 |
| antibiotics | #12339 |
| 006 | #12341 |
| gm | #12351 |
| completed | #12354 |
| european continental | #12371 |
| minority | #12421 |
| linkage | #12422 |
| reasons | #12444 |
| ifngamma | #12445 |
| relevance | #12447 |
| lung tissue | #12462 |
| colonization | #12463 |
| 170 | #12467 |
| inflammatory cytokine | #12469 |
| european | #12469 |
| lymphocyte activation | #12520 |
| saline | #12546 |
| 17 years | #12583 |
| scarce | #12583 |
| 117 | #12590 |
| defense | #12609 |
| length polymorphism | #12616 |
| predictors | #12620 |
| tobacco | #12634 |
| crohns disease | #12638 |
| discriminating | #12641 |
| 203 | #12655 |
| residence characteristics | #12657 |
| tested | #12664 |
| collect | #12680 |
| detectable | #12682 |
| 156 | #12683 |
| cd3 | #12684 |
| total | #12687 |
| child development | #12695 |
| cystic fibrosis | #12696 |
| contributing | #12697 |
| residential | #12708 |
| multicentre | #12731 |
| beta2 | #12735 |
| aspect | #12741 |
| swedish | #12751 |
| enhancer | #12752 |
| 204 | #12773 |
| clinical manifestations | #12796 |
| 184 | #12815 |
| lung diseases | #12819 |
| combinations | #12856 |
| 104 | #12860 |
| pregnancy | #12873 |
| aspects | #12899 |
| sedentary | #12908 |
| translated | #12918 |
| infants | #12943 |
| elevated levels | #12943 |
| united kingdom | #12946 |
| debate | #12955 |
| human genome | #12959 |
| inflammatory bowel | #12963 |
| coded | #12998 |
| 154 | #13016 |
| annually | #13056 |
| 52 | #13056 |
| 220 | #13057 |
| elusive | #13067 |
| extracellular vesicles | #13082 |
| future | #13086 |
| suffer | #13086 |
| glucocorticoids humans | #13096 |
| genetic rna | #13096 |
| intrauterine | #13097 |
| measurable | #13120 |
| delayed | #13147 |
| conversely | #13160 |
| schistosomiasis | #13161 |
| differential effects | #13191 |
| strong association | #13209 |
| glucocorticoid | #13217 |
| methodological | #13236 |
| great | #13255 |
| developing countries | #13257 |
| 127 | #13262 |
| consultation | #13264 |
| 276 | #13267 |
| 018 | #13274 |
| proportions | #13279 |
| stimulated | #13297 |
| weaning | #13299 |
| hallmark | #13313 |
| 017 | #13323 |
| manifestations | #13333 |
| gene | #13338 |
| odds ratios | #13351 |
| nucleotide risk | #13354 |
| pediatric | #13397 |
| crp | #13407 |
| initiate | #13419 |
| 11 | #13424 |
| burden | #13446 |
| bowel | #13447 |
| kingdom | #13448 |
| auc | #13449 |
| mechanisms underlying | #13450 |
| 210 | #13457 |
| 20th century | #13476 |
| younger | #13480 |
| secretion | #13500 |
| 129 | #13518 |
| considerable | #13527 |
| 045 | #13543 |
| relevant | #13545 |
| confirm | #13567 |
| beijing | #13578 |
| visits | #13581 |
| 188 | #13602 |
| statistically | #13612 |
| respiratory syncytial | #13621 |
| 1989 | #13652 |
| inheritance | #13663 |
| 181 | #13690 |
| argue | #13695 |
| 020 | #13702 |
| depending | #13723 |
| lavage | #13735 |
| 014 | #13736 |
| pneumonia | #13774 |
| study association | #13782 |
| neighboring | #13790 |
| impairment | #13810 |
| sweden | #13833 |
| schistosoma | #13835 |
| severe | #13852 |
| concerns | #13856 |
| cohorts | #13856 |
| establishing | #13859 |
| genomics humans | #13875 |
| human pair | #13893 |
| ranged | #13900 |
| multiplex | #13937 |
| loci | #13953 |
| membrane glycoproteins | #14048 |
| mental health | #14054 |
| additionally | #14064 |
| chromosomes | #14069 |
| fat mass | #14090 |
| restore | #14107 |
| tendency | #14138 |
| nucleotide polymorphism | #14141 |
| establish | #14142 |
| subgroups | #14166 |
| immigrants | #14182 |
| randomly selected | #14189 |
| examples | #14202 |
| fetal development | #14226 |
| expand | #14234 |
| 183 | #14237 |
| concomitant | #14257 |
| socioeconomic status | #14258 |
| multigene | #14259 |
| disease genome | #14278 |
| refined | #14314 |
| breast | #14318 |
| unsaturated | #14320 |
| addresses | #14337 |
| independently | #14350 |
| health organization | #14355 |
| tightly | #14399 |
| amniotic fluid | #14424 |
| severity | #14432 |
| 121 | #14439 |
| penicillium | #14441 |
| epidemiologic studies | #14443 |
| tuberculosis | #14444 |
| 1 month | #14454 |
| studying | #14492 |
| 007 | #14492 |
| derivation | #14517 |
| tolerance | #14521 |
| contributed | #14529 |
| conclude | #14532 |
| systematically | #14533 |
| elevated | #14573 |
| humans | #14580 |
| factors socioeconomic | #14586 |
| cystic | #14593 |
| stranded | #14599 |
| food intake | #14600 |
| horse | #14606 |
| animals antigens | #14624 |
| 6 | #14638 |
| differentially expressed | #14641 |
| effector cells | #14675 |
| 205 | #14693 |
| striking | #14700 |
| lymphocyte count | #14703 |
| lipopolysaccharide | #14704 |
| filament | #14706 |
| transcription | #14707 |
| representative | #14726 |
| tetradecanoylphorbol | #14755 |
| classify | #14766 |
| trimester | #14772 |
| operate | #14777 |
| represents | #14788 |
| glycoproteins | #14799 |
| maximal | #14801 |
| cells patients | #14821 |
| determines | #14831 |
| 2 years | #14850 |
| seropositivity | #14866 |
| genetic analysis | #14890 |
| mice mice | #14912 |
| 002 | #14917 |
| ancestry | #14925 |
| maternal age | #14929 |
| clostridium | #14981 |
| marker | #14999 |
| ctla4 | #15005 |
| 162 | #15012 |
| ethnic | #15032 |
| male | #15042 |
| receptor | #15068 |
| compared healthy | #15084 |
| modulates | #15087 |
| disparities | #15118 |
| 00001 | #15123 |
| stronger | #15140 |
| p00001 | #15177 |
| luciferase | #15184 |
| gram | #15200 |
| longitudinal studies | #15223 |
| immune cells | #15233 |
| 131 | #15264 |
| hong kong | #15269 |
| cumulative | #15330 |
| copd | #15346 |
| nfkappab | #15356 |
| environmental monitoring | #15362 |
| socioeconomic | #15368 |
| gestational age | #15392 |
| curve | #15407 |
| physician | #15419 |
| integrate | #15467 |
| induce | #15469 |
| assessing | #15476 |
| modulated | #15501 |
| cells dcs | #15509 |
| perinatal | #15516 |
| pregnancy risk | #15527 |
| gonadal | #15550 |
| marked | #15553 |
| 003 | #15556 |
| dysregulation | #15556 |
| feces | #15556 |
| 110 | #15569 |
| built | #15581 |
| archaea | #15621 |
| tgfβ | #15667 |
| cytometry | #15669 |
| controlling | #15688 |
| inflammatory agents | #15708 |
| dietary fats | #15739 |
| cell surface receptors | #15743 |
| igg | #15765 |
| genotype | #15766 |
| il1 | #15772 |
| imply | #15830 |
| pregnant | #15831 |
| exclusive | #15843 |
| developed countries | #15863 |
| 47 | #15874 |
| cells animals | #15894 |
| 116 | #15895 |
| socioeconomic factors | #15901 |
| sensitivity specificity | #15922 |
| reflected | #15966 |
| humans inflammation | #15992 |
| agreement | #16016 |
| varies | #16017 |
| diagnosed | #16043 |
| unrelated | #16046 |
| casecontrol study | #16049 |
| filled | #16050 |
| transient | #16060 |
| conditional | #16084 |
| interleukin1beta | #16103 |
| major | #16105 |
| 12 | #16129 |
| located | #16168 |
| homozygous | #16182 |
| effector | #16208 |
| inducer | #16232 |
| anti inflammatory | #16238 |
| transducing | #16239 |
| psychosocial | #16242 |
| 93 | #16314 |
| born | #16347 |
| dendritic cells | #16365 |
| define | #16372 |
| causing | #16382 |
| bacterial | #16387 |
| 7 | #16394 |
| genome wide | #16420 |
| varied | #16428 |
| squared | #16431 |
| volatile | #16432 |
| 082 | #16433 |
| bacteria | #16447 |
| represented | #16476 |
| height | #16488 |
| ibd | #16518 |
| established | #16536 |
| identifying | #16549 |
| participants | #16561 |
| thought | #16634 |
| triggered | #16636 |
| areas | #16662 |
| broad | #16671 |
| academic | #16675 |
| functionally | #16694 |
| microsatellite | #16697 |
| genetic polymorphism | #16725 |
| characterizing | #16726 |
| 0006 | #16756 |
| dendritic | #16762 |
| centre | #16765 |
| 084 | #16783 |
| distributed | #16795 |
| agricultural | #16798 |
| dead | #16800 |
| nitric oxide | #16855 |
| chromosome | #16895 |
| bowel disease | #16898 |
| personal | #16912 |
| 91 | #16918 |
| 09 | #16918 |
| investigating | #16978 |
| utilize | #16980 |
| opportunities | #17033 |
| promoter | #17034 |
| steroid | #17056 |
| anti bacterial | #17061 |
| dna bacterial | #17074 |
| 81 | #17089 |
| mother | #17091 |
| epigenetic | #17095 |
| continuing | #17105 |
| messenger | #17106 |
| progression | #17115 |
| monocytes | #17130 |
| genotypes | #17190 |
| confirms | #17201 |
| individual | #17225 |
| seasons | #17244 |
| 53 | #17287 |
| untranslated | #17292 |
| denmark | #17301 |
| 137 | #17321 |
| retinoic | #17351 |
| earlier | #17361 |
| drug therapy | #17361 |
| cross | #17377 |
| encountered | #17387 |
| taxonomic | #17423 |
| visible | #17455 |
| strong | #17549 |
| excluding | #17551 |
| tnfalpha | #17598 |
| heterozygote | #17605 |
| alleles | #17619 |
| avoidance | #17647 |
| bronchoalveolar lavage | #17656 |
| bacterial agents | #17666 |
| introduced | #17690 |
| cd4 cells | #17717 |
| dcs | #17724 |
| initiating | #17727 |
| comparing | #17740 |
| newborns | #17784 |
| quantified | #17787 |
| regression | #17798 |
| lesser | #17810 |
| geographical | #17857 |
| interviewed | #17866 |
| 84 | #17903 |
| covering | #17927 |
| prospective | #17949 |
| bmi | #17963 |
| animals | #17994 |
| 009 | #18003 |
| drawn | #18014 |
| disease chronic | #18024 |
| longitudinal | #18047 |
| particulate | #18073 |
| monthly | #18086 |
| 77 | #18100 |
| altered | #18146 |
| 085 | #18150 |
| publication administration | #18171 |
| children adolescents | #18178 |
| snp | #18187 |
| neurotrophic | #18224 |
| systemic lupus erythematosus | #18235 |
| samples | #18263 |
| restriction fragment | #18268 |
| negative | #18269 |
| dismutase | #18321 |
| susceptibility | #18324 |
| demographics | #18339 |
| recognize | #18347 |
| inflammatory responses | #18460 |
| inflammatory bowel disease | #18499 |
| chemokines | #18511 |
| served | #18518 |
| difference | #18526 |
| mast cell | #18536 |
| 148 | #18545 |
| replication | #18548 |
| exists | #18580 |
| immunization | #18589 |
| remain | #18590 |
| intervals | #18593 |
| secretory | #18604 |
| carried | #18634 |
| fold | #18655 |
| provided | #18675 |
| 83 | #18683 |
| 36 | #18709 |
| symptom | #18710 |
| differentially | #18718 |
| variation genome | #18742 |
| rise | #18757 |
| weight | #18797 |
| epithelial cells | #18798 |
| sum | #18807 |
| candidate | #18807 |
| additional | #18812 |
| immunophenotyping | #18818 |
| families | #18838 |
| basis | #18843 |
| 1997 | #18843 |
| 28 | #18854 |
| maintain | #18856 |
| variants | #18858 |
| 13 | #18882 |
| fragment length | #18919 |
| missing | #18966 |
| lower | #18985 |
| sampling | #19004 |
| receptors cell | #19024 |
| intake | #19030 |
| vitamin | #19034 |
| experiencing | #19122 |
| susceptible | #19133 |
| fats | #19173 |
| balb mice | #19208 |
| crosssectional study | #19250 |
| c57bl mice | #19256 |
| promoter regions | #19283 |
| polymerase | #19291 |
| locus | #19302 |
| clinical presentation | #19308 |
| 1992 | #19352 |
| contributes | #19382 |
| termed | #19414 |
| trait loci | #19415 |
| mouse model | #19415 |
| clear | #19476 |
| partially | #19504 |
| completely | #19506 |
| elucidate | #19510 |
| socio | #19512 |
| × 10 | #19521 |
| pollutants | #19552 |
| validated | #19554 |
| necrosis | #19582 |
| illustrate | #19602 |
| lasting | #19718 |
| time polymerase | #19720 |
| healthrelated quality | #19789 |
| polymerase chain | #19797 |
| 1998 | #19855 |
| inbred balb mice | #19855 |
| chronic obstructive | #19868 |
| 5 years | #19869 |
| selecting | #19937 |
| carrying | #19967 |
| baseline | #19977 |
| context | #19977 |
| negatively | #19998 |
| 95 confidence interval | #20023 |
| inbred balb | #20051 |
| interferon gamma | #20056 |
| easy | #20065 |
| acetaminophen | #20066 |
| shared | #20130 |
| 74 | #20150 |
| 64 | #20157 |
| health | #20163 |
| activates | #20164 |
| summary | #20181 |
| reporter | #20212 |
| serological | #20244 |
| adjusting | #20271 |
| 1 year | #20289 |
| interacting | #20295 |
| autoimmune diseases | #20301 |
| 61 | #20339 |
| stimulation | #20363 |
| 14 | #20418 |
| identifies | #20457 |
| demonstrating | #20473 |
| 2003 | #20528 |
| humans longitudinal | #20557 |
| returned | #20566 |
| ratio | #20593 |
| 26 | #20613 |
| inflammatory | #20615 |
| interactions | #20618 |
| behavior female | #20629 |
| nitric | #20636 |
| chain reaction | #20655 |
| upregulated | #20694 |
| highest | #20707 |
| genetically | #20746 |
| immunologic | #20771 |
| recurrent | #20779 |
| cells female | #20794 |
| interleukin | #20806 |
| wide | #20813 |
| clarify | #20844 |
| blood | #20864 |
| 51 | #20870 |
| cd4 cell | #20884 |
| rodents | #20894 |
| infectious | #20895 |
| causal | #20898 |
| create | #20974 |
| mucosal | #20983 |
| named | #20988 |
| obstructive | #20991 |
| interval | #21015 |
| suggesting | #21054 |
| 59 | #21130 |
| hereditary | #21187 |
| identical | #21192 |
| followup | #21199 |
| regulation | #21207 |
| epithelial cell | #21236 |
| essentially | #21325 |
| kappab | #21354 |
| variety | #21563 |
| mast | #21565 |
| celiac disease | #21617 |
| infection | #21622 |
| endpoint | #21718 |
| tumor necrosis | #21799 |
| reduced | #21829 |
| 10 years | #21837 |
| measures | #21851 |
| stress psychological | #21874 |
| alterations | #22024 |
| definitive | #22102 |
| assess | #22118 |
| continued | #22161 |
| correlate | #22201 |
| familial | #22235 |
| ensure | #22257 |
| frequency | #22288 |
| abolished | #22332 |
| continental ancestry | #22431 |
| reflecting | #22432 |
| unchanged | #22438 |
| validation | #22455 |
| score | #22546 |
| frequent | #22558 |
| tumor necrosis factor | #22615 |
| 95 confidence | #22620 |
| balb | #22645 |
| closely | #22684 |
| genes | #22753 |
| coupled | #22803 |
| continuously | #22829 |
| reactive | #22841 |
| indicating | #22843 |
| comparable | #22875 |
| murine | #22957 |
| 22 | #22977 |
| neonatal | #22988 |
| supported | #23008 |
| introduce | #23009 |
| type 1 | #23013 |
| report | #23048 |
| ifnγ | #23104 |
| necrosis factor | #23137 |
| predict | #23148 |
| lived | #23179 |
| increasingly | #23205 |
| rich | #23217 |
| count | #23292 |
| smoking | #23305 |
| modulating | #23348 |
| late | #23357 |
| mechanisms | #23394 |
| confidence | #23438 |
| 1 | #23526 |
| young | #23528 |
| adjustment | #23611 |
| exclude | #23665 |
| endopeptidases | #23709 |
| adolescents | #23720 |
| factors united | #23849 |
| defined | #23927 |
| extensive | #23929 |
| body | #24002 |
| dietary | #24027 |
| intracellular | #24110 |
| 5 | #24167 |
| 3 | #24232 |
| lymphocytes | #24242 |
| aimed | #24342 |
| increasing | #24355 |
| symptomatic | #24455 |
| depend | #24530 |
| reduces | #24548 |
| interaction | #24609 |
| collected | #24626 |
| adults | #24658 |
| remains | #24734 |
| needed | #24798 |
| responsible | #24851 |
| rsv | #24888 |
| 15 | #24969 |
| putative | #25032 |
| identification | #25068 |
| enrolled | #25223 |
| representing | #25239 |
| yielded | #25263 |
| determine | #25273 |
| extracellular | #25281 |
| analysis performed | #25297 |
| sex factors | #25359 |
| documented | #25522 |
| anti | #25535 |
| describing | #25574 |
| comprised | #25660 |
| matter | #25795 |
| transcriptase polymerase | #25871 |
| continue | #25896 |
| lymphocyte | #25994 |
| decreased | #26047 |
| enabling | #26157 |
| diminished | #26261 |
| previous | #26271 |
| healthy | #26310 |
| 16 | #26319 |
| profiling gene | #26374 |
| implicated | #26377 |
| dioxide | #26380 |
| inflammation | #26386 |
| tended | #26519 |
| applied | #26644 |
| contained | #26780 |
| describes | #26787 |
| generally | #26891 |
| multivariate | #26969 |
| capable | #27003 |
| unaffected | #27064 |
| presenting | #27110 |
| moderate | #27144 |
| 18 | #27195 |
| heterozygous | #27203 |
| acquired | #27213 |
| oligonucleotide | #27226 |
| concluded | #27331 |
| undergone | #27359 |
| topic | #27376 |
| proteins signal | #27393 |
| reached | #27432 |
| large | #27637 |
| recognized | #27654 |
| positive lymphocytes | #27691 |
| 001 | #27802 |
| linked | #27832 |
| preschool female | #27932 |
| models genetic | #27987 |
| predicted | #28046 |
| 0005 | #28071 |
| subsequently | #28087 |
| quantitative | #28099 |
| respect | #28131 |
| represent | #28157 |
| impaired | #28234 |
| reverse transcriptase | #28434 |
| continental | #28581 |
| plays | #28633 |
| positive | #28648 |
| immunoenzyme | #28655 |
| occurring | #28707 |
| screened | #28708 |
| square distribution | #28750 |
| transcriptase | #29017 |
| quantitative trait | #29137 |
| versus | #29158 |
| allowed | #29194 |
| comparison | #29267 |
| affect | #29339 |
| administered | #29469 |
| easily | #29520 |
| human | #29690 |
| weak | #29736 |
| possess | #29786 |
| physical | #29792 |
| pair | #29885 |
| correlated | #29909 |
| chain | #29911 |
| characterize | #29984 |
| gastrointestinal | #30316 |
| providing | #30537 |
| 005 | #30590 |
| aims | #30608 |
| factual | #30658 |
| 2 | #30659 |
| confirmed | #30719 |
| markedly | #30761 |
| 4 | #30907 |
| eligible | #31311 |
| fatty | #31332 |
| upper | #31437 |
| frequently | #32564 |
| mice knockout | #32696 |
| predictive tests | #32836 |
| peripheral | #32944 |
| humanized | #33092 |
| expression | #33163 |
| registered | #33261 |
| functional | #33617 |
| dominated | #33759 |
| selected | #33999 |
| mediated | #34372 |
| independent | #34407 |
| activate | #34542 |
| acids | #34703 |
| occur | #34769 |
| mediate | #35225 |
| conducted | #35568 |
| national | #35610 |
| evaluate | #35821 |
| 0001 | #35859 |
| developed | #36145 |
| characterized | #36394 |
| measurements | #36573 |
| express | #37054 |
| measured | #37778 |
| follow studies | #37967 |
| appears | #37978 |
| biological | #38141 |
| examined | #38373 |
| include | #39853 |
| adult | #39859 |
| clinically | #40140 |
| united | #42200 |
| mice inbred | #42559 |
| consistent | #42590 |
| excluded | #42832 |
| expression regulation | #43143 |
| inbred | #45657 |
Bericht ausführen | |
Prominent publications by Erika RM von Mutius
KOL-Index: 23349
BACKGROUND: Exposure to paracetamol during intrauterine life, childhood, and adult life may increase the risk of developing asthma. We studied 6-7-year-old children from Phase Three of the International Study of Asthma and Allergies in Childhood (ISAAC) programme to investigate the association between paracetamol consumption and asthma.
METHODS: As part of Phase Three of ISAAC, parents or guardians of children aged 6-7 years completed written questionnaires about symptoms of asthma, ...
| Bekannt für Risk Asthma | 7 Years | Year Life | Children Aged | Rhinoconjunctivitis Eczema |
KOL-Index: 18397
BACKGROUND: Phase III of the International Study of Asthma and Allergies in Childhood measured the global prevalence of symptoms of asthma, rhinoconjunctivitis, and eczema in children.
OBJECTIVE: To investigate the associations between the use of antibiotics in the first year of life and symptoms of asthma, rhinoconjunctivitis, and eczema in children 6 and 7 years old.
METHODS: Parents or guardians of children 6 and 7 years old completed written questionnaires on current symptoms and ...
| Bekannt für International Study | Rhinoconjunctivitis Eczema | Year Life | Symptoms Asthma | 95 Risk Factors |
Phenotypes of Atopic Dermatitis Depending on the Timing of Onset and Progression in Childhood
[ PUBLICATION ]
Importance: Atopic dermatitis is an inflammatory, pruritic skin disease that often occurs in early infancy with a chronic course. However, a specific description of subtypes of atopic dermatitis depending on the timing of onset and progression of the disease in childhood is lacking.
Objective: To identify different phenotypes of atopic dermatitis using a definition based on symptoms before age 6 years and to determine whether some subtypes are more at risk for developing other allergic ...
| Bekannt für Atopic Dermatitis | 6 Years | Age Children | Allergic Diseases | Food Allergy |
KOL-Index: 17686
BACKGROUND: Associations between exposure to cats and dogs and respiratory and allergic outcomes in children have been reported in affluent countries, but little is known about such associations in less-affluent countries.
METHODS: The International Study of Asthma and Allergies in Childhood, phase 3 was carried out in children aged 6-7 years and adolescents aged 13-14 years across the world. Questions about cats and dogs in the home were included in an additional questionnaire. Using ...
| Bekannt für Cats Dogs | Asthma Rhinoconjunctivitis | Affluent Countries | Children Adolescents | International Study |
KOL-Index: 15451
BACKGROUND: There is increasing evidence that environmental exposures determining childhood illnesses operate early in life. Prenatal exposure to a farming environment through the mother might also play an important role.
OBJECTIVE: We sought to investigate the role of maternal exposures to environments rich in microbial compounds for the development of atopic sensitization, asthma, and corresponding alterations in the innate immune system in offspring.
METHODS: In the children of the ...
| Bekannt für Atopic Sensitization | Innate Immunity | Farm Exposure | Microbial Compounds | Expression Receptors |
Perennial allergen sensitisation early in life and chronic asthma in children: a birth cohort study
[ PUBLICATION ]
BACKGROUND: Reduced lung function is a feature of chronic asthma, which becomes apparent at school age. Unknown factors between birth and school age determine the progressive loss of pulmonary function in children with persistent asthma. We investigated the role of allergic sensitisation and allergen exposure early in life.
METHODS: The German Multicentre Allergy Study followed 1314 children from birth to 13 years of age. We regularly interviewed parents about their child's asthma and ...
| Bekannt für Chronic Asthma | School Age | Life Children | Birth Cohort | Allergen Exposure |
Prevalence of asthma and allergic disorders among children in united Germany: a descriptive comparison.
[ PUBLICATION ]
OBJECTIVES: To compare the prevalence of asthma and allergic disorders among children in Munich, western Germany, and Leipzig, eastern Germany, where environmental exposure, particularly air concentrations of sulphur dioxide and particulate matter, and living conditions have differed over the past 45 years.
DESIGN: Prevalence surveys among school-children aged 9-11 years in Leipzig and Munich. Self completion of written questionnaire by the children's parents and lung function ...
| Bekannt für Allergic Disorders | Munich Leipzig | Prevalence Asthma | Seasonal Surveys | Living Conditions |
KOL-Index: 14833
BACKGROUND: Asthma is a complex disease that has genetic and environmental causes. The genetic factors associated with susceptibility to asthma remain largely unknown.
METHODS: We carried out a genomewide association study involving children with asthma. The sample included 793 North American children of European ancestry with persistent asthma who required daily inhaled glucocorticoid therapy and 1988 matched controls (the discovery set). We also tested for genomewide association in an ...
| Bekannt für European Ancestry | Association Asthma | Single Nucleotide Receptors | Tumor Necrosis Factor | Human Pair |
Early life exposure to farm animals and symptoms of asthma, rhinoconjunctivitis and eczema: an ISAAC Phase Three Study
[ PUBLICATION ]
BACKGROUND: Associations between early life exposure to farm animals and respiratory symptoms and allergy in children have been reported in developed countries, but little is known about such associations in developing countries.
OBJECTIVE: To study the association between early life exposure to farm animals and symptoms of asthma, rhinoconjunctivitis and eczema in a worldwide study.
METHODS: Phase Three of the International Study of Asthma and Allergies in Childhood (ISAAC) was carried ...
| Bekannt für Farm Animals | Asthma Rhinoconjunctivitis | Isaac Phase | Early Life | Affluent Countries |
KOL-Index: 14598
The German reunification offers a unique opportunity to study the impact of environmental factors on the development of childhood respiratory and allergic disorders in ethnically similar populations. We investigated the prevalence of asthma, hay fever, atopy, and bronchial hyperresponsiveness (BHR) in 9- to 11-year old children in West Germany (n = 5,030) and East Germany (n = 2,623). A self-administered questionnaire was distributed to the parents. Children underwent cold air challenge ...
| Bekannt für East Germany | Asthma Fever | Prevalence Bhr | Environmental Factors | Atopic Sensitization |
Phase II of the International Study of Asthma and Allergies in Childhood (ISAAC II): rationale and methods
[ PUBLICATION ]
International comparative studies, investigating whether disease incidence or prevalence rates differ between populations and, if so, which factors explain the observed differences, have made important contributions to the understanding of disease aetiology in many areas. In Phase I of the International Study of Asthma and Allergies in Childhood (ISAAC), the prevalence rates of symptoms of asthma, allergic rhinitis and atopic eczema in 13-14-yr-olds, assessed by standardised ...
| Bekannt für International Study | Asthma Allergies | Prevalence Rates | Atopic Eczema | Childhood Isaac |
KOL-Index: 13844
BACKGROUND: Mutations in the filaggrin gene (FLG) have been shown to play a significant role in ichthyosis vulgaris and eczema, 2 common chronic skin diseases. However, their role in the development of other atopic diseases such as asthma and rhinitis has not yet been clarified in large population-based studies.
OBJECTIVES: To study the effect of FLG mutations at the population level and their effect on other atopic phenotypes.
METHODS: Association analysis of the 2 common FLG-null ...
| Bekannt für Filaggrin Mutations | Atopic Eczema | Allergic Rhinitis Asthma | Role Development | Disease Genotype Humans |
Increased food diversity in the first year of life is inversely associated with allergic diseases
[ PUBLICATION ]
BACKGROUND: The role of dietary factors in the development of allergies is a topic of debate, especially the potential associations between infant feeding practices and allergic diseases. Previously, we reported that increased food diversity introduced during the first year of life reduced the risk of atopic dermatitis.
OBJECTIVE: In this study we investigated the association between the introduction of food during the first year of life and the development of asthma, allergic rhinitis, ...
| Bekannt für Food Diversity | Allergic Diseases | Year Life | Development Asthma | Atopic Sensitization |
Schlüsselpersonen für Atopic Dermatitis
Top -Kols der Welt
Wählen Sie einen Suchphrase aus atopic dermatitis , atopic dermatitis patients , atopic dermatitis psoriasis , atopic dermatitis children , atopic dermatitis asthma
Erika RM von Mutius:Expertenwirkung
Konzepte für welcheErika RM von Mutiushat direkten Einfluss:Atopic dermatitis, Childhood asthma, Allergic diseases, Atopic sensitization, Allergic rhinitis, International study, Farm milk, East germany.
Erika RM von Mutius:KOL -Auswirkungen
Konzepte im Zusammenhang mit der Arbeit anderer Autoren, für diefor which Erika RM von Mutius hat Einfluss:Atopic dermatitis, Allergic rhinitis, Childhood asthma, Food allergy, Lung function, Air pollution, Early life.
Tools
Ist das dein Profil? Fordern Sie Ihr Profil an URL kopieren Einbetten Sie den Link zu Ihrem Profil ein |